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Q fever infections
History of Q fever  
Eighty years ago, in 1935, the Australian pathologist Edward Holbrook Derrick was 
the first to describe Q fever after an outbreak of febrile illness among abattoir work-
ers in Brisbane, Queensland, Australia[7]. To avoid negative associations with either 
the cattle industry or Queensland, the name Query (Q) fever was chosen over ‘abat-
toir fever’ or ‘Queensland rickettsial fever’[8]. Two years later, Frank Macfarlane 
Burnet and Mavis Freeman isolated the bacterium from one of Derrick’s patients, 
and named it Rickettsia burnetii[9, 10]. At the same time, two American scientists, 
Herald Rea Cox and Gordon Davis isolated the same bacterium from a tick found 
at the Nine Mile Creek in Montana, USA[11]. In 1948, R. burnetii was classified into 
a new genus, Coxiella[12]. Even though the causative agent was now known, the 
‘temporary’ given name Q fever remained. 
 
Bacteriology
Coxiella burnetii is a small (0.3 - 1.0 µm) intracellular Gram-negative bacterium. 
Phylogenically, it is classified in the order of Legionellales and based on its 16S 
rRNA, it falls in the gamma group of the Proteobacteria[13]. C.  burnetii can be 
cultured from animal and human samples using cell culture, embryonated eggs or 
under the more recently described axenic (host cell-free) culture conditions[14]. Due 
to the formation of a spore-like form, C. burnetii is highly resistant to harsh environ-
mental conditions such as high temperature and ultraviolet light[15]. C. burnetii has 
two distinct morphological forms; a metabolically inactive extracellular small cell 
variant (SCV) that provides C. burnetii its resistant characteristics, and a large cell 
variant (LCV) which is the intracellular metabolically active form[16]. Its strong resis-
tant character together with its extreme infectivity, classified C. burnetii as a group B 
bioterrorism agent by the Centers for Disease Control and Prevention in the USA[17]. 
The circular genome of C. burnetii is 1.995.275 base pairs long and comprises a 
facultative 33- to 42-kb plasmid. Four plasmid types have been described, QpH, 
QpRS, QpDG and QpDV, and some bacteria are plasmidless[18-20].  
 
One of the major features of C. burnetii is the antigenic variation of its lipopolysac-
charide (LPS), known as phase variation. In natural conditions, the virulent phase 
The Gram-negative bacterium Coxiella burnetii is the causative agent of Q fever 
in both humans and animals. The world largest Q fever outbreak occurred in the 
Netherlands between 2007 and 2010, with more than 4.000 reported acute human 
Q fever cases. However, seroprevalence studies show that at least 40.000 indivi- 
duals were infected with C. burnetii[1, 2]. The outbreak started in the spring of 2007 
when six individuals with acute Q fever were admitted to the hospital with signs of 
pneumonia. At the end of 2007, a total of 168 acute Q fever cases were reported; 
a huge increase compared to the annual average of 30 human cases in the years 
before 2007. At first, the outbreak was thought to be an isolated incident, but the 
number of human cases increased to 1000 in 2008 and even to 2354 in 2009[3]. 
By then, evidence was found that persons living close to a dairy goat farm with 
recent abortion problems or individuals who had been in close contact with goat 
lambs were at higher risk to become infected[4, 5]. These findings pointed to dairy 
goat farms with Q fever-induced abortions as the main source of the Dutch human 
Q fever outbreak[6]. By the end of 2012, Dutch authorities declared the Q fever 
outbreak to be over, after about 60.000 pregnant goats had been culled and the 
remaining dairy goats had been given mandatory vaccination additional to hygienic 
measures, a transport ban and a breeding ban[5].
The magnitude of the outbreak led to many concerns and unanswered questions, 
and research was deemed necessary. In the past years, over 20 projects have 
been executed to expand the expertise and knowledge about Q fever. The research 
presented in this thesis focuses on the recognition of C.  burnetii by the human 
and goat immune system. This introductory chapter gives an overview about the 
C. burnetii bacterium and Q fever infections, provides information about the immu-
nology of Q fever infections and describes the aim and outline of the project in 
more detail. 
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Differentiation of isolates is extremely important for both epidemiology and diag-
nosis of C.  burnetii. When examined only by 16S RNA, C.  burnetii isolates show 
considerable genetic homogeneity[33]. Restriction fragment length polymor-
phism and microarray whole genome comparison identified six distinct genomic 
groups (I to VI)[34, 35]. A useful tool for typing C. burnetii is multiple locus variable 
number tandem repeats analysis (MLVA). In the Dutch outbreak, MLVA typing of 
patient samples and material from farms with abortion problems due to C. burnetii 
revealed that one predominant genotype was responsible for clinical disease in 
humans and goats[36, 37]. Apparently, some C.  burnetii isolates have a certain 
predilection to infect specific hosts only, explaining the low number of humans 
infected by C. burnetii from cattle. Overall, different C. burnetii isolates can have a 
diverse genetic background and they can have a different preference of hosts. It 
can be questioned whether these differences of C. burnetii isolates can result in 
the different clinical manifestations found in humans and goats upon infection.   
Clinical manifestations
Goat
Observations in the field and during experimental infections clearly show C. burnetii 
as a cause of abortion and stillbirth, mainly at the end of the gestation. Despite 
of this serious clinical outcome, infection with C. burnetii does not result in any 
preceding clinical symptoms as seen in infected humans[38-41]. Metritis, inflam-
mation of the endometrium of the uterus, can be present in dairy goat herds where 
Q fever abortions occurred. The offspring of C. burnetii-infected goats can have a 
low body weight and high mortality. Furthermore, nurturing of apparently healthy 
kids can be difficult due to digestive tract and respiratory disorders[42]. 
During an infection, the trophoblasts of the allantochorion are the target cells 
of C.  burnetii and replication of the bacterium occurs in these cells[43]. During 
abortions of infected goats, up to 109 organisms per gram placenta tissue are 
excreted, leading to a massive spread into the environment[38]. In both abort-
ing and non-aborting goats, C.  burnetii DNA has been detected in milk, vaginal 
mucus and/or feces[39]. The shedding of bacteria can also occur in subsequent 
pregnancies[44].
I LPS is found, which corresponds with smooth LPS as found in the Enterobacte-
riaceae family[21, 22]. Unique for C. burnetii phase I LPS is the presence of galac-
tosaminuronyl-α-glucosamide disaccharide, virenose and dihydrohydroxystreptose 
in the O-chain[23]. After multiple passages under laboratory conditions, modifica-
tion of the LPS can occur, resulting in an antigenic shift to the non-virulent phase II 
LPS. This phase variation is due to chromosomal deletions involving a large group 
of LPS biosynthesis genes, arranged in the O-antigen cluster[24-26]. The LPS of 
C. burnetii is an important virulence factor, however in comparison with e.g. Entero-
bacteriaceae LPS the endotoxic activity of both C. burnetii phase I and phase II LPS 
is 100 to 1000 times less[27]. 
Epidemiology
C. burnetii can infect a wide range of insects and animals such as marine wildlife, 
ticks, stellar sea lions, cats, horses and birds[21, 28, 29], but domestic ruminants 
and their products are the main route for human exposure[18]. In most animals, 
infection with C. burnetii does not result in disease. Exceptions are goats and sheep 
where infection can result in late-term abortion. Mammals excrete the bacteria 
through their urine, feces, milk and birth products like placenta and amniotic fluid. 
These products contain high loads of C. burnetii and can persist in the environment 
for years[30]. Facilitated by windy, warm and dry weather, contaminated aerosols 
are able to travel up to 5km[30]. Analysis of commercial available cow milk and 
other milk products revealed a high prevalence of C. burnetii among dairy cattle 
population worldwide. Also, the genotypes of C.  burnetii found in the consumer 
milk products were highly similar and could indicate a possible clonal spread of 
C. burnetii among the European dairy cattle population[31]. However, this genotype 
is only incidentally found in humans, suggesting that the risk of obtaining Q fever 
is much lower via exposure to infected cattle than infected small ruminants[31]. 
Infected goats and sheep experience abortions which result in large spread of 
C. burnetii, while cattle do not show this symptom. In 2012, a large review study 
was conducted in which among others the prevalence of C. burnetii in goats, sheep 
and cattle was investigated[32]. It revealed that in most outbreaks, infection of 
humans occurred via infected domestic small ruminants, i.e. goats or sheep. In 
contrast, no evidence was found of a major contribution of cattle in the history of Q 
fever in humans in the four studied countries (the Netherlands, Germany, Bulgaria 
and France)[32]. It has not been described that C. burnetii can be transmitted from 
human to human.
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Q fever fatigue syndrome  
Up to 60% of the individuals with a past acute Q fever infection suffer from post-in-
fection fatigue symptoms[6]. For example, a study among 85 patients from the 
Netherlands with acute Q fever showed that 52% of the individuals had persistent 
symptoms, in particular fatigue, at six months after disease onset. Furthermore, 
after one year, 25% still had complaints[50]. A second Dutch study among 515 
acute Q fever patients revealed that 20% had severe fatigue and an impaired health 
status at 12–26 months of follow-up[51]. The fatigue following acute Q fever has 
been named Q fever fatigue syndrome (QFS)[52]. Based on the published Dutch 
algorithm, QFS can be diagnosed when there is a severe fatigue for at least six 
months after an identified acute Q fever infection. The fatigue must have been 
absent before the episode of acute Q fever and it must cause significant disabili-
ties in the daily life of the patient. Also, at least, chronic Q fever or other causes of 
fatigue, like somatic or physical problems, need to be excluded[52]. At the moment 
a randomized placebo-control trial which compares cognitive behavioral ther-
apy, long-term doxycycline and placebo therapy is ongoing and will fill the gap of 
evidenced-based recommendations for the treatment of QFS[53]. 
Immunology of Q fever infections
 
From the host point of view, the recognition of C. burnetii by the immune system 
plays an important role in the development of the infection. An important ques-
tion is how the immune system recognizes C. burnetii in humans and goats. As 
described in the previous section, goats and humans display a diverse clinical 
outcome upon C. burnetii infection. Furthermore, there is a wide variety in the symp-
toms of humans infection. One of the research aims of this thesis is to examine the 
immune response against C. burnetii in humans and goats. More knowledge about 
the recognition of C. burnetii by important pattern recognition receptors (PRRs) and 
the induction of cytokine responses, could provide answers to the different clinical 
symptoms observed in goats and human, and among infected humans. In the next 
few paragraphs we briefly review what is known about the immunology in goats 
and human during Q fever infection.
Human
Primary infection (asymptomatic and acute Q fever)  
In most of the infected individuals (60%), the clinical signs of Q fever infection are 
subclinical or very mild. The incubation period is approximately 20 days, and when 
the infected individual starts to develop symptoms it is referred to as acute Q fever. 
Acute Q fever usually presents itself as a self-limited flu-like syndrome which is 
characterized by fever, pulmonary symptoms, fatigue and headache. Often there 
are also signs of hepatitis[10, 21, 45]. Even though most acute Q fever infections 
resolve spontaneously and only a small minority (2%) of the patients need to be 
hospitalized, antibiotic treatment is recommended. In the Netherlands, doxycycline 
(200mg daily for 14 days) is described to reduce the duration of the symptoms in 
case an acute Q fever is suspected or confirmed[46, 47].
Chronic Q fever  
Several months to years after the initial infection, chronic Q fever develops in 2-5% 
of the infected individuals[18]. Individuals with cardiac valve abnormalities or an 
aneurysm or vascular reconstruction have an increased risk to develop chronic Q 
fever[18]. Endocarditis and vascular infections (aortic aneurysm or vascular pros-
thesis infection) are frequently described manifestations. Other less common char-
acterizations of chronic Q fever include lung infections, hepatitis and osteomyeli-
tis[47]. It is problematic to diagnose chronic Q fever, as it is based on the presence 
of symptoms, risk factors, detection of C. burnetii in blood, serological test results 
and diagnostic imaging. Therefore, during the Dutch Q fever outbreak, the Dutch Q 
fever Consensus group proposed a guideline to categorize chronic Q fever patients 
into three categories: proven, probable and possible. The guideline on these chronic 
Q fever diagnostics were nicely depicted by Wegdam-Blans et al.[48]. Independent 
of the category, all chronic Q fever patients need frequent monitoring consisting of 
clinical and microbiological follow-ups every three months. Chronic Q fever patients 
are preferably treated with a combination of doxycyline and hydroxychloroquine for 
at least 18-24 months[47]. The mortality of chronic Q fever is 25%, and can reach 
up to 60% when left untreated[49]. Up to now it is unknown what factors determine 
the switch from a primary infection to chronic Q fever. Therefore, we are unable to 
predict which patients are likely to develop chronic Q fever and we are unable to 
prevent this. For this reason, the current practice is to follow all patients clinically 
for at least one year. Diagnosis of chronic Q fever is difficult and treatment is prob-
lematic due to the long duration of therapy which can be unsuccessful in the end.  
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Human
Antibodies
The antibody response against C. burnetii develops approximately seven to fifteen 
days after the symptom onset[21, 47]. Several techniques can be used to measure 
C.  burnetii antibodies: indirect immunofluorescence assay (IFA), enzyme-linked 
immunosorbent assay (ELISA) and complement fixation test (CFT)[21]. During 
acute Q fever, IgM phase II antibodies will appear almost immediately, subsequently 
IgM phase I and IgG phase II will present simultaneously and finally IgG phase I will 
appear[61]. C. burnetii infection in humans leads to a transition of phase II anti-
gens to phase I antigens; during an acute or recent infection anti-bodies against 
phase II are most present, while phase I antibodies predominate during chronic 
infections[62].
Complement system  
Not many studies have focused on the role of complement activation by C. burnetii. 
Thirty years ago it was demonstrated that the virulent phase I LPS was serum resis-
tant and poorly activated the complement system, while phase II LPS was killed by 
complement factors in human serum and activated the alternative pathway[63]. 
The complement system is important for antibody-mediated immunity against 
many bacterial pathogens, however of none of the three complement pathways 
play an essential role in antibody-mediated immunity to C. burnetii[64].
 
Pattern recognition receptors
TLR4 is mostly expressed by macrophages and dendritic cells and its main ligand 
is LPS from Gram-negative bacteria[65]. C. burnetii phase I possesses tetra-acy-
lated LPS, which in other bacteria like Rhodobacter sphaeroides or the lpxL2 mutant 
of Neisseria meningitides H44/76 is found to be a very weak cytokine inducer and 
can even act as a TLR4 antagonist[66-68]. In humans there is no role of TLR4 in 
mediating in vitro cytokine production by PBMCs, however TLR4 knockout mice 
exhibited a defect in cytokine production and granuloma formation[69, 70].   
 
TLR2 can be found on a large range of cells of the immune system, i.e. monocytes, 
macrophages and antigen presenting cells[71]. It binds many ligands, like bacterial 
lipoproteins, peptidoglycan from Gram-positive bacteria and lipoarabinomannan 
from the mycobacterial cell-wall[72]. Studies in mice, reporter cell-lines and human 
The immune system  
The immune system can be divided into the innate immune response versus the 
adaptive immune response. Innate immunity is an ancient form of host defense 
as it is also found in plants and insects, which becomes active in the first minutes 
to hours after exposure to micro-organisms[54]. In contrast to the innate immune 
response, the later responding adaptive immune response is highly specific to the 
invading pathogen and can provide long-lasting protection due to the formation 
of memory. The major components of the innate immune system include epi- 
thelial barriers, soluble molecules (complement proteins, cytokines, and natural anti- 
bodies), phagocytes (macrophages and neutrophils), and pattern recognition 
receptors (PRRs)[55]. The main cells of the adaptive immune system are lympho-
cytes (B- and T-cells), antigen-presenting cells and effector cells. Micro-organisms 
express unique pathogen-associated molecular patterns (PAMPs) on their surfaces 
which are recognized by PRRs of the host immune cells to activate host-defense 
mechanisms, such as phagocytosis and cytokine signaling[56]. Important PRRs 
involved in recognition of bacteria are Toll-like receptors (TLRs; TLR1, TLR2, TLR4, 
and TLR6) and Nucleotide- binding oligomerization domain receptor 1 and 2 (NOD1 
and NOD2).
Part of the humoral innate immune system is the complement system, which can 
be activated via three main pathways: the classical, lectin and alternative pathway. 
The classical pathway is initiated when the specific immunoglobulins IgM or IgG 
form clusters after recognition of an antigen on the surface of the bacterium, and 
is therefore often referred to as antibody-dependent. The lectin pathway is acti-
vated when mannose-binding lectin (MBL) or ficolins bind to certain sugars on the 
surface of bacteria. The alternative pathway is initiated by many bacteria, viruses 
and fungi, by the activation of factor-D[57-59]. All three pathways eventually lead to 
the activation of complement factor-3 (C3). Subsequently C5 convertase is formed 
and cleaved into the anaphylatoxin C5a and C5b. In the end, this last fragment 
binds to C6, C7, C8 and C9, resulting in the formation of the terminal complement 
complex (TCC)[58, 60]. Formation of TCC leads to the induction of among others, 
pro-inflammatory cytokines and cell lysis. 
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on pregnancy. Most of the research is performed on pregnant goats, as abortion 
is one of the most important clinical presentations of Q fever infection. In preg-
nant woman, adverse pregnancy outcome has also been associated with Q fever 
infection[21]. However, no evidence was found for this adverse effect during the 
Dutch Q fever outbreak[85]. In both goats and humans, the initial Q fever infection 
is mainly asymptomatic. Goats do not show any clinical symptoms during infec-
tion until abortion occurs. In humans, 60% of the infected individuals do not suffer 
from any clinical symptoms and the remaining 40% develop acute Q fever which is 
often self-limiting. On the contrary, a majority of the infected goats eventually abort 
or have a still birth, while only 1-5% of the infected humans will develop the more 
severe chronic Q fever. In goats, we know that the thropoblasts in the allantocho-
rion of the placenta are the primary target cells for C. burnetii. In contrast, in chronic 
Q fever patients the bacteria can be found surrounding the heart valve where it 
accumulates and forms septic matter. These differences in clinical outcome 
percentages may be explained by the initial recognition of C. burnetii by the hosts 
immune cells. It can be hypothesized that a decreased initial recognition of the Q 
fever bacterium leads to an attenuated innate immune response and evasion of the 
host defense against infection. 
Objective and outline of this thesis
The aim of this thesis is to assess how C.  burnetii is recognized and induces 
immune system responses in goats and humans, in order to determine whether 
insufficient immune recognition and response lead to persistence and abortion 
in goats and chronic disease in humans. The interplay between C.  burnetii and 
the host immune system is an essential factor in the invasion and persistence of 
C. burnetii. Up to now, it is unclear how C. burnetii evades the immune system of 
goats and humans and is able to survive in these hosts. In order to elucidate how 
C. burnetii evades the immune system, more basic knowledge is needed about the 
innate immune response upon C.  burnetii infection. However, investigations are 
hindered by several factors: In goats, the problem is that carriership is asympto- 
PBMCs have demonstrated TLR2 as an important regulator of immune responses 
against C. burnetii[69, 73-75]. The TLR2 receptor is able to form heterodimers with 
either TLR1 or TLR6; TLR1/TLR2 heterodimers mainly recognize triacylated lipopep-
tides, whereas TLR2/TLR6 heterodimers recognize diacylated lipopeptides[76, 77]. 
A decade ago TLR10 was discovered, however its ligand and function remained 
unknown for a long period[78]. TLR10 shares a variety of agonists with TLR1 
and, similar to TLR1, requires TLR2 for recognition[79]. More recently, the inhibi-
tory effect of TLR10 on TLR2 derived immune responses was demonstrated[80]. 
 
In contrast with the discussed TLRs, which are located on the surface of cell 
membrane, the NOD-like receptors are expressed intracellular. NOD1 and NOD2 
recognize the bacterial peptidoglycan structures g-D-glutamyl-meso-diaminopime-
lic acid (iE-DAP) and muramyl dipeptide (MDP), respectively[81]. They are mainly 
expressed by macrophages, dendritic cells and epithelial cells[82]. NOD2 plays a 
role in the induction of a cytokine response induced by C. burnetii in both mice[69, 
83].
Goat
Experimental C. burnetii infection in goats elicited a strong IgM phase II and IgG 
phase II humoral response, starting 2 to 3 weeks post intranasal inoculation. 
Antibodies against phase I arose at a later stage of the infection. During the first 
weeks of infection, cell-mediated immune responses were minimal as no systemic 
cytokine mRNA (i.e. IL-1β, TNF-α and IFN-γ) was measured and the outcome of 
IFN-γ Elispot on C. burnetii stimulated PBMCs were low[84]. Cell-mediated immune 
responses, like the up-regulation of TNF-α, IL-1β and IFN-γ, were first detected in 
the first week after parturition. However, these cell-mediated immune responses 
did not differ enough to distinguish between C. burnetii-infected and non-infected 
pregnant animals[84]. 
Differences between Q fever infections in humans and goats
In the Netherlands, the Q fever outbreak was concentrated around humans and 
goats. In the above paragraphs we already discussed the symptoms and immu-
nology of Q fever infection in both species separately. Here, we emphasize more 
on the differences and similarities between Q fever infection in humans and goats. 
The first difference between C.  burnetii infection in goats and humans is based 
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After studying the immune responses against C.  burnetii in humans, Chapter 6 
focuses on the innate immune response of goats during an experimental C. burnetii 
infection.  
Next to the hosts perspective, we also investigated the infection from the patho-
gen side. Does the origin of the C. burnetii bacterium determine infectivity and are 
there differences between C.  burnetii strains that cause acute or chronic infec-
tions in humans? In Chapter 7 a large collection of C. burnetii isolates with diverse 
mammalian origins ranging from human and goat to sheep and cattle, are studied 
in relation to the cytokine responses they elicit in human immune cells. 
In the general discussion and summary (Chapter 8) the major findings of this 
thesis are presented and discussed in relation to the international literature. In 
addition, future perspectives and recommendations concerning the early detection 
of Q fever infections and treatment are provided.
matic and therefore hard to recognize, until a miscarriage ensues in pregnant goats. 
This could lead to a large reservoir of infected goats that are able to spread the 
disease. In humans, the problem is the development of chronic disease in a small 
proportion of individuals. These individuals need long term therapy and it cannot 
be predicted which patients develop chronic Q fever. The findings we present in this 
thesis concerning the immunological reaction to C. burnetii in humans and goats, 
could eventually lead to better diagnostic tests for humans and animals and treat-
ments for patients with Q fever.
Chapters 2-6 presents the (innate) immune response of goat and human hosts 
against Coxiella burnetii. Chapter 2 addresses the humoral part of the innate 
immune system. We examined which complement pathways are involved in the 
recognition of C. burnetii in humans and which pathway is necessary for a proper 
cytokine response in C. burnetii-stimulated human peripheral blood mononuclear 
cells (PBMCs). 
Next to the humoral part of the innate immune system, the cellular recognition plays 
a central function in the first defense against micro-organisms. Especially Toll-
like receptors (TLRs)1, 2, 4 and 6 and Nucleotide-binding oligomerization domain 
(NOD) like receptors 1 and 2 play an important role in the recognition of bacteria. 
Chapter 3 describes whether these TLRs and NLRs are involved in the recognition 
of C. burnetii in vitro. Chapter 4 presents the role of TLR10, a receptor which inhi-
bits TLR2-induced cytokine responses, in C. burnetii induced cytokine responses.   
 
Whether defects in recognition of C. burnetii by the innate immune system lead to 
the development of chronic Q fever was investigated by genetic analysis among 
139 chronic Q fever patients and 220 controls. Within these individuals, specific 
single nucleotide polymorphisms (SNPs) in the genes coding for the pattern recog-
nition receptors were identified and discussed in several chapters. Chapter 2 
shows the role of SNPs in mannose-binding lectin. Chapter 4 examined whether 
genetic variation in TLR10 influences the probability to develop chronic Q fever 
after an initial infection. Chapter 5 focuses on TLR1, 2, 4 and 6, NOD 1 and 2 
and downstream pathways in relation to the development of chronic Q fever.  
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Introduction
Coxiella burnetii is the causative agent of Q fever, a disease that generally presents 
as an acute flu-like illness or pneumonia in approximately 40% of the infected 
individuals. A persistent chronic infection develops in 2-5% of the individuals 
with an initial infection, and is mainly characterized by endovascular infections or 
endocarditis[1]. 
Defense against micro-organisms is mediated by the early reactions of the innate 
immunity, later targeted and amplified by adaptive immune responses. Recogni-
tion of pathogen associated molecular patterns (PAMPs) by pattern recognition 
receptors (PRRs) is a key step in the activation of the cellular part of the innate 
immune system, whereas plasma zymogens belonging to the complement system, 
are pivotal in the humoral innate immune response. The complement system can 
be activated via three main pathways: the classical, lectin and alternative pathway. 
Activation of the complement system leads to pathogen opsonization by comple-
ment factor C4b and C3b, to formation of the terminal complement or membrane 
attack complex (TCC or MAC) and it produces anaphylatoxins C4a, C3a and C5a 
that activates cells, promote chemotaxis and stimulate cytokine production. The 
classical pathway is strongly initiated by IgM or IgG-complexes attached to the 
antigen, and therefore often referred to as antibody-dependent. The lectin path-
way has a similar function as the classical pathway and is activated via mannose- 
binding lectin (MBL) and ficolins bound to repetitive sugar molecules on the 
pathogen. The alternative pathway, which accounts for up to 80-90% of the total 
complement activation, is activated by many bacteria, viruses and fungi but mainly 
functions as an amplification system of the classical and the lectin pathway. In 
brief, activation of each pathway eventually leads to activation of complement 
factor-3 (C3). Subsequently a C5 convertase is formed (C4b2a3b through the clas-
sical and lectin pathways or C3bBbC3b through the alternative pathway), and C5 is 
cleaved into C5b and the anaphylatoxin C5a. The first fragment eventually binds to 
C6, C7, C8 and several units of C9, leading to the formation of the TCC[2, 3]. 
Mannose-binding lectin, which is important for the activation of the lectin pathway, 
recognizes N-acetyl-D-glutosamine, mannose, N-acetyl-mannosamine, fructose 
Abstract
Background: Knowledge of complement system activation by Coxiella burnetii is 
limited. We investigated how C. burnetii activates the complement system and how 
this influences cytokine pr oduction. In addition, we investigated whether polymor-
phisms in MBL2 are associated with chronic Q fever development.
Methods: C.  burnetii-stimulated plasma or PBMCs were incubated with anti-C2 
(classical pathway), anti-MBL (MBL-pathway), anti-factor D (alternative pathway) 
or anti-C5 to measure the effect on terminal complement complex (TCC) formation 
and cytokine induction. Polymorphisms in MBL2 were examined in 139 chronic Q 
fever patients and 220 controls.
Results: Anti-factor D inhibited complement activation by C.  burnetii. In the 
presence of anti-C. burnetii antibodies, only anti-C2 and anti-factor D combined led 
to a decrease in TCC formation. Inhibition of C5a or factor D led to decreased IL-1β, 
TNF-α and IL-6 induction in C.  burnetii-stimulated PBMCs. Conversely, anti-MBL 
reduced IFN-γ, IL-22 and IL-17 production significantly. MBL haplotypes were not 
different between chronic Q fever patients and controls. 
Conclusion: C. burnetii activated the alternative pathway of complement in healthy 
controls, while the classical pathway was also involved in seropositive individu-
als. Production of monocyte-derived cytokines was mediated by C5a which was 
formed after activation of the alternative pathway by C. burnetii. MBL augmented 
the induction of T-cell-derived cytokines. 
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silver staining, using purified phase I (RSA493) and phase II (RSA439) C. burnetii 
NM LPS (kindly provided by R. Toman) as controls[19, 20]. The concentration 
was determined using Taqman (Quanta BioSciences) real-time PCR as described 
previously[21]. Heat killed C. burnetii cultures were prepared by heating the cultures 
for 30 minutes at 99°C.
Inhibitory anti-complement antibodies
Mouse immunoglobin G1 (IgG1) monoclonal antibodies against human C2 (clone 
175-62), factor D (fD) (clone 166-32), C5 (clone 137-30), C5a (clone 137-26) and 
the isotype matched control (clone G3-519) were a kind gift from Michael Fung 
(Tanox Inc, Texas, USA). Purified mouse IgG1 monoclonal antibody to human 
mannose-binding lectin (MBL) (clone 3B6) was purchased from the Antibodyshop 
(BioPorto Diagnostics A/S, Gentofte, Denmark). All antibodies were used in a 
concentration of 25 μg/ml.
Preparation of plasma samples for complement activation
Polypropene tubes of 5 ml were hand-filled with 100 μl of [3.3 mg/ml] lepirudin 
(Redswan, Utrecht, the Netherlands). Blood was drawn from the individuals and 
centrifuged for 10 minutes at 1700rpm at 4°C. Subsequently, plasma was taken 
and incubated for 30 minutes with either phosphate buffered saline (PBS), anti-C2, 
anti-fD, anti-MBL, anti-C5 or isotype control in combination with C. burnetii Nine Mile 
1x107 or PBS as control. Complement activation was stopped by adding 250mM 
ethylenediaminetetraacetic acid (EDTA). Samples were stored at -20°C until TCC 
activation was measured by enzyme linked immunosorbent assay (ELISA).
Serum samples
Serum from healthy seronegative (anti-C. burnetii phase I IgG [IgG1] <16) persons 
was used in the peripheral blood mononuclear cells (PBMCs) experiments. The 
complement in this serum was inactivated by 30 minutes incubation at 56°C. In 
some TCC experiments, seropositive serum was used of one patient with a past 
Q fever infection (IgG1/IgG2 256/512, IgM1/IgM2 128/32) and two chronic Q fever 
patients (IgG1/IgG2 >4096, IgM1/IgM2 negative). 
Study population
Blood was drawn from chronic Q fever patients and controls. The patients were 
and glucose[4]. Six important single nucleotide polymorphisms (SNPs) are known 
within the gene coding for MBL (MBL2), which have a major effect on the MBL 
serum concentration and protein structure[5]. Three of these SNPs are located in 
exon 1 in codons 52 (Arg52Cys), 54 (Gly54Asp), and 57 (Gly57Glu) and are associ-
ated with MBL deficiency. The wild-type allele is named ‘A’, while the mutant alleles 
are called D, B and C respectively. In addition, three SNPs in the promoter region 
have an effect on the circulating MBL concentrations[6]. These SNPs are termed 
‘H/L’, ‘X/Y’ and ‘P/Q’, and the four main promoter haplotypes described in different 
populations are LXP, LYP, LYQ and HYP[6, 7]. Due to a strong linkage disequilibrium, 
the six SNPs together are responsible for seven common haplotypes reported 
in Caucasian populations; HYPA, LYQA, and LYPA are associated with increased 
expression of circulating MBL, and LXPA, HYPD, LYPB, and LYQC are associated 
with deficiency of this protein[8, 9]. MBL deficiency is quite common, as approxi-
mately 5% of the population have no detectable MBL in their plasma and 35-40% of 
the individuals have low concentrations[10].
Research has mainly focused on the role of TLRs and NLRs in the recognition of 
C. burnetii and the development of acute or chronic Q fever infections[11-16]. To 
our knowledge only a few articles discuss the role of complement activation during 
C.  burnetii infection[17, 18]. We aimed to identify which complement pathway is 
activated by C. burnetii Nine Mile phase I in healthy individuals and in chronic Q 
fever patients. We examined which complement pathway is involved in C. burnetii 
induced cytokine production. Finally, we examined whether the presence of SNPs 
in the MBL gene leads to a higher susceptibility to develop chronic Q fever.
Material and Methods
Coxiella burnetii 
Coxiella burnetii Nine Mile phase I was a kind gift from the Bundeswehr Institute for 
Microbiology (Munich, Germany) and cultured at the Central Veterinary Institute. 
Lipopolysaccharide (LPS) phase determination was performed by SDS-PAGE and 
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Table	1:	Characteristics	of	the	chronic	Q	fever	patients	and	controls	for	genetic	analysisdiagnosed with a probable or proven chronic Q fever, as defined by the Dutch 
consensus on chronic Q fever[22]. The control group consisted of individuals 
from the same area also with valvular or vascular abnormalities and serological 
evidence of an initial C.  burnetii infection, but without symptoms or serological 
evidence of chronic Q fever. In Table 1 the demographic and clinical characteris-
tics, retrieved from the patients' and controls’ medical records, are summarized. A 
more detailed description of the background and recruitment of the patients and 
controls is described by Schoffelen et al.[12]. The study was approved by the Ethi-
cal Committee of Radboud university medical center, Nijmegen, The Netherlands. 
Subjects were enrolled after providing written informed consent. Institutional 
Review Boards of participating hospitals approved the inclusion of patients and 
controls in this study. All experiments were conducted according to the principles 
expressed in the Declaration of Helsinki.
PBMC isolation
Buffy coats from healthy donors were obtained from Sanquin (Nijmegen, the Neth-
erlands). Peripheral blood mononuclear cells (PBMCs) were isolated according to 
standard protocols with minor modifications as described previously[23]. The cells 
were counted in a ZH Coulter Counter (Beckman Coulter) and adjusted to 5x106 
cells/ml in RPMI. A volume of 100 µl was added to each well of a round-bottom 96 
well plate (Costar, Corning, The Netherlands). After 24 hours and 7 days, the super-
natants were harvested and stored at -20°C until further analysis.
Genomic DNA isolation and single nucleotide polymorphism analysis 
DNA from the patients and controls was isolated using the Gentra Pure Gene Blood 
kit (buffy coats and whole blood) (Qiagen, USA) or the Isohelix isolation kit for 
buccal swabs (Isohelix, UK), according to the manufacturer’s protocols. Four SNPs 
in the MBL2 gene (rs11003125, rs7096206, rs5030737 and rs1800451) were geno-
typed with a Sequenom mass-spectrometry genotyping platform. The fifth SNP in 
MBL2 (rs1800450) was analyzed using a pre-designed TaqMan® SNP genotyping 
assay (Applied Biosystems, USA). Before genotyping of the fifth SNP, DNA isolated 
from heparin-anticoagulated whole blood was treated with heparinase I (Sigma-Al-
drich, USA) as described previously[24]. Details of the SNPs can be found in Table 
2.
Abbreviations: IQR, interquartile range.
a Fisher exact test for categorical variables and Mann-Whitney for continuous variables.
b  Both vascular and valvular risk conditions in 9 case-patients and 22 controls.
C  Case-patients: Auto-immune disease with immunosuppressive drugs n=14; renal insufficiency n=1; 
renal transplantation n=1; malignancy n=3; prednis(ol)one use not specified n=1. Controls: Autoim-
mune disease with immunosuppressive drugs n=5; renal transplantation n=2; malignancy n=4; pred-
nis(ol)on use not specified n=4.
 Chronic Q fever Control Cohort P-valuea 
 Cohort
	 (n=139)	 (n=220)
Median	age,	y	(IQR) 70.0 (63.0-75.6) 67.6 (58.3-74.3) 0.02
Male	sex	(%) 114 (82) 169 (77) 0.29
Classification of chronic Q fever
Proven (%)  92 (66.2) 0
Probable (%)  47 (33.8) 0
Cardiovascular risk factor for 
chronic Q feverb 
Vascular aneurysm / prosthesis (%) 95 (68.3) 129 (58.6) 0.07
Valvular defect / prosthesis (%) 39 (28.1) 111 (50.5) <0.001
Immunocompromised statec	(%)	 21 (15.1) 14 (6.4) 0.01
Serology	(Median,	IQR)
C. burnetii phase I IgG 4096 (2048-16384)
C. burnetii phase II IgG 4096 (2048-16384)
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(CI) were reported. Differences between experimental groups were tested using 
either the Mann-Whitney U test or the Wilcoxon matched-pairs signed rank test, as 
mentioned in the Figure legends. The data are expressed as mean ± standard error 
of the mean (SEM) unless indicated otherwise. GraphPad Prism 5 software was 
used. Differences with a p-value <0.05 were considered statistically significant.
Results
The alternative complement pathway is activated by Coxiella burnetii in healthy 
individuals
Plasma derived from lepirudin-anticoagulated blood from healthy individuals was 
incubated for 30 minutes with C. burnetii NM in the presence of monoclonal anti-
bodies blocking C2 (classical pathway), MBL (lectin pathway), factor D (alterna-
tive pathway) or C5 (the final common pathway). TCC formation was used as a 
read out of final common pathway activation. Figure 1 shows that TCC formation 
was significantly reduced in the presence of anti-factor D compared to the isotype 
control. The same trend was observed after inhibition of C5. In contrast, the addi-
tion of anti-C2 or anti-MBL did not lead to a reduced TCC formation. Untreated 
plasma was capable of minor spontaneous formation of complement (Figure 1, 
striped bar).
Antibodies against Coxiella burnetii in serum of chronic Q fever patients activate the 
classical complement pathway
To investigate the role of C. burnetii specific antibodies in complement activation, 
serum from either C. burnetii-seronegative individuals or seropositive serum from 
individuals with a past or chronic Q fever infection (anti-C. burnetii phase I and II 
IgG ≥ 256) was incubated with plasma derived from lepirudin-anticoagulated whole 
blood from healthy individuals. In the plasma samples incubated with seroneg-
ative serum, TCC formation was strictly dependent on the alternative (factor D) 
pathway activation. In plasma incubated with anti-C. burnetii seropositive serum, 
inhibition of the alternative pathway (factor D) activation led to a significant but 
Table	2:	MBL2 SNPs analysed in the study
Cytokine and TCC measurement 
Cytokine production was measured using ELISA according to the respective manu-
facturers' protocols. ELISA kits were purchased from Sanquin (PeliKine Compact, 
Amsterdam, the Netherlands) for interleukin 6 (IL-6), IL-10, and IFN-γ, and from R&D 
Systems (Minneapolis) for tumor necrosis factor alpha (TNF-α), IL-1β, IL-17 and 
IL-22. Measurement of TCC was done as previously described with minor modifi-
cations[25]. Maxi-sorp plates (Nunc) were coated overnight with antiE1195B. As a 
secondary antibody, biotin-labeled anti-C6, was used. Adsorption was measured at 
450 nm using a Bio-Rad multiplate reader (Bio-Rad Laboratories, Veenendaal, the 
Netherlands).
Statistics
The presence of Hardy-Weinberg equilibrium (HWE) for all five SNPs in MBL2 in 
healthy controls was analyzed using a web-based HWE calculator[26]. The asso-
ciation between susceptibility to chronic Q fever and a SNP was investigated by 
means of univariate logistic regression models (Fisher’s exact test) with IBM SPSS 
18 software (IBM Corp., USA). SNPs were evaluated using a dominant and reces-
sive model analyses, for which odds ratios (OR) including 95% confidence intervals 
SNP ID nucleotide amino acid alleles effect genotyping assay
 change change
rs11003125	 c.-618G>C  H and L  MBL serum Sequenom
    concentration
rs7096206	 c.-289G>C  Y and X  MBL serum Sequenom
    concentration
rs5030737 c.154C>T  p.Arg52Cys  A and D MBL deficiency Sequenom
  (D52C)
rs1800451 c.170G>A p.Gly57Glu  A and C MBL deficiency Sequenom
  (G57E)
rs1800450 c.161G>A p.Gly54Asp  A and B MBL deficiency Taqman
  (G54D)
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incomplete decrease in TCC formation, whereas inhibition of the classical pathway 
(anti-C2) did not lead to a significant decline in TCC formation. Interestingly, inhi-
bition of both classical and alternative pathways, by using anti-C2 and anti-factor 
D combined, led to a decrease in complement activation similar to inhibition of C5 
(Figure 2A). Thus, in C. burnetii-seronegative individuals the complement system 
was activated via the alternative pathway, while in individuals with positive anti-
C. burnetii serology both the classical and the alternative pathway were involved. 
The results shown in Figure 2A suggested that addition of seropositive serum to 
healthy plasma resulted in a higher TCC formation in general. This observation 
was confirmed by stimulating plasma from healthy individuals and plasma from 
chronic Q fever patients with C. burnetii NM. The TCC formation in C. burnetii-stim-
ulated plasma of chronic Q fever patients was significantly higher than in plasma 
of healthy individuals (Figure 2B).
Figure	2:	The	classical	pathway	is	activated	by	C. burnetii in the presence of C. burnetii seroposi- 
tive serum 
A)	 Plasma derived from lepirudin-anticoagulated whole blood of healthy individuals stimulated with 
C. burnetii Nine Mile 1x107/ml in the presence of isotype control, anti-C2, anti-MBL anti-fD or anti-C5. 
Either seronegative serum (IgG1 < 16) or serum from seropositive past/chronic Q fever patients (IgG1 ≥ 
256) was added. The striped bar shows the result of non-stimulated plasma. n=4-6 
B) Plasma derived from lepirudin-anticoagulated whole blood of healthy individuals (n=8) and chronic 
Q fever patients (n=14) stimulated with PBS or C. burnetii Nine Mile 1x107/ml. After 30 min incubation, 
complement activation was stopped with by adding 250 mM EDTA and TCC activation was measured by 
ELISA. Mean ± SEM are presented, **p<0.01, ***p<0.001, Wilcoxon matched-pairs U-test signed rank test. 
Figure	1:	TCC	activation	by	C. burnetii is dependent on the alternative pathway 
Plasma-derived from lepirudin-anticoagulated whole blood of healthy individuals (seronegative; anti- 
C. burnetii phase 1 IgG<16) was stimulated with heat inactivated C. burnetii NM 1x107/ml in the presence 
of isotype control, anti-C2, anti-MBL, anti-fD or anti-C5. After 30 minutes incubation, complement activa-
tion was stopped by adding 250 mM EDTA, and TCC activation was measured by ELISA. The striped bar 
shows the result of non-stimulated plasma. Mean ± SEM of three to four separate experiments, giving 
n=5 (anti-C5) or n=8, are presented. **p<0.01, Wilcoxon matched-pairs U-test signed rank test. 
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Monocyte-derived cytokine production after Coxiella burnetii stimulation is dependent 
on	C5a	and	mediated	by	the	alternative	pathway,	while	T-cell-derived	cytokine	produc-
tion involves mannose binding lectin 
The finding that C. burnetii-induced cytokine production by PBMCs is decreased 
by inactivation of the serum and thus likely partly dependent on the activation of 
complement, raised the question which complement pathway is involved in cyto-
kine induction by C. burnetii. After 24h stimulation of PBMCs from healthy individ-
uals with C. burnetii in the presence of anti-C2, anti-MBL, anti-factor D and anti-
C5a, monocyte-derived cytokines (IL-β, TNF-α and IL-6) were measured. Inhibition 
of the alternative pathway by blocking factor D and blocking the anaphylatoxin 
C5a resulted in significantly lower IL-1β and IL-6 production and the same trend, 
although not significant, was observed for TNF-α (Figure 4A). Inhibition of the 
classical pathway and lectin pathway by respectively anti-C2 and anti-MBL did not 
result in lower cytokine responses from C. burnetii stimulated PBMCs.
We also investigated the role of the complement pathways in the production of 
T-cell-derived cytokines, IL-17, IL-22 and IFN-γ, after 7 days of C. burnetii stimula-
tion. Heat inactivation of complement factors in serum led to a lower IL-17, IL-22 
and IFN-γ response, although not as much as compared to IL-1β, TNF-α and IL-6 
(Figure 4A/B). The most surprising finding was the significant decrease in IL-17, 
IL-22 and IFN-γ production when MBL was inhibited (Figure 4B). In contrast to 
what was found for IL-1β, TNF-α and IL-6, inhibition of factor D did not result in 
lower IL-17, IL-22 and IFN-γ production (Figure 4B). In both monocyte-derived and 
T-cell-derived cytokines, inhibition of the classical pathway did not lead to lower 
cytokine production by stimulated PBMCs (Figure 4A/B). The role of C5a is less 
straightforward, it seems that inhibition of C5a results in less IL-22 and IFN-γ, but 
has no effect on IL-17 production.
Coxiella burnetii-induced cytokine production is partly dependent on heat-labile factors 
in serum
The influence of complement factors in serum on the cytokine production of 
C. burnetii-stimulated PBMCs of healthy individuals was examined. The amount of 
cytokines produced by PBMCs after C. burnetii stimulation in the absence of serum 
did not differ much from unstimulated PBMCs. In the presence of serum, a solid 
production of IL-1β, TNF-α and IL-6 was observed (Figure 3). After inactivating the 
serum by 30 minutes heating at 56°C, IL-1β and IL-6 production by C. burnetii-stim-
ulated PBMCs was significantly, but not completely decreased (Figure 3).
Figure	3:	Cytokine	production	by	C. burnetii-stimulated PBMCs is partly dependent on complement 
factors
PBMCs stimulated with C. burnetii Nine Mile 1 x106 in the absence of serum, in the presence of 10% serum 
or 10% heat-inactivated serum. Striped bars show cytokine production without stimulation, in the pres-
ence of 10% serum. IL-β, TNF-α and IL-6 were measured in the supernatant by ELISA after 24h incubation. 
Mean ± SEM are presented of four separate experiments, giving n=8, *p<0.05; **p<0.01, Mann-Whitney 
U-test. 
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Polymorphisms in the MBL2 gene do not lead to a higher susceptibility to develop 
chronic Q fever
Recent findings by Schoffelen et al. indicated that chronic Q fever patients are able 
to produce large amounts of IFN-γ upon C. burnetii stimulation[27]. As our study 
revealed that in the absence of MBL, the IFN-γ response against C. burnetii was 
reduced, we were intrigued to examine the role of genetic variations in the MBL2 
gene in the development of chronic Q fever. DNA was collected from 139 chronic 
Q fever patients (both probable and proven). Individuals from the same area with 
valvular or vascular abnormalities predisposing to chronic Q fever were collected 
as controls (n=220). The controls had serological evidence of a previous C. burnetii 
infection, but did not develop chronic Q fever. The distribution of all five SNPs did 
not differ between the chronic Q fever patients and the matched controls (data 
not shown).To investigate the haplotype distribution among the chronic patients 
group and controls, a distinction was made between medium and high producers 
based on their X/Y and L/H genotype (rs7096206 and rs11003125 respectively). 
Subsequently, low MBL producers were separated based on mutations in the MBL 
gene caused by the presence of D, B or C. These mutations are dominant and result 
in low MBL production independent of the presence of either X,Y,L or H. In the 
controls, 41.9% of the individuals bear one of the mutant alleles (D, C or B) causing 
low MBL levels, this percentage equals that of chronic Q fever patients (41.7%) with 
a MBL deficient genotype (p=0.53). Also, the percentage of medium and high MBL 
producers did not differ between the groups (Table 3).
Figure	4:	Cytokine	production	is	mediated	by	the	alternative	pathway
PBMCs stimulated with C. burnetii Nine Mile 1x106/ml in the absence of serum, in the presence of 10% 
serum, heat-inactivated serum or serum that was one hour pretreated with isotype control, anti-C2, anti-
MBL, anti-fD or anti-C5a. Striped bars show cytokine production without stimulation, in the presence of 
10% serum. 
A) IL-1β, TNF-α and IL-6 were measured in the supernatant by ELISA after 24h incubation.
B) IL-17, IL-22 and IFN-γ were measured after 7 days incubation. Mean values with SEM of two to four 
separate experiments, giving n=4 (anti-C5a), n=6-8 (all others), ns = not significant *p<0.05; **p<0.01, 
Wilcoxon matched-pairs signed rank test. 
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Discussion
In this study we showed that in healthy individuals the C.  burnetii activates the 
alternative pathway of the complement system. In serum of Q fever patients, both 
the classical and alternative pathway were activated. Furthermore, the induction of 
monocyte-derived cytokines (IL-1β, TNF-α and IL-6) is mediated by the anaphyla-
toxin C5a which is formed after activation of the alternative pathway by C. burnetii. 
An unexpected finding was the role of MBL, which did not influence complement 
activation by C.  burnetii, but did have a striking effect on IFN-γ, IL-22 and IL-17 
production. As previous studies revealed a high IFN-γ production by chronic Q fever 
patients upon C. burnetii stimulation, the influence of genetic variants in the MBL2 
gene on predisposition to chronic Q fever was examined. However, the distribution 
of high and low MBL serum haplotypes did not differ between the chronic Q fever 
patients and the control individuals and thus in patients the MBL concentration is 
not decisive in the progression towards chronic Q fever.
In general, Gram-negative bacteria can activate individual pathways or a combi-
nation of any: Chlamydia trachomatis for example activates the alternative path-
way[28], Bordetella persussis activates the classical pathway[29], and Neisseria 
meningitidis activates both the alternative and the lectin pathway[2]. Our study 
revealed that in C.  burnetii-naive individuals, only the alternative pathway was 
activated by C. burnetii. As can be expected, activation of both the alternative and 
the classical pathway was observed in the presence of anti-C.  burnetii seropos-
itive serum, considering that the classical pathway is activated by immunoglob-
ulins which are recognized by C1q. In 1988, two years before the lectin pathway 
was discovered, Vishwanath et al. concluded that C.  burnetii phase I (smooth) 
LPS poorly activated complement, while our findings suggested that C.  burnetii 
NM phase I activates complement via the alternative pathway[18]. Several condi-
tions can explain the difference between these observations. First, the C. burnetii 
isolates used in Vishwanaths study were passed in guinea pigs and (cell cultures 
of) chicken embryos, while the C. burnetii Nine Mile isolate in our study was passed 
in mice and cultured in BGM cells[30]. Differences in these passage methods could 
influence the expression of surface molecules of the isolates, and thereby have 
an effect on the complement activation. Secondly, different techniques were used 
Table	3:	Distribution	of	MBL	haplotypes	in	patients	with	chronic	Q	fever	and	controls
	 Low	MBL	serum	 Medium	MBL	serum	 High	MBL	serum	
 haplotypesa haplotypesa haplotypesa
 (presence of either D,B (LX/LX, LY/LX, HX/LX,  (LY/LY, HY/LY, HH/HX, HY/HX, 
 or C) HY/HX) HY/HY)
	 n	(%)	 n	(%)	 n	(%)
Patients 55 (41.7) 61 (46.2) 16 (12.2)
Controls 83 (41.9) 90 (45.5) 25 (12.6)
a MBL serum haplotypes as described by de Messias-Reason et al.[9].
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associated with the development of chronic Q fever. However, our analysis showed 
that the distribution of the MBL2 haplotypes did not differ between chronic Q fever 
patients and controls. Thus, the presence of SNPs in MBL2 and the corresponding 
MBL serum levels, are not associated with chronic Q fever.
In conclusion, this study shows that the complement system is activated by 
C. burnetii, involving both the alternative and classical pathway. Despite the involve-
ment of MBL in C.  burnetii-induced IFN-γ production, no association was found 
between polymorphisms in the MBL2 gene - directly related to MBL serum levels 
- and the likelihood to develop chronic Q fever. The role of MBL in C. burnetii phago-
cytosis and infection would be interesting to address in future studies.
to detect complement activation. While we made use of enzyme-linked immu-
nosorbent assay (ELISA), Vishwanath et al. measured complement haemolytic 
activity[18]. 
C. burnetii NM expresses sugars, such as mannose and N-acetyl-D-glucosamine, 
which can be recognized by MBL. Mannose (D-mannose) can be found in both 
the O-specific chain and the core region, while N-acetyl-D-glucosamine can only be 
found in the O-specific chain of phase I LPS[31, 32]. Despite of multiple passages 
of the C. burnetii NM strain used in our study, silverstaining of the LPS indicated 
that it was still in phase I. Based on the presence of these sugars, we hypothesized 
that MBL is able to recognize C. burnetii. However, we did not find evidence that the 
lectin pathway plays a role in complement activation by C. burnetii.
We showed that monocyte-derived cytokine production by C.  burnetii in healthy 
individuals partly depends on complement factors, in particular factor D. The 
immune response against several other micro-organisms also depends on serum 
factors to mount a proper cytokine response, i.e. Candida albicans and Strepto-
coccus pyogenes[33, 34]. Besides complement components, serum contains other 
elements such as albumin, α-, β- and γ- globulins and hormones which can contrib-
ute to the cytokine production by micro-organisms[35]. Furthermore, the presence 
of the soluble serum factor LBP (LPS-binding protein), can significantly enhance 
the PBMCs response to LPS via CD14[36]. It can be hypothesized that these 
factors play a role in cytokine induction by C. burnetii as well, explaining the partial 
decrease in cytokine production after heat-inactivation of the serum. Several stud-
ies demonstrated that MBL could play a role in the regulation of monocyte-derived 
cytokine inflammation[37-40]. However, we did not observe any effect of MBL on 
the C.  burnetii-induced production of IL-1β, TNF-α or IL-6 production by PBMCs 
after 24h. In contrast, MBL did have an effect on the production of IL-17, IL-22 
and IFN-γ, which are primary T-cell-derived cytokines (and also NK-cell-derived in 
case of IFN-γ). These findings could imply that, MBL influences the recognition of 
C. burnetii antigens to T-cells, independent of complement system activation.
Based on the high amount of IFN-γ production by PBMCs of chronic Q fever patients 
in response to C. burnetii[41], and our finding that MBL is involved in C. burnetii-in-
duced IFN-γ production, we hypothesized that genetic variability in MBL2, might be 
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Introduction
Coxiella burnetii is the causative agent of Q fever which can lead to either acute or 
chronic infection in humans. Acute Q fever is associated with inflammation, hepa-
titis and pneumonia. Chronic Q fever, defined as a cardiovascular chronic infec-
tion, develops over several months to years following an initial infection and is 
characterized primarily by endocarditis or endovascular infection[1]. Even though 
only a small proportion (2-5%) of the infected individuals develops chronic Q fever, 
the burden for patients is significant, as long-term antimicrobial drug treatment is 
necessary and mortality can reach to more than 60% when left untreated[1, 2]. In 
the Netherlands, one specific C. burnetii genotype, referred to as C. burnetii 3262, 
dominated the Q fever outbreak, which resulted in several thousands of cases and 
more than 250 chronically infected patients[3]. 
The innate immune system provides the first line of host defense against micro- 
organisms. Unique pathogen associated molecular patterns (PAMPs) on the sur- 
faces of micro-organisms are recognized by the pattern recognition receptors 
(PRRs) of the host immune cells in order to activate host defense mechanisms 
such as phagocytosis and cytokine signaling[4]. The main PRRs involved in recog-
nition of bacteria are Toll-like receptors (TLRs) (TLR1, TLR2, TLR4 and TLR6) 
and the Nucleo-tide-binding oligomerization domain (NOD) receptors NOD1 and 
NOD2. Previous studies in mice and reporter cell lines have demonstrated TLR2 
as an important regulator of immune responses against C. burnetii[5-7]. The TLR2 
receptor is able to form heterodimers with either TLR1 or TLR6; TLR1/TLR2 hetero- 
dimers mainly recognize triacylated lipopeptides, whereas TLR2/TLR6 heterod-
imers recognize diacylated lipopeptides[8, 9]. Polymorphisms in TLR1 and TLR6 
have been associated with increased susceptibility to candidemia, invasive 
aspergillosis, impaired mycobacterial signaling and innate immune responses 
in sepsis[10-13]. NOD1 and NOD2 recognize bacterial peptidoglycan structures, 
respectively g-D-glutamyl-meso-diaminopimelic acid (iE-DAP) and muramyl dipep-
tide (MDP)[14]. They are associated with the recognition of a broad range of bacte-
ria and interact with TLR2 through the Receptor-Interacting Protein (RIP)-Like Inter-
acting Caspase-Like Apoptosis Regulatory Protein Kinase (RICK) as the central 
signaling molecule[15].
Abstract
Infection with Coxiella burnetii can lead to acute and chronic Q fever. Toll-like recep-
tor 1 (TLR1), TLR2, TLR4, TLR6, Nucleotide-binding oligomerization domain recep-
tor 1 (NOD1), NOD2, and the mitogen-activated protein kinases are central in the 
innate immune response against microorganisms, but little is known about their 
role in the recognition of C. burnetii in humans.
Human peripheral blood mononuclear cells (PBMCs) were stimulated with 
C. burnetii Nine Mile and the Dutch outbreak isolate C. burnetii 3262. TLRs were 
inhibited using specific antibodies or antagonists. Additionally, the influence of 
human polymorphisms in TLRs and Nod-like receptors (NLRs) on C.  burnetii–
induced cytokine production was assessed.
Inhibition of TLR2, p38, JNK, and ERK led to decreased cytokine responses in 
C. burnetii–stimulated human PBMCs. Humans with polymorphisms in TLR1 and 
NOD2 had reduced cytokine production, compared with humans with wild-type 
genotypes, after stimulation. Interestingly, polymorphisms in TLR6 led to decreased 
cytokine production after C. burnetii 3262 stimulation but not after C. burnetii Nine 
Mile stimulation.
The TLR1/TLR2 heterodimer and NOD2 are important recognition receptors for 
the induction of cytokine responses against C. burnetii in humans. Furthermore, 
an interesting finding was the divergent recognition of C. burnetii Nine Mile and 
C. burnetii 3262.
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Study population
PBMCs were derived from buffy coats of blood donors (Sanquin, the Nether-
lands) and from whole blood of volunteers (SNP analyses). All were healthy Dutch 
volunteers of European descent. Donor blood was not serologically screened for 
C. burnetii infection and the individuals were not immunized[21]. In the SNP experi-
ment with C. burnetii 3262, cells were isolated from n=85 volunteers (23-73 years 
old, 23% females and 77% males). In the experiment with C. burnetii NM, cells were 
isolated from n=123 volunteers (22-70 years old, 16% females and 84% males). The 
NOD2 deficient individuals bear the homozygous NOD2 3020insC polymorphism. 
The 3020insC polymorphism was analyzed as described previously[22]. Venous 
blood was drawn after informed consent was obtained. The experiments were 
conducted according to the principles expressed in the Declaration of Helsinki. 
Isolation of human peripheral blood mononuclear cells and stimulation 
Peripheral blood mononuclear cells (PBMCs) from healthy and NOD2 deficient indi-
viduals were isolated as described previously[23]. A volume of 100 µl containing 
5x105 cells was added to a round-bottom 96-well plate (Corning, The Netherlands) 
and incubated with C. burnetii NM or C. burnetii 3262 (ranging from 1x106- 1x107/
ml) in the presence of 10% human serum. After 24 hours, supernatants were 
harvested and stored at -20°C. In some experiments, PBMCs were pre-incubated 
for 60 minutes with antagonizing or inhibiting agents. A monoclonal antibody for 
blocking TLR2 (clone TL2.1) and mouse IgG2a isotype were used at a concentration 
of 5µg/ml (InvivoGen, France). Highly purified Bartonella quintana LPS (100ng/ml) 
was used as a TLR4 antagonist[24]. P38 was inhibited using 1mMol/L p38 inhibitor 
SB202190 (Sigma-Aldrich, the Netherlands)[25]. JNK and ERK1/2 were inhibited 
by respectively 20μMol/L JNK SP600125 (AG Scientific, USA) and 10μMol/L MEK 
U0126 (Promega, USA).
Cytokine measurement
Cytokine production was measured using enzyme-linked immunosorbent assay 
(ELISA). The following kits were used: interleukin 6 (IL-6) (Sanquin, the Nether-
lands), tumor necrosis factor-α (TNF-α), IL-1β, (R&D Systems, USA) and mouse IL-6 
(Invitrogen, USA). Absorption was measured at 450 nm (Bio-Rad Laboratories, the 
Netherlands). 
An unanswered question is how C. burnetii is initially recognized by the immune 
system in humans, and how C. burnetii evades these mechanisms leading to acute 
and chronic Q fever in patients. Previously, it has been shown that the defective 
immune response that accompanies chronic Q fever is associated with the failure 
of C. burnetii to induce lymphocyte proliferation, the absence of granulomas and 
cytokine dysfunction[1, 16]. However, our group recently showed that chronic Q fever 
patients have high T-cell derived IFN-γ production upon contact with C. burnetii[17]. 
This finding may indicate that a defective innate immune recognition of C. burnetii 
and subsequent induction of appropriate cytokines are important for the patho-
genesis of chronic Q fever and may not be due to the failure to activate lympho-
cytes. To investigate this hypothesis, more fundamental knowledge is needed on 
the PRRs involved in sensing C. burnetii. Therefore, this study investigates the role 
of TLR1, TLR2, TLR4, TLR6, NOD1, NOD2 and the downstream MAP-Kinases p38, 
JNK and ERK in the recognition of two C. burnetii phase I strains, the reference 
strain C. burnetii Nine Mile and the Dutch outbreak isolate C. burnetii 3262. The 
study will provide a better insight in the recognition of C. burnetii by PRRs in general 
and could be used in further investigations on immunological causes of chronic Q 
fever infection. 
Material and Methods
Coxiella burnetii strains
Two C. burnetii strains were used: C. burnetii Nine Mile RSA493 (NM) phase I (a 
kind gift from the Bundeswehr Institute for Microbiology (Munich, Germany)) and 
C. burnetii X09003262 (3262) phase I, isolated from the placenta of an aborted 
goat in the Netherlands[3]. Both strains were cultured on Buffalo Green Monkey 
cells and the numbers of Coxiella DNA copies was determined using Taqman real-
time PCR as described previously[18]. LPS phase determination was performed 
by SDS-PAGE and silver staining, using purified phase I (RSA493) and phase 
II (RSA439) C.  burnetii NM LPS (kindly provided by R. Toman) as controls[19, 
20]. Both C. burnetii strains were inactivated by heating for 30 minutes at 99°C. 
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iments using antagonists or inhibitors, the Wilcoxon matched-pairs signed rank 
test was used. GraphPad Prism 5 software was used. Differences with a p-value 
<0.05 were considered statistically significant.
Table	1:	Single-Nucleotide	Polymorphisms	(SNPs)	Used	in	the	Study
Genomic DNA isolation and single nucleotide polymorphism analysis
DNA was isolated using the Gentra Pure Gene Blood kit (Qiagen, USA) according 
to the manufacturer’s protocol for whole blood. Polymorphisms were identified 
using a pre-designed TaqMan® SNP genotyping assay (Applied Biosystems, USA) 
or Illumina Immunochip. The following SNPs were analyzed: TLR1 (rs5743611, 
rs4833095, rs5743618), TLR2 (rs5743704), TLR4 D299G/T399I (rs4986790/
rs4986791), TLR6 P249S (rs5743810), NOD2 (rs2066842, rs5743293, rs2066845, 
rs2066844, rs9302752, rs7194886, rs8057341, rs751271, rs3135499) and NOD1 
insertion/deletion polymorphism NOD1 +32656 (Table 1).
Animals
TLR1, TLR2 and TLR6 knockout mice were kindly provided by Prof. S. Akira (Depart-
ment of Host Defense, Osaka University, Osaka, Japan) and are fully backcrossed 
to C57BL/6 background. Age and gender matched control C57BL/6 mice were 
obtained from Charles River Wiga (Sulzfeld, Germany). Mice were housed in filter-
top cages, and water and food were provided ad libitum. Wild type, NOD1, NOD2 
and NOD1/2 knockout mice were bred and maintained in the St. Jude Children's 
Research Hospital, Memphis, TN, USA. Bone marrow derived macrophages 
(BMDMs) were used in all experiments. After dissecting of the mouse legs, the 
bone marrow was flushed out using sterile PBS. Differentiation into macrophages 
occurred in 7 days at 37°C and 5% CO2 in Dulbecco's Modified Eagle Medium/Nutri-
ent Mixture F-12 (Gibco, Invitrogen, USA) supplemented with 30% L929 medium, 
10% heat-inactivated filtered foetal bovine serum (Invitrogen, USA), 1% non essen-
tial amino acids and 1% 100 U/mL penicillin and 100 mg/mL streptomycin. At day 
6, the BMDMs were counted and added to either a 24-wells plate in a concentration 
of 1x106 cells/ml or a 96-wells plate in a concentration of 1x105 cells/ml. After 24h 
of resting at 37°C, the cells were stimulated with medium, C. burnetii NM 1x106/ml, 
C. burnetii 3262 1x106-1x107/ml, Pam3Cys 10μg/ml and E. coli LPS 10μg/ml.
The experiments were approved by the Ethics Committee on Animal Experiments 
of the Radboud University Medical Center, and protocols were approved by the 
St.  Jude Children’s Research Hospital’s Committee on the Use and Care of Animals.
Statistical analysis
The data are expressed as mean ± SEM unless indicated otherwise. Differences 
between experimental groups were tested using the Mann-Whitney U test. In exper-
Gene SNP ID Mutation Nucleotide AA Change TaqMan
   change*  Assay ID
TLR1 rs4833095 Missense C > T S248N C__44103606_10
TLR1 rs5743611 Missense G > C R80T C__27855269_10
TLR1 rs5743618  G > T S602I Hs00248869_CE
TLR2 rs5743704 Missense C > A P631H C__25607736_10
TLR4 rs4986790 Missense A > G D299G C__11722238_20
TLR4 rs4986791 Missense C > T T399I C__11722237_20
TLR6 rs5743810 Missense C > T P249S C___1180648_20
NOD1 rs6958571#   +32656
NOD2 rs2066842 Missense C > T P268S C__11717470_20
NOD2 rs2066847 Frameshift  1007finsC
NOD2 rs2066845 Missense C > G G908R C__11717466_20
NOD2 rs2066844 Missense C > T  R702W C__11717468_20
NOD2 rs9302752  C > T 
NOD2 rs7194886  C > T
NOD2 rs8057341  A > G
NOD2 rs751271  G > T
NOD2 rs3135499  A > C 
Genotyped using 
the Illumina  
Immunochip plat-
form, as described 
by Smeekens et al. 
[39].
* The first nucleotide (and corresponding AA) is the ancestral nucleotide and therefore is considered the 
wild-type allele.
#  This is the SNP Database reference for wa t/g single base pair substitution at the same position with-
out the accompanying insertion/deletion.
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Results
Role	for	TLR2,	but	not	TLR4,	in	C. burnetii induced cytokine response in humans
TLR4 is an important receptor for lipopolysaccharide (LPS). As C. burnetii phase 
I possesses tetracyclated LPS[26], it can be hypothesized that TLR4 could play a 
role in cytokine production by C. burnetii. Upon TLR4 blockade by the TLR4 anta- 
gonist Bartonella LPS, the IL-1β, IL-6 and TNF-α responses of PBMCs after E. coli 
LPS stimulation are effectively inhibited. However, this potent TLR4 antagonist was 
unable to inhibit C. burnetii NM and C. burnetii 3262 induced cytokine responses in 
PBMCs (Figure 1A).
PBMCs pre-incubated with an antagonistic antibody directed against TLR2 
produced less IL-1β and IL-6 after encounter with C. burnetii NM and C. burnetii 
3262 (Figure 1B). TNF-α levels were decreased after stimulation with C. burnetii 
3262; conversely, this was not observed after stimulation with C. burnetii NM and 
the TLR2 ligand Pam3Cys (Figure 1B). Additionally, the role of TLR4 and TLR2 in 
C. burnetii recognition was investigated using PBMCs from volunteers with or with-
out single nucleotide polymorphisms (SNPs) in these genes. Polymorphisms in 
TLR4 (D299G and T399I) did not result in decreased cytokine responses (Figure 
1C). PBMCs from volunteers homozygous for a SNP in TLR2 (P631H) showed 
significantly decreased IL-1β responses after stimulation with C.  burnetii 3262 
only (Figure 1D). An explanation can be that the location of the TLR2 SNP is more 
important for the binding of C. burnetii 3262 than for C. burnetii NM or Pam3Cys.
Finally, we investigated the role of TLR2 in the cytokine induction by C.  burnetii 
in murine BMDMs. BMDMs derived from TLR2 knockout mice had reduced IL-6 
production compared to the wild type mice after stimulation with C. burnetii NM 
and C. burnetii 3262 (Figure 1E).
Cytokine induction by C. burnetii	NM	stimulation	of	human	PBMCs	depends	on	TLR1,	
while C. burnetii	3262	recognition	is	mediated	by	both	TLR1	and	TLR6
The finding that TLR2 plays an important role in the recognition of C. burnetii led 
to the question whether this response is mainly mediated by TLR1/TLR2 or TLR2/
TLR6 heterodimers[27]. 
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PBMCs of individuals bearing the homozygous mutant variant of TLR1 (S609I) 
and TLR1 (N248S) produced significantly less IL-1β and TNF-α after stimulation 
with C. burnetii NM and C. burnetii 3262 than individuals who are heterozygous for 
these particular SNPs or bear the wild type variant (Figure 2A). The same trend was 
observed for the TLR1 (R80T) SNP, of which only a few individuals in the cohort 
carry the homozygous variant. Decreased cytokine responses were also observed 
in these individuals after stimulation with the purified TLR2 ligand Pam3Cys (data 
not shown). Among the individuals carrying the TLR6 (P249S) SNP, the cytokine 
responses induced by the two C. burnetii strains differed from each other. C. burnetii 
NM stimulation did not result in decreased IL-1β and TNF-α production, while 
stimulation with C.  burnetii 3262 revealed a significantly lower IL-1β and TNF-α 
production compared with individuals who are heterozygous or bear the wild type 
variant (Figure 2B). However, stimulation with fibroblast stimulating ligand-1 (FSL-
1), a TLR2/6 agonist, did not result in lowered cytokine responses (data not shown).
In mice, BMDMs derived from TLR1 knockout mice produced less IL-6 after stimu- 
lation with C.  burnetii NM, while this was not observed after C.  burnetii 3262 
stimulation. On the other hand, IL-6 production of BMDMs from TLR6 knockout 
mice was strongly diminished after stimulation with both C.  burnetii NM and 
C. burnetii 3262 (Figure 2C).
The	role	of	NOD2	in	C. burnetii induced cytokine response
NLRs are involved in initiating an immune response against micro-organisms 
through recognition of bacterial peptidoglycan. As shown in Figure 3A, PBMCs of 
individuals heterozygous and homozygous for the NOD1 insertion-deletion +32656 
polymorphism display similar IL-1β and TNF-α production after C. burnetii NM and 
C. burnetii 3262 stimulation as individuals bearing the wild type genotype.
In contrast, PBMCs from NOD2 deficient individuals, produced significantly less 
IL-1β and IL-6 than PBMCs from healthy controls after C.  burnetii 3262 stimula-
tion (Figure 3B). The same trend was observed after C.  burnetii NM stimulation 
(Figure 3B) and for TNF-α production (not shown). The effect of nine NOD2 SNPs 
was further analyzed. Stimulation with C. burnetii NM resulted in decreased, yet 
not significant, TNF-α production in six out of these nine analyzed NOD2 SNPs, 
while four of these SNPs modulated stimulation with C. burnetii 3262, resulting in 
Figure	1:	Recognition	of	C. burnetii	by	TLR2,	but	not	by	TLR4,	in	human	and	mice	
1A/B)	PBMCs were pre-treated with (Figure 1A) medium or Bartonella LPS 100μg/ml or (Figure 1B) isotype 
control IgG2B or anti-TLR2 for one hour and subsequently stimulated with RPMI (striped bar), C. burnetii 
NM 1x106/ml, C.  burnetii 3262 1x106/ml, E. coli LPS 10ng/ml or Pam3Cys 10μg/ml in the presence of 
serum, n=5-9. Mean values ± SEM are shown, *p<0.05, ** p<0.01 Wilcoxon matched-pairs signed rank 
test two-tailed. 
1C-D) PBMCs of healthy individuals genotyped for the TLR4 D299G/T399I SNP (Figure 1C) and TLR2 
P631H (Figure 1D) were stimulated with RPMI (striped bar), C. burnetii NM 3x106/ml and C. burnetii 3262 
3x106/ml in the presence of serum. Data are mean values with SEM *p<0.05, ** p<0.01 Mann-Whitney U 
test. IL-1β, TNF-α and IL-6 were measured in the supernatant by ELISA after 24h incubation. 
1E) Bone marrow derived macrophages from wild type and TLR2 knockout mice were stimulated with 
DMEM, C. burnetii NM 1x106/ml, C. burnetii 3262 1x106/ml, Pam3Cys 10μg/ml and E. coli LPS 10μg/ml. 
mIL-6 was measured after 24h incubation using ELISA. Data are combined results of 2 separate exper-
iments containing three mice in each group (Pam3Cys stimulation one experiment only). The mIL-6 
production of the wild type mice is set on 100%.
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Figure	2:	Recognition	of	C. burnetii	by	TLR1	and	TLR6	in	human	and	mice	
2A-B) PBMCs of healthy individuals genotyped for the TLR1 S602I, TLR1 N248S and TLR1 R80T SNP 
(Figure 2A) and TLR6 P249S SNP (Figure 2B) were stimulated with RPMI (striped bar), C. burnetii NM 
3x106/ml and C. burnetii 3262 3x106/ml in the presence of serum. IL-1β and TNF-α were measured in the 
supernatant by ELISA after 24h incubation. *p<0.05, ** p<0.01, *** p<0.001 Mann-Whitney U test. 
2C) Bone marrow derived macrophages of wild type, TLR1 knockout and TLR6 knockout mice were stim-
ulated with medium only, C. burnetii Nine Mile 1x106/ml and C. burnetii 3262 1x106-1x107/ml. After 24h 
stimulation, mouse IL-6 was measured by ELISA. White bars represent the wild type mice, grey bars 
represent the TLR1 knockout mice and the black bars represent the TLR6 knockout mice. Experiments 
were performed in duplicates (3-4 mice in each group), mean± SEM are depicted. The IL-6 production of 
the wild type mice is set on 100%. *p<0.05, ** p<0.01, Mann-Whitney U test.
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lower TNF-α and IL-1β production. Figure 3C shows these TNF-α responses of the 
NOD2 1007finsC, NOD2 G908R and NOD2 R702W SNPs after C. burnetii NM and 
C. burnetii 3262 stimulation. 
In mice, C. burnetii NM stimulation of BMDMs led to a 35% reduction of IL-6 produc-
tion in NOD1 knockout mice compared to wild type, while in NOD2 knockout and 
double knockouts the IL-6 production was reduced more than 50% (Figure 3D). 
Unfortunately, stimulation of the BMDMs with C. burnetii 3262 resulted in low produc-
tion of IL-6 and was not useful to compare the different groups (data not shown). 
 
Figure	3:	NOD2	is	involved	in	the	recognition	of	C. burnetii,	while	NOD1	is	not	
3A) PBMCs of healthy volunteers genotyped for the NOD1 SNP ND1 +32656 were stimulated with RPMI 
(striped bar), C. burnetii NM 3x106/ml and C. burnetii 3262 3x106/ml.
3B) PBMCs of individuals with a homozygous NOD2 3020insC mutation and PBMCs of healthy controls 
were stimulated with RPMI, C. burnetii NM 1-2x106/ml, C. burnetii 3262 1-2x106/ml and muramyl dipeptide 
(MDP) 5μg/ml. The IL-1β and IL-6 production of the healthy controls is set on 100%. 
3C) PBMCs of healthy volunteers genotyped for the NOD2 SNPs 1007finsC, NOD2 G908R and NOD2 
R702W were stimulated with RPMI (striped bar) C. burnetii NM 3x106/ml and C. burnetii 3262 3x106/ml. 
In all experiments, PBMCs were stimulated in the presence of human serum. IL-1β, IL-6 and TNF-α were 
measured in the supernatant by ELISA after 24h incubation. * p<0.05, ** p<0.01, Mann-Whitney U test. 
3D) Bone marrow derived macrophages of wild type, NOD1 knockout, NOD2 knockout and NOD1/2 knock-
out mice were stimulated with medium only and C. burnetii Nine Mile 1x107/ml. After 24h stimulation, 
mouse IL-6 was measured by ELISA. White bars represent the wild type mice, light grey bars represent 
the NOD1 knockout mice, dark grey represent the NOD2 knockout mice and the black bars represent the 
NOD1/2 knockout mice. Experiments were performed in duplicates (n=2-3), mean± SEM are depicted. The 
IL-6 production of the wild type mice is set on 100%. *p<0.05, ** p<0.01, Mann-Whitney U test.
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Discussion
In the present study we investigated the role of TLRs and NLRs in the recognition 
of C. burnetii. Using different approaches, we found clear evidence for involvement 
of TLR1, TLR2 and NOD2 but not for TLR4 and NOD1. An additional important find-
ing was the divergent recognition of C. burnetii NM and the Dutch outbreak isolate 
C. burnetii 3262. C. burnetii NM was mediated by TLR1/TLR2 only, while C. burnetii 
3262 was recognized by both the TLR1/TLR2 and TLR2/TLR6 heterodimers. Inter-
estingly, recognition of these two strains also differed with respect to the role of 
TLR6 in men and mice.
Our results revealed no important role of TLR4 in mediating in-vitro cytokine produc-
tion by human PBMCs after C. burnetii encounter. Although Honstrette et al.[29] 
reported that TLR4 knockout mice exhibited a defect in cytokines production and 
granuloma formation, our observation that C. burnetii-induced cytokine production 
in humans is not TLR4 mediated is not surprising. As reported before, LPS with a 
tetra-acylated lipid A component as expressed by bacteria such as Rhodobacter 
sphaeroides or the lpxL2 mutant of Neisseria meningitidis H44/76, is found to be a 
very weak cytokine inducer and even act as TLR4 antagonists[30, 31]. Accordingly, 
an antagonistic effect of C. burnetii phase I lipid A has been demonstrated[7]. 
We observed an important role of TLR2 in C. burnetii recognition in mice and, more-
over, our study revealed that TLR2 is also important for C. burnetii recognition by 
human PBMCs. C. burnetii NM and C. burnetii 3262 are both able to induce cytokine 
production via TLR2 signaling, which suggests that both strains comprise PAMPs 
which can activate TLR2. C. burnetii phase II activation of TLR2 has previously been 
reported by Zamboni et al.[7]. They showed that macrophages from TLR2 knock-
out mice were highly permissive to C.  burnetii growth compared to either TLR4 
knockout or wild type mice. Furthermore, they found that macrophages from TLR2 
knockout mice produced lower levels of TNF-α and IL-12[7]. While Zamboni et al. 
used the avirulent C. burnetii phase II, we used the virulent C. burnetii phase I which 
is the infective phase that is found in the environment. 
P38,	JNK	and	ERK	are	downstream	mediators	of	C. burnetii-induced cytokine production
MAPKs like p38, JNK and ERK have been proven to be downstream of TLRs and their 
activation eventually lead to cytokine production, proliferation, and apoptosis[28].
Here we confirm this function of MAPKs upon C.  burnetii stimulation as inhibi-
tion of p38 and ERK led to significant decreased IL-1β, TNF-α and IL-6 produc-
tion in PBMCs (Figure 4). PBMCs pre-incubated with a specific JNK inhibitor also 
produced less IL-1β and TNF-α after C. burnetii stimulation, however IL-6 produc-
tion was not altered in comparison to the DMSO control (Figure 4).
 
Figure	4:	Involvement	of	MAPKs	in	C. burnetii-induced cytokine production 
PBMCs of eight healthy volunteers were pre-treated with DMSO (control), p38 inhibitor, JNk inhibitor or 
ERK inhibitor for one hour and subsequently stimulated with RPMI (striped bar), C. burnetii NM 1x106/ml 
and C. burnetii 3262 1x106/ml, in the presence of human serum. IL-1β, TNF-α and IL-6 were measured in 
the supernatant by ELISA after 24h incubation. Mean values ± SEM of three separate experiments are 
shown. *p<0.05, ** p<0.01, Wilcoxon matched-pairs signed rank test two-tailed.
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MCP-1 mRNA responses in C. burnetii stimulated BMDMs of NOD2 knockout mice 
compared to wild type mice. Our results showed lower IL-6 responses in C. burnetii 
stimulated BMDMs of NOD1 knockout mice compared to wild type mice, but even 
a larger decrease was observed in NOD2 knockout mice. As the IL-6 response was 
not further decreased in the NOD1/2 knockout mice, we suggest that the role of 
NOD2 is more important. 
The strain C. burnetii 3262 was the predominant genotype found during the Q fever 
outbreak in the Netherlands. This single genotype of C. burnetii caused the largest 
outbreak of Q fever ever reported world-wide. Besides increased exposition of 
humans to this pathogen due to intensive goat-herding, it may be hypothesized 
that this strain is less effectively recognized by the human immune system and is 
therefore more virulent than other strains. However, our study showed that, similar 
to C. burnetii NM, C. burnetii 3262 in humans was recognized by TLR1, TLR2 and 
NOD2, and induced a robust pro-inflammatory cytokine response.
Interestingly, we observed a possible role for TLR6 in cytokine induction by 
C. burnetii 3262, while this was not seen for C. burnetii NM. It can be questioned 
whether extended activation of the immune response is beneficial for the infected 
individual, as enhanced uptake of C. burnetii by monocytes and macrophages can 
favor the intracellular replication of C.  burnetii, leading to a possible infection. 
However, it has to be further investigated whether the recognition of C.  burnetii 
3262 by TLR6 can lead to increased virulence. 
It is not completely clear why chronic Q fever only develops in a small proportion 
of infected individuals. Although patient-related factors such as the presence of 
valvular pathology or atherosclerotic vascular disease are a contributing factor, 
polymorphisms in PRR genes may also predispose to the development of chronic Q 
fever. Studies performed in our group show associations between polymorphisms 
in TLR1, TLR2 and TLR6 with increased susceptibility to complicated skin and skin 
structure infections[36]. In addition, others observed associations concerning the 
TLR6 SNP with malaria and invasive aspergillosis and overrepresentation of TLR2 
in tuberculosis patients[13, 37, 38]. Therefore, it would be interesting for future 
studies to investigate whether polymorphisms in TLR1, TLR2, TLR6 and NOD2 
are retrieved more often in chronic Q fever patients, and if they can be related to 
disease severity after C. burnetii infection or to specific C. burnetii strains.
We additionally investigated the role of TLR1 and TLR6 in cytokine induction by 
C.  burnetii, because TLR2 forms heterodimers with either TLR1 or TLR6. We 
addressed the issue by performing experiments with PBMCs from individuals 
with known SNPs in TLR1 and TLR6. We found that individuals carrying poly-
morphisms in TLR1 showed a diminished cytokine response against C.  burnetii 
NM and C.  burnetii 3262. Our findings suggest that the TLR1/TLR2 heterodimer 
plays a role in C. burnetii recognition. BMDMs of TLR1 knockout mice stimulated 
with C. burnetii NM have a reduced IL-6 production compared to wild type mice. 
Conversely, stimulation with C. burnetii 3262 did not lead to lower cytokine produc-
tion in TLR1 knockout BMDMs. 
The role of TLR6 in the induction of a cytokine response against C. burnetii is less 
clear. Our results in human PBMCs suggest that C.  burnetii 3262 is recognized 
by TLR6, while this is not the case for C. burnetii NM. This can be explained by a 
different binding site of C. burnetii 3262 to TLR6 compared to C. burnetii NM and 
FSL-1. In mice, it seemed that TLR6 plays a major role in the cytokine induction by 
C. burnetii, for both the reference strain as well as the Dutch outbreak isolate. We 
observed a different role for TLR1 and TLR6 in mice and humans in our experiments, 
showing that innate immune recognition of C. burnetii can differ between mice and 
men. However, much of the so far published data on innate immune recognition of 
C. burnetii is derived from murine experiments. We can conclude that assumptions 
on immune recognition of C. burnetii in humans based on murine studies alone, 
should be made carefully[32, 33].
The shared intracellular localisation of the NOD2 receptor and C. burnetii together 
with the confirmed role of TLR2 in the recognition of C. burnetii made the investi-
gation of NOD2 of interest. Our study in humans revealed that NOD2 plays a major 
role in cytokine induction upon C.  burnetii encounter, as individuals bearing the 
NOD2 3020insC mutation (causing a loss of function of the NOD2 gene[22]) have 
significant lower cytokine responses. This finding was further strengthened by 
our observation in individuals bearing SNPs in NOD2. The important role for both 
TLR2 and NOD2 signaling in the induction of cytokines has been demonstrated 
for other bacteria, for example B. burgdorferi and Mycobacterium paratuberculo-
sis[23, 34]. So far, only one other research group has investigated the role of NOD2 
in C.  burnetii infection[35]. They concluded that NOD2 is not essential for the 
control of C. burnetii infection in mice, although they observed lower TNF-α and 
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Introduction
Coxiella burnetii is a Gram-negative intracellular bacterium that can cause either 
acute and/or chronic Q fever infection in humans. Whereas the majority of infected 
individuals develops no symptoms, approximately 40% of the infected individuals 
presents with acute symptoms, usually pneumonia or hepatitis. Several months 
to years following initial infection, chronic Q fever develops in 1-5% of the individ-
uals, which is characterized primarily by endocarditis or endovascular infection[1]. 
Despite intensive research in the past years, the underlying cause of why only a 
minority of the individuals with an initial infection develops chronic Q fever remains 
unknown. A possible explanation is insufficient early recognition of the bacte-
rium by the innate immune system, which can lead to a deficient elimination of 
C. burnetii and a reduced initiation of adaptive immune responses.
Recognition of invading micro-organisms by the host immune cells starts with 
the activation of the innate immune system. Pattern recognition receptors (PRRs) 
recognize pathogen-associated molecular patterns (PAMPs) expressed among 
others on the surface of micro-organisms. These PRRs comprise among others the 
Toll-like receptor (TLR) family, which consists of ten members in humans, and are 
able to recognize a large panel of ligands. In a recent study we examined the role of 
TLR1, TLR2 and TLR6 in the recognition of C. burnetii. We observed that TLR2 plays 
an essential role and revealed that both C. burnetii Nine Mile (NM) and the Dutch 
outbreak isolate C. burnetii 3262 are recognized by the TLR1/TLR2 heterodimers, 
while TLR2/TLR6 was also involved in recognizing C. burnetii 3262[2].
TLR10 was discovered in 2001 by Chuang et al. revealing large homology with TLR1 
and TLR6, sharing respectively 50% and 49% of the overall amino acid sequence[3]. 
For a long time TLR10 was considered an orphan receptor as the ligand and func-
tion was unknown[3]. In 2010, Guan et al. reported that TLR10 shares a variety 
of agonists with TLR1 and, similar to TLR1, requires TLR2 for recognition[4]. 
Recently, we demonstrated the inhibitory effect of TLR10 on TLR2 derived immune 
responses[5]. This inhibitory effect of TLR10 on TLR2 derived immune responses 
and its ability to form heterodimers with TLR2, led us to examine the role of TLR10 
in C. burnetii-induced cytokine responses and to investigate whether genetic vari-
ation in TLR10 influences the probability to develop chronic Q fever after an initial 
infection. 
Abstract
Coxiella burnetii, the causative agent of Q fever, is recognized by TLR2. TLR10 
can act as an inhibitory receptor on TLR2-derived immune responses. Therefore, 
we investigated the role of TLR10 on C. burnetii-induced cytokine production and 
assessed whether genetic polymorphisms in TLR10 influences the development of 
chronic Q fever. HEK293 cells, transfected with TLR2, TLR10 or TLR2/TLR10, and 
human peripheral blood mononuclear cells (PBMCs) in the presence of anti-TLR10, 
were stimulated with C. burnetii. In both assays, the absence of TLR10 resulted in 
increased cytokine responses after C. burnetii stimulation. In addition, the effect 
of single nucleotide polymorphisms (SNPs) in TLR10 was examined in healthy 
volunteers whose PBMCs were stimulated with C. burnetii Nine Mile or the Dutch 
outbreak isolate C.  burnetii 3262. Individuals bearing SNPs in TLR10 displayed 
increased cytokine production upon C. burnetii 3262 stimulation. Furthermore, 139 
chronic Q fever patients and 220 controls were genotyped for TLR10 N241H, I775V 
and I369L. None of these polymorphisms were associated with increased suscep-
tibility to chronic Q fever. In conclusion, TLR10 has an inhibitory effect on in vitro 
cytokine production by C. burnetii, but the presence of TLR10 polymorphisms does 
not lead to an increased risk of developing chronic Q fever.
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Patient and control group
Blood was drawn from patients with probable or proven chronic Q fever, as defined 
by the Dutch consensus guideline on chronic Q fever[10]. The control group 
consisted of individuals from the same area with valvular or vascular abnormali- 
ties predisposing to chronic Q fever, who had serological evidence of exposition to 
C. burnetii, without evidence of chronic Q fever. Demographic and clinical charac- 
teristics were retrieved from medical records and summarized in Table 1. A more 
detailed description of the background and recruitment of the patients and controls 
is described by Schoffelen et al.[11]. The study was approved by the Ethical Commit-
tee of Radboud University Medical Center, Nijmegen, The Netherlands. Subjects 
were enrolled after providing written informed consent. Institutional Review Boards 
of participating hospitals approved the inclusion of patients and controls in this 
study. All experiments were conducted according to the principles expressed in the 
Declaration of Helsinki.
Isolation	of	human	peripheral	blood	mononuclear	cells,	stimulation	and	TLR10	inhibition
PBMCs from healthy individuals were isolated according to standard protocols 
(Invitrogen, USA) as described previously[12]. 5x105 cells were added to a round- 
bottom 96-well plate (Corning, The Netherlands) and incubated with medium 
(RPMI), C. burnetii NM or C. burnetii 3262 in the presence of 10% human serum. 
After 24 hours, supernatants were harvested and stored at -20°C. In some experi-
ments, PBMCs were pre-incubated for 60 minutes with neutralizing anti-TLR10 
antibody (Abcam, UK, Clone 3C10C5) or mouse IgG1к monoclonal antibody (Clone 
11711, R&D Systems, USA) as isotype control.
Cytokine measurements
Cytokine production was measured in the supernatants using ELISA according to 
the manufacturer’s protocols. The following kits were used: IL-6, IL-8 (Sanquin, the 
Netherlands), TNF-α, IL-1β, IL-1RA (R&D Systems, USA). Absorption was measured 
at 450 nm (Bio-Rad Laboratories, the Netherlands). 
Genomic DNA isolation and single nucleotide polymorphism analysis 
DNA from the healthy volunteers (buffy coats), patients and controls (buffy coats 
and whole blood) was isolated using the Gentra Pure Gene Blood kit (Qiagen, USA) 
Material and methods
Coxiella burnetii
C. burnetii Nine Mile (NM) RSA493 phase I (a kind gift from the Bundeswehr Insti-
tute for Microbiology (Munich, Germany)) and C. burnetii X09003262 (3262) phase 
I were used. C. burnetii 3262 was isolated from the placenta of a goat that aborted 
in the Netherlands during the Q fever outbreak[6]. Both strains were cultured on 
Buffalo Green Monkey cells and the numbers of C. burnetii DNA copies was deter-
mined using Taqman real-time PCR as described previously[7]. Both C.  burnetii 
strains were heat-inactivated for 30 minutes at 99°C.
HEK293	cells
Transfection of HEK293 cells with human TLR2, TLR10 and both TLR2/TLR10 was 
performed as previously described and confirmed by RT-PCR and flowcytometry[5, 
8]. All HEK293 cells were cultured under selection in DMEM F12 medium (Gibco, 
Life Technologies, USA) supplemented with 100 U/ml Penicillin (Invitrogen, USA), 
100 µg/ml Streptomycin (Invitrogen, USA) and 7.5% non-heat inactivated Fetal 
Bovine Serum (HyClone, USA) at 37°C and 5% CO2. 1x106 cells were added to a 
96-wells plate and stimulated with either medium (DMEM), Pam3Cys 1 µg/ml (EMC 
Microcollections, Germany), Escherichia coli LPS 10ng/ml (Sigma-Aldrich, USA) or 
C. burnetii NM 1x107/ml. After 24h stimulation, the supernatants were collected and 
IL-8 was measured using enzyme-linked immunosorbent assay (ELISA) (Sanquin, 
The Netherlands).
Study population
Healthy volunteers
PBMCs were derived from buffy coats of blood donors (Sanquin, the Netherlands). 
DNA for SNP analysis was derived from whole blood of volunteers. The latter 
were healthy Dutch volunteers of Western European descent. Donor blood was 
not screened for C. burnetii antibodies and the individuals were not vaccinated for 
Q fever[9]. In the SNP experiment with C. burnetii 3262, cells were isolated from 
85 volunteers (23-73 years old, 23% females and 77% males). In the experiment 
with C. burnetii NM, cells were isolated from 123 volunteers (22-70 years old, 16% 
females and 84% males). Venous blood was drawn after informed consent was 
obtained. 
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Polymorphisms were identified using a pre-designed TaqMan® SNP genotyping 
assay (Applied Biosystems, USA). The following SNPs in TLR10 were analyzed 
in the healthy control group; N241H (rs11096957), M326T (rs11466653), I775V 
(rs4129009) and I369L (rs11096955). In the patient and control study, only N241H, 
I775V and I369L were examined. Details of the SNPs can be found in Table 2.
Statistics
The presence of Hardy-Weinberg equilibrium (HWE) for TLR10 N241H, I775V and 
I369L in healthy controls was analyzed using a web-based HWE calculator[14]. The 
association between susceptibility to chronic Q fever and a SNP was investigated 
by means of Fisher’s exact test and univariate logistic regression models with IBM 
SPSS 18 software (IBM Corp., USA). SNPs were evaluated using a dominant and 
recessive model analyses, for which odds ratios (OR) including 95% confidence 
intervals (CI) were reported. Differences between experimental groups (HEK293 
cells and healthy individuals) were tested using the Mann-Whitney U test. In experi-
ments using anti-TLR10, the Wilcoxon matched-pairs signed rank test was used. 
The data are expressed as mean ± SEM unless indicated otherwise. GraphPad 
Prism 5 software was used. Differences with a p-value <0.05 were considered 
statistically significant.
Table	2:	Single	nucleotide	polymorphisms	analyzed	in	the	study
according to the manufacturer’s protocol. A part of the DNA samples from patients 
and controls were isolated from buccal swabs, as described by the manufacturer’s 
protocol (Isohelix, UK). DNA isolated from heparin derived whole blood was treated 
with heparinase I (Sigma-Aldrich, USA) as described previously[13]. 
Table	1:	Baseline	characteristics	of	the	chronic	Q	fever	patients	and	controls
Gene SNP ID Mutation Nucleotide AA Change TaqMan
   change*  Assay ID
TLR10 rs11096957 Missense A > C N241H C____309088_10
TLR10 rs4129009 Missense A > C I775V C____309084_10
TLR10 rs11096955 Missense A > C I369L C____309086_10
TLR10 rs11466653 Missense T > C M326T C__25643406_10
Abbreviations: AA, amino acid
* The first nucleotide (and corresponding AA) is the ancestral nucleotide and therefore is considered the 
wild-type allele
Abbreviations: IQR, interquartile range
a Fisher exact test for categorical variables and Mann-Whitney U test for continuous variables.
b  Both vascular and valvular risk conditions in 9 chronic Q fever patients and 22 controls.
C  Chronic Q fever patients: Auto-immune disease with immunosuppressive drugs n=14; renal insuffi-
ciency n=1; renal transplantation n=1; malignancy n=3; prednis(ol)one use n=1. Controls: Autoimmune 
disease with immunosuppressive drugs n=5; renal transplantation n=2; malignancy n=4; prednis(ol)on 
use n=4.
 Chronic Q fever Control Cohort P-valuea 
 Cohort
	 (n=139)	 (n=220)
Median	age,	y	(IQR) 70.0 (63.0-75.6) 67.6 (58.3-74.3) 0.02
Male	sex	(%) 114 (82) 169 (77) 0.29
Classification of chronic Q fever
Proven (%)  92 (66.2) 0
Probable (%)  47 (33.8) 0
Cardiovascular risk factor for 
chronic Q feverb 
Vascular aneurysm / prosthesis (%) 95 (68.3) 129 (58.6) 0.07
Valvular defect / prosthesis (%) 39 (28.1) 111 (50.5) <0.001
Immunocompromised statec (%)	 21 (15.1) 14 (6.4) 0.01
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Results
Co-transfection	of	HEK293	cells	with	TLR2	and	TLR10	decreases	IL-8	production	after	
C. burnetii stimulation
To investigate the effect of TLR10 on the recognition of C. burnetii, HEK293 cells 
transfected with human TLR2, TLR10 or both TLR2 and TLR10 were stimulated with 
the reference strain C. burnetii NM. 
Figure 1 shows that stimulation of HEK293 cells expressing human TLR10 with 
C.  burnetii NM 1x107/ml resulted in 2-fold (p=0.015) increased IL-8 production 
compared to stimulated non-transfected HEK293 cells. In contrast, the IL-8 produc-
tion increased 7-fold (p=0.002) in C. burnetii NM stimulated HEK293 cells trans-
fected with human TLR2. Co-transfection with both TLR2 and TLR10 resulted in 
significant reduction of IL-8, indicating an inhibitory effect of TLR10 on C. burnetii- 
induced IL-8 production by HEK293 cells. Similar results were observed after 
stimulation with the TLR2 ligand Pam3Cys, whereas no differences were observed 
after stimulation with the TLR4 ligand E. coli LPS (Figure 1).
Figure	2:	 Inhibition	of	TLR10	 in	PBMCs	 leads	 to	 increased	cytokine	 responses	after	C. burnetii 
stimulation 
PBMCs of healthy volunteers were incubated with IgG1 isotype control or anti-TLR10 for 1h and subse-
quently stimulated with either medium control (RPMI, striped bar), C. burnetii NM 1x106/ml or C. burnetii 
3262 1x106/ml or Pam3Cys 10µg/ml. After 24h incubation, IL-β, TNF-α, IL-6, IL-8 (2A) and IL-1RA (2B) 
were measured in the supernatant by ELISA. Data are presented as mean values with SEM, n=9 from 3 
experiments, *p<0.05, ** p<0.01, Mann-Whitney U test.
Figure	1:	TLR10	inhibits	IL-8	production	by	Coxiella burnetii-stimulated	HEK293	cells	
HEK293 cells and HEK293 cells expressing human TLR2, TLR10 and TLR2/10 were stimulated with 
medium (DMEM), C. burnetii NM 1x107/ml, Pam3Cys 1µg/ml or E. coli LPS 10ng/ml. After 24 incuba-
tion, IL-8 was measured in the supernatant by ELISA. Data are mean values with SEM, n=8, * p<0.05, 
***p<0.001, Mann-Whitney U test.
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Inhibition	 of	 TLR10	 leads	 to	 increased	 cytokine	 responses	 in	C.  burnetii stimulated 
human PBMCs
The inhibitory effect of TLR10 on C.  burnetii-induced cytokine production was 
further investigated by stimulation of human PBMCs with C.  burnetii NM and 
C.  burnetii 3262 in the presence or absence of TLR10 neutralizing antibodies. 
When PBMCs were pre-incubated with anti-TLR10 and stimulated with C. burnetii 
3262, a significantly increased production of IL-1β, TNF-α and IL-8 was observed, 
and a similar trend was seen for IL-6 (Figure 2A). Stimulation with C. burnetii NM 
resulted in a significantly increased IL-1β production in the presence of anti-TLR10. 
The same, though not significant, trend was observed for the production of TNF-α, 
IL-6 and IL-8 (Figure 2A). Oosting et al.[5], hypothesized that the increased pro- 
inflammatory response could be a reduced production of the anti-inflammatory 
cytokine IL-1RA. Therefore, the IL-1RA production was measured in PBMCs stimu-
lated with both C. burnetii strains in the presence of anti-TLR10. Figure 2B shows 
that, similar to the other cytokines measured, the IL-1RA production is significantly 
increased when the function of TLR10 is inhibited.
PBMCs from healthy individuals with single nucleotide polymorphisms in TLR10 
produce more cytokines upon C. burnetii	3262	stimulation  
The effect of genetic variation in TLR10 on C. burnetii induced cytokine produc-
tion by PBMCs was examined in healthy individuals, genotyped for three polymor-
phisms in TLR10; N241H (rs11096957), I369L (rs11096955), I775V (rs4129009) 
and M326T (rs11466653). Hereto, their PBMCs were stimulated with C.  burnetii 
NM and C. burnetii 3262 for 24h. The polymorphisms I369L and N241H were in 
complete linkage in the cohort of healthy individuals and therefore the results were 
combined. Stimulation with C. burnetii NM resulted in an increased IL-1β, TNF-α 
and IL-6 production. However no differences in cytokine expression were found 
between the different genotypes of TLR10 N241H/I369L (Figure 3A) and I775V 
(Figure 3B). In contrast, heterozygosity for TLR10 N241H/I369L and TLR10 I775V 
led to increased TNF-α and IL-6 production after stimulation with C. burnetii 3262 
(Figure 3A and 3B). PBMCs derived from individuals heterozygous for the TLR10 
M326T polymorphism did not display higher cytokine levels upon stimulation with 
either C. burnetii NM or C. burnetii 3262 (data not shown). 
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Polymorphisms in TLR10 are not associated with chronic Q fever 
To assess the role of TLR10 polymorphisms N241H, I369L and I775V in the suscep-
tibility to chronic Q fever, DNA samples of 139 chronic Q fever patients and 220 
controls were analyzed. The controls are individuals from the same area with risk 
factors for chronic Q fever (valvular or vascular abnormalities) and serological 
evidence of C.  burnetii exposure (anti-C.  burnetii phase II IgG antibodies ≥1:32) 
without evidence of chronic Q fever. In case of TLR10 N241H >93% of all subjects 
were successfully genotyped, for TLR10 I775V the percentage reached >95%, and 
86% in case of TLR10 I369L. All polymorphisms were in HWE in the control group. 
No significant differences in genotype distribution were found between the chronic 
Q fever cohort and the control cohort, the P values for N241H, I369L and I775V 
after the Fisher's exact test were respectively 0.39, 0.56 and 0.30 (Table 3). Also, 
univariate logistic regression analysis in both the dominant as recessive model 
revealed that TLR10 polymorphism N241H, I369L and I775V were not associated 
with susceptibility to chronic Q fever (Table 3).
Figure	3:	SNPs	in	TLR10 lead to increased cytokine responses after C. burnetii 3262 stimulation  
PBMCs of healthy individuals genotyped for TLR10 N241H/I369L (3A) and TLR10 I775V (3B) were stimu-
lated with medium (RPMI, striped bar), C. burnetii NM 3x106/ml or C. burnetii 3262 3x106/ml in the pres-
ence of serum. Cytokines were measured in the supernatant by ELISA after 24h incubation. The numbers 
between brackets behind the genotypes indicate the number of individuals analyzed. Data are presented 
as mean values with SEM, *p<0.05, ** p<0.01, *** p<0.001, Mann-Whitney U test.
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Table	3:	Distribution	of	TLR10	genotypes	in	patients	with	chronic	Q	fever	and	controls
Dominant model analysisb Recessive model analysisb
p	value	 OR	(95%	CI)	 p	value	 OR	(95%	CI)
0.54 0.87 (0.56-1.36) 0.74 0.90 (0.48-1.69)
 
 
0.62 0.89 (0.56-1.40) 0.94 0.95 (0.22-4.02)
 
 
0.48 0.83 (0.52-1.30) 0.87 0.89 (0.46-1.74)
 
 
Abbreviations: AA, amino acid
a Fisher's exact test
b Logistic regression
Polymorphism Genotype distribution p valuea
	 No.	(%)	 No.	(%)	 No.	(%)
TLR10	(N241H)	 AA AC CC 0.39
Patients 57 (42.5) 59 (44.0) 18 (13.4)
Controls 80 (39.2) 94 (46.1) 30 (14.7)
TLR10	(I775V) AA AC CC 0.30
Patients 91 (67.4) 41 (30.4) 3 (2.2)
Controls 138 (64.8) 70 (32.9) 5 (2.3)
TLR10	(I369L) AA AC CC 0.56
Patients 54 (43.5) 54 (43.5) 16 (12.9)
Controls 74 (39.4) 87 (46.3) 27 (14.4)
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strain C.  burnetii NM compared to the Dutch outbreak isolate C.  burnetii 3626. 
Recently, we reported divergent recognition of these two strains by the TLR1/TLR2 
and TLR2/TLR6 heterodimers[2]. C. burnetii 3262 is recognized by both TLR1/TLR2 
and TLR2/TLR6 heterodimers, while the sensing of C.  burnetii NM only involves 
the TLR1/TLR2 heterodimer[2]. TLR10 is closely related to both TLR1 and TLR6, 
and experiments have shown that the inhibitory effects of TLR10 are mediated 
via interaction with TLR2 and possibly TLR1 and TLR6[4, 18]. From our results it 
can be hypothesized that the suppressive function of TLR10 on C. burnetii-induced 
cytokines is more likely to be associated with TLR6 than TLR1, as the presence 
of genetic variants in TLR10 had more effect on cytokine production by PBMCs 
stimulated with C. burnetii 3262 than C. burnetii NM. A second explanation can be 
the presence of a different binding site of the two C. burnetii strains to the TLR10 
receptor. In case of C. burnetii NM, the presence of polymorphisms in TLR10 does 
not influence cytokine production by PBMCs, while cytokine production derived 
by C. burnetii 3262 stimulation was suppressed by the presence of the common 
genotypes of the TLR10 polymorphisms. Based on these findings it can be hypo- 
thesized that the examined polymorphisms in TLR10 do not influence the binding 
of C. burnetii NM to TLR10, while this can be presumed for C. burnetii 3262. This 
also suggests a difference between C.  burnetii strains, that might influence the 
susceptibility of individuals to different C. burnetii strains.
Recently, the genetic variation in pattern recognition receptors in chronic Q fever 
patients and controls was investigated. The presence of single nucleotide poly-
morphisms in TLR1 (R80T, rs5743611), NOD2 (1007fsX1, rs2066847) and MyD88 
(-938C>A, rs4988453) was differently distributed among chronic Q fever patients 
compared to control individuals, indicating that these genes are associated with 
development of chronic Q fever[11]. Although in vitro human and mice studies 
showed a significant role for TLR2 in C.  burnetii recognition, no evidence was 
found that particular SNPs in TLR2 led to increased susceptibility to either acute 
or chronic Q fever[2, 11, 19-21]. Barreiro et al. reported that TLR10 is under selec-
tive pressure in European countries and that polymorphisms in TLR10 are able to 
influence its function[22]. Indeed, polymorphism in TLR10 I775V and N241H are 
both involved in the susceptibility to prostate cancer, Crohn’s disease and compli-
cated skin and skin structure infections[17, 23-25]. Based on our in-vitro findings 
and the association of TLR10 polymorphisms with several diseases, we studied 
Discussion
In the present study, we examined the role of TLR10 on C. burnetii-induced cytokine 
production and investigated whether genetic variants in TLR10 were associated 
with development of chronic Q fever. The results demonstrate that TLR10 inhibits 
cytokine induction of C.  burnetii mediated by TLR2. In addition, individuals with 
polymorphisms TLR10 N241H/I369L or I775V revealed higher cytokine production 
after PBMC stimulation with the Dutch outbreak isolate C. burnetii 3262. Despite 
these observed effects of TLR10 on the production of cytokines in vitro, polymor-
phisms in TLR10 were not associated with the development of chronic Q fever.
While the function and ligands of TLR1, TLR2 and TLR6 have been studied exten-
sively, less is known about the role of TLR10 in general and in C. burnetii recogni-
tion. Similar to most TLRs, TLR10 signals via the myeloid differentiation primary 
response gene 88 (MyD88) adaptor protein, it however does not evoke common 
TLR-induced signaling including NF-κB and IL-8 driven pathways[4, 5]. TLR10 is 
located in a gene cluster on chromosome 4 with TLR1, TLR2 and TLR6 and studies 
suggest that TLR10 is able to form heterodimers with TLR2 as well as TLR1 and 
TLR6[4, 15, 16]. More recently, it was demonstrated that TLR10 acts as an anti- 
inflammatory receptor, suppressing TLR2 driven cytokine production[5]. Our results 
strengthened our finding that C. burnetii signals via TLR2[2] and C. burnetii can be 
added to the broad range of TLR2 micro-organisms, including Borrelia burgdorferi, 
Yersinia pestis and Bacteroides fragilis[5, 8, 17] in which inhibitory effects of TLR10 
on cytokine induction has been observed.
C. burnetii 3262 stimulated PBMCs showed an enhanced cytokine production in 
individuals bearing genetic variation in TLR10 N241H/I369L and I775V. We investi-
gated this in C. burnetii induced cytokine production by PBMCs from healthy volun-
teers having these polymorphisms. This finding was also observed in response to 
the TLR1/2 ligand Pam3Cys, Borrelia burgdorferi, Yersinia pestis and Bacteroides 
fragilis[5, 8, 17]. In contrast, cytokine production by PBMCs from individuals carrying 
polymorphisms in TLR10 N241H/I369L or I775V did not differ after stimulation with 
C. burnetii NM compared to individuals without these SNPs. The results presented 
here could suggest a possible different role for TLR10 in sensing the laboratory 
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the genetic variation within TLR10 in chronic Q fever patients and controls. To 
examine this, 139 chronic Q fever patients and 220 controls (individuals with same 
risk factors and a previous Q fever infection) were genotyped for TLR10 N241H, 
I369L and I775V. No significant differences in genotype distribution of TLR10 
N241H and TLR10 I775V were observed between chronic Q fever patients and 
controls, demonstrating that these polymorphisms in TLR10 do not influence the 
risk to develop chronic Q fever. TLR10 I369L is located in the region of the receptor 
dimer interface of the TLR2/TLR10 heterodimer[4]. It can therefore be assumed 
that this SNP has a more potential role on TLR10 than the other SNPs examined. 
However, TLR10 I369L was also not associated with the development of chronic Q 
fever.
In the Dutch Q fever outbreak, C.  burnetii 3262 was the predominant genotype 
responsible for clinical disease in humans[6, 26]. We therefore assume that the 
chronic Q fever patients in this study are infected with this strain. Even though our 
in-vitro study showed a larger effect of TLR10 on cytokine production by C. burnetii 
3262 than C. burnetii NM, infection with C. burnetii 3262 and genetic variations in 
TLR10 are not associated with a tendency to develop chronic Q fever.
In the present study, we only compared the genetic variation of TLR10 within 
chronic Q fever patients and individuals who have had an initial infection, but did 
not develop chronic Q fever. Therefore, whether TLR10 has a role in development of 
symptoms or severity in acute Q fever was not studied.
In conclusion, the present study demonstrates that TLR10 suppresses the cytokine 
production of human mononuclear cells after encounter with C. burnetii. Despite 
the evident inhibitory effect of TLR10 on C. burnetii-induced cytokine production, 
the observed functional consequences of polymorphisms in TLR10 in healthy indi-
viduals are only observed upon C. burnetii 3262 stimulation and are not linked to 
the development of chronic Q fever. In addition, the present study confirms the 
important role of TLR2 in the recognition of C. burnetii.
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Introduction
Q fever is an infection with the intracellular Gram-negative bacterium Coxiella 
burnetii. Although most symptomatic individuals experience only mild flu-like 
symptoms or pneumonia (acute Q fever), some patients develop a persistent 
infection with severe complications including endocarditis and vascular (pros-
thesis) infection (chronic Q fever). Persistent infection occurs in overall 1-5% of 
C. burnetii-infected subjects and develops insidiously, which contributes to its late 
diagnosis and high mortality. It is well established that the main risk factors for 
chronic infection are pre-existing abnormalities of cardiac valves (including valvu-
lar prosthesis), vascular aneurysms, vascular prosthesis and immunosuppres-
sion[1, 2]. However, in a large outbreak in the Netherlands from 2007 to 2010, only 
a minority of patients with these risk factors developed chronic Q fever after (sero-
logical evidence of) infection with C. burnetii[3, 4]. Inefficient early recognition of 
the bacterium by the innate immune system followed by incomplete eradication 
and/or inadequate initiation of adaptive immune responses may be a contributing 
factor in the development of chronic Q fever.
The innate immune system provides the first barrier against C. burnetii infection. 
In general, pattern recognition receptors (PRRs) on innate immune cells recognize 
molecular moieties on the surface of microorganisms. Toll-like receptors (TLRs) 
and nucleotide-binding oligomerization domain proteins (NODs) are the main PRRs 
involved in the recognition of bacteria. TLRs interact with several adaptor proteins, 
including myeloid differentiation primary response gene 88 (MyD88) and Toll inter-
leukin-1 receptor domain-containing adaptor protein (TIRAP), to activate transcrip-
tion factors, leading to production of proinflammatory cytokines, activation of anti-
microbial mechanisms and subsequent initiation of adaptive immune responses. 
MyD88 is also required for the production of interleukin (IL)-1, IL-18 and IL-33, which 
emphasizes its importance for host defense against microorganisms. We recently 
demonstrated that C.  burnetii-induced cytokine production by human innate 
immune cells is mediated through recognition by the heterodimer TLR1/TLR2 on 
the cell membrane and by the cytoplasmic NOD2[5]. TLR6 appears to be involved 
specifically in the recognition of the C. burnetii strain 3262 that was isolated during 
the outbreak in the Netherlands[5]. Microorganisms such as C. burnetii use phago-
Abstract
Q fever is an infection caused by Coxiella burnetii. Persistent infection (chronic Q 
fever) develops in 1-5% of patients. We hypothesize that inefficient recognition of 
C. burnetii and/or activation of host-defense in individuals carrying genetic variants 
in pattern recognition receptors or adaptors would result in an increased likelihood 
to develop chronic Q fever.
Twenty-four single nucleotide polymorphisms (SNPs) in genes encoding TLRs, 
NOD-like receptor-2, αvβ3-integrin, CR3, and adaptors MyD88 and TIRAP were geno-
typed in 139 chronic Q fever patients and in 220 control individuals with cardiovas-
cular risk-factors and previous exposure to C. burnetii. Associations between these 
SNPs and chronic Q fever were assessed by univariate logistic regression models. 
Cytokine production in whole blood stimulation assays was correlated to relevant 
genotypes.
Polymorphisms in TLR1(R80T), NOD2(1007fsX1) and MYD88(-938C>A) were asso-
ciated with chronic Q fever. No association was observed for polymorphisms in 
TLR2,TLR4,TLR6,TLR8,ITGAV,ITGB3,ITGAM and TIRAP. No correction for multiple 
testing was performed since only genes with a known role in initial recognition of 
C. burnetii were included. In the whole-blood assays, individuals carrying the TLR1 
80R-allele showed increased IL-10 production upon C. burnetii exposure.
Polymorphisms in TLR1(R80T), NOD2(L1007fsX1) and MYD88(-938C>A) are asso-
ciated with predisposition to development of chronic Q fever. For TLR1, increased 
IL-10 responses to C. burnetii in individuals carrying the risk allele may contribute 
to the increased risk of chronic Q fever.
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Material and Methods
Ethics statement
The study was approved by the Ethical Committee of Radboud university medical 
center, Nijmegen, The Netherlands. Subjects were enrolled after providing writ-
ten informed consent (or waiver when deceased [n=5], as approved by the Ethical 
Committee). Institutional Review Boards of participating hospitals approved the 
inclusion of patients and controls in this study. The study has been performed in 
accordance with the Declaration of Helsinki.
Subjects
All patients with probable or proven chronic Q fever, as defined by the Dutch consen-
sus on chronic Q fever (Table 1)[18], who visited the outpatient clinic at the Depart-
ments of Internal Medicine of the participating hospitals, were asked to partici-
pate in the study. The recruitment of patients took place between July 2011 and 
July 2014 at Radboud university medical center (Nijmegen), Canisius-Wilhelmina 
Hospital (Nijmegen), Catharina Hospital (Eindhoven), Elkerliek Hospital (Helmond), 
Atrium Medical Center (Heerlen), Elisabeth Hospital (Tilburg), Bernhoven Hospi-
tal (Oss) and Jeroen Bosch Hospital (’s-Hertogenbosch). Demographic and clini-
cal characteristics (classification based on serological titers and imaging results, 
cardiovascular risk factors, immunosuppressive co-morbidity or medication) were 
retrieved from the patients’ medical records. The population-matched control 
group consisted of individuals from the same area with valvular or vascular abnor-
malities predisposing to chronic Q fever, who had serological evidence of expo-
sition to C. burnetii (anti-C. burnetii phase II IgG antibodies ≥1:32) without clinical 
symptomatology or serological evidence of chronic Q fever. These individuals were 
recruited in the Q fever pre-vaccination screening campaign January-April 2011 
[19, 20] and in a Q fever screening of patients with vascular risk factors living in the 
Q fever outbreak area[21].
Genotyping
From patients who came to the outpatient clinic or to the Q fever pre-vaccination 
screening, venous blood was drawn and stored at -80°C until use. DNA was isolated 
from these blood samples using standard methods[22]. Other participants, both 
cytosis as an efficient mechanism of entry into monocytes/macrophages where 
they can survive intracellularly in a parasitophorous vacuole (PV)[6]. An important 
role in C. burnetii uptake has been described for leucocyte response integrin (αvβ3 
integrin) and complement receptor 3 (CR3 [αMβ2, CD11b/CD18]). Virulent phase 
I C.  burnetii uptake is mediated by αvβ3 integrin, while phagocytosis of avirulent 
phase II C. burnetii also involves CR3[7, 8]. 
Genetic variants in immune cell receptors such as TLRs and NODs and their adap-
tors have been associated with increased susceptibility to bacterial infections[9-16]. 
Thus, it is tempting to speculate that inefficient recognition of C. burnetii and acti-
vation of host defense in certain individuals carrying genetic variants in these 
receptors or adaptors, would result in an ineffective early clearance of the bacte-
rium and an increased likelihood to develop chronic Q fever. No study so far has 
been able to investigate this, due to the low prevalence of the disease. The recent 
Q fever outbreak in the Netherlands led to over 4000 reported acute Q fever cases 
and more than 250 cases of chronic Q fever[17], which offered an unique opportu-
nity to study this. 
We hypothesized that certain polymorphisms in the host’s PRR genes or in genes 
encoding their signaling adaptor proteins influence the risk of persistent C. burnetii 
infection and hence the development of chronic Q fever. To test this hypothesis, 
we analyzed the prevalence of specific single nucleotide polymorphisms (SNPs) in 
11 candidate genes – TLR1,TLR2,TLR4,TLR6, TLR8,MYD88,TIRAP,NOD2,ITGAV,ITGB3 
and ITGAM (CD11b) – in a cohort of 139 chronic Q fever patients and a control 
cohort of 220 individuals, living in the same area and with valvular or vascular 
predisposing factors for chronic Q fever, who had contracted C.  burnetii (based 
on positive serology) but did not develop chronic Q fever. The genetic study was 
complemented with functional assays investigating the effect of the specific 
polymorphisms on the in vitro cytokine production in whole blood incubated with 
C. burnetii.
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patients and controls, received a buccal swab kit (Isohelix, Cell Projects Ltd., 
Harrietsham, Kent, UK) to obtain epithelial cells for DNA isolation. DNA was isolated 
using a buccal DNA isolation kit (Isohelix), according to the manufacturer’s proto-
col. SNPs were selected based on known functional effects on protein function 
or gene expression, published associations with human diseases and/or haplo-
view data. In total, 25 SNPs in TLR1,TLR2,TLR4,TLR6, TLR8,TIRAP,MYD88,NOD2,IT-
GAV,ITGB3 and ITGAM were genotyped with a Sequenom mass-spectrometry geno-
typing platform. Quality control was performed by duplicating 5% of the samples 
within and across plates, by the incorporation of positive and negative control 
samples and by sequencing samples to verify the various genotypes.
In-vitro whole blood stimulation and cytokine measurements
In a subgroup of the control subjects – those who participated in the Q fever 
pre-vaccination screening study as described earlier[23] – whole blood assays 
were performed and C.  burnetii-induced cytokines were measured (n=93). In 
short, venous blood was drawn into 5 ml endotoxin-free lithium-heparin tubes 
(Vacutainer, BD Biosciences) and samples were processed within 12 hours. Blood 
was aliquoted in separate tubes and incubated at 37°C for 24 hours with heat- 
inactivated (30 min at 99°C) C. burnetii Nine Mile (NM) RSA493 phase I [24](107 
bacteria/ml), mitogen (positive control) or without stimulus (negative control) 
as previously described[23]. After incubation, blood cultures were centrifuged at 
4656 g for 10 minutes and supernatants were collected. Supernatants were stored 
at -20ºC until cytokine concentrations – including IL-1β, tumor-necrosis factor 
(TNF), IL-2, IL-6 and IL-10 – were measured by a commercially available magnetic 
beads multiplex assay according to manufacturer’s instructions (Merck Millipore, 
Billerica, MA, USA). 
Statistical analysis
Presence of Hardy-Weinberg equilibrium (HWE) was analysed for all 24 SNPs 
separately in the control cohort[25]. For the two TLR8 SNPs on the X-chromosome, 
only the female subjects were included in the HWE analysis and relative allele 
frequencies were subsequently compared between female and male subjects. 
The difference in genotype frequencies between the patients and the control 
group were analyzed by means of a gene dosage model, with Fisher’s exact test 
to test for significance. Subsequent dominant and recessive model analysis was 
Table	1:	Classification	chronic	Q	fever	according	to	the	Dutch	consensus	guidelines
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Classification Criteria
Proven chronic Q fever 1. Positive C.burnetii PCR in blood or tissuea
OR
 2. IFA titer of ≥ 1:800 or 1:1,024 for C.burnetii phase I IgGb 
 AND
 –  definite endocarditis according to the modified Duke criteria [50]
  OR
–  proven large vessel or prosthetic infection by imaging studies   
  (FDG-PET, CT, MRI or AUS)
Probable chronic Q fever IFA titre of ≥ 1:800 or 1:1024 for C.burnetii phase I IgGb 
 AND 
 One or more of the following criteria:
 – Valvulopathy not meeting the major criteria of the modified Duke   
  criteria [50]
– Known aneurysm and/or vascular or cardiac valve prosthesis   
  without signs of infection by means of TEE/TTE, FDG-PET, CT, MRI   
  or abdominal ultrasound
 – Suspected osteomyelitis, pericarditis, or hepatitis as manifestation  
  of chronic Q fever
– Pregnancy
 – Symptoms and signs of chronic infection, such as fever, weight   
  loss and night sweats, hepato-splenomegaly, persistent raised ESR  
  and CRP
 – Granulomatous tissue inflammation, proven by histological   
 examination
 – Immunocompromised state
Probable chronic Q fever IFA titer of ≥ 1:800 or 1:1024 for C.burnetii phase I IgGb without   
 manifestations meeting the criteria for proven or probable chronic   
 Q fever
Abbreviations: IFA, immunofluorescence assay; FDG-PET, fluorodeoxyglucose positron emission tomo- 
graphy; MRI, magnetic resonance imaging; CT, computer tomography; TEE, transesophageal echocardio- 
graphy; TTE, Transthoracic echocardiography. AUS, abdominal ultrasound.
a In absence of acute infection.
b  Cutoff is dependent on the IFA technique used (≥1:800 for a technique developed in house and ≥1:1024 
for a commercial IFA technique).
102  SNPS IN PRR GENES IN CHRONIC Q FEVER CHAPTER 5	 103
one of the three NOD2 polymorphisms and one of the two MYD88 polymorphisms 
was revealed in the dominant model: NOD2 L1007fsX1 (P = 0.02; OR, 3.34 [95% CI, 
1.22-9.14]) and MYD88 -938C>A (P = 0.04; OR, 2.15 [95% CI, 1.05-4.39]) (Table 4). 
In comparison to controls, patients were more often heterozygous for the allelic 
variant of these SNPs.
Table	2:	Baseline	patient	characteristics	of	the	chronic	Q	fever	patients	and	controls
performed by means of univariate logistic regression, for which odds ratios (ORs) 
and their 95% confidence intervals (95% CI) were reported. Because the choice of 
the genetic variants was based exclusively on gene products with an established or 
suspected role in C. burnetii recognition, rather than exploratory, no correction for 
multiple testing was performed. Statistical analyses were carried out with the IBM 
SPSS software (version 20). Cytokine concentrations in the in vitro whole blood 
stimulation assays were stratified according to genotype and compared using 
Mann-Whitney U-tests, using GraphPad Prism (GraphPad software Inc., version 5). 
Overall, statistical tests were two-sided and a P-value below 0.05 was considered 
statistically significant.
Results
Baseline characteristics
In total, 139 (92 proven and 47 probable) chronic Q fever patients and 220 control 
subjects without chronic Q fever but with serological evidence of C. burnetii expo-
sure and a risk factor for chronic Q fever were included in the study. Demographic 
and clinical characteristics of patients and control subjects are summarized in 
Table 2. Patients were slightly older than controls (2.4 yrs difference in median 
age). In both groups, vascular risk factors were more prevalent than cardiac valvu-
lar risk factors. Valvular risk factors were, however, more prevalent in the control 
subjects than in the patients. Chronic Q fever patients were more often immuno-
compromised than the control subjects.
SNPs	in	MYD88,	NOD2	and	TLR1	are	associated	with	chronic	Q	fever
Genotyping of patients and controls was successful for all polymorphisms in 
genes encoding TLRs, NOD2, MyD88, TIRAP, αvβ3 integrin and CR3 presented in 
Table 3. For each polymorphism, >94% of the subjects were genotyped. All SNPs 
were in Hardy-Weinberg equilibrium in the control group, except for ITGB3 rs4642 
(χ2=6.18). This SNP was excluded from further analysis. 
In the analysis of all chronic Q fever patients, a significantly different distribution of 
Abbreviations: IQR, interquartile range
a Fisher exact test for categorical variables and Mann-Whitney for continuous variables.
b Both vascular and valvular risk conditions in 9 case-patients and 22 controls.
c Case-patients: Auto-immune disease with immunosuppressive drugs n=14; renal insufficiency n=1; 
renal transplantation n=1; malignancy n=3; prednis(ol)one use not specified n=1. Controls: Auto- 
immune disease with immunosuppressive drugs n=5; renal transplantation n=2; malignancy n=4; pred-
nis(ol)on use not specified n=4.
 Chronic Q fever Control Cohort P-valuea 
 Cohort
	 (n=139)	 (n=220)
Median	age,	y	(IQR) 70.0 (63.0-75.6) 67.6 (58.3-74.3) 0.02
Male	sex	(%) 114 (82) 169 (77) 0.29
Classification of chronic Q fever
Proven (%)  92 (66.2) 0
Probable (%)  47 (33.8) 0
Cardiovascular risk factor for 
chronic Q feverb 
Vascular aneurysm / prosthesis (%) 95 (68.3) 129 (58.6) 0.07
Valvular defect / prosthesis (%) 39 (28.1) 111 (50.5) <0.001
Immunocompromised statec	(%)	 21 (15.1) 14 (6.4) 0.01
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When only proven chronic Q fever patients were considered, TLR1 R80T was signifi-
cantly differently distributed among patients and controls in the dominant model (P 
= 0.034, OR, 0.48 [95% CI, 0.24-0.95) (Table 5), while it was marginally significant 
(P = 0.08, OR, 0.61 [95% CI, 0.35-1.06) when all patients (both proven and proba-
ble) were included. Patients were less often heterozygous or homozygous for the 
allelic variant of this SNP. The distributions of NOD2 L1007fsX1 and MYD88 -938C> 
showed a trend toward significance among patients and controls (P = 0.065 and 
P = 0.091, respectively) when only proven chronic Q fever patients were included 
in the analysis.
No associations were observed between polymorphisms in TLR2,TLR4,TLR6,TI-
RAP,ITGAV, ITGB3,ITGAM and development of chronic Q fever.
TLR1	SNP	R80T	affects	in vitro	IL-10	production	by	C. burnetii-stimulated whole blood 
Functional consequences of TLR1 R80T, NOD2 L1007fsX1 and MYD88 -938C>A 
were studied by C. burnetii-stimulation of whole blood obtained from 93 control 
subjects with different TLR1 R80T, NOD2 L1007fsX1 and MYD88 -938C>A geno-
types. Cytokine production of IL-1β, TNF, IL-2, IL-6 and IL-10 was measured after 
24 hours of stimulation. Decreased IL-10 production was observed upon stimula-
tion with C. burnetii by blood cells with TLR1 80T containing genotypes, which is 
associated with lower susceptibility to chronic Q fever. Pro-inflammatory cytokine 
production, including IL-1β, IL-6, TNF and IL-2, was not different among TLR1 R80T 
genotypes (Figure 1).
IL-1β, TNF and IL-10 responses to C. burnetii in relation to NOD2 L1007fsX1 and 
MYD88 -938C>A polymorphisms revealed no significant differences (Figure 2). IL-6 
and IL-2 are not shown (P-value of 0.78 and 0.58 for IL-6 and IL-2 respectively, 
when stratified by genotype NOD2 1007fsX1; P-value of 0.51 and 0.52 for IL-6 and 
IL-2 when stratified by genotype MYD88 -938C>A).
Table	3:	Genotyped	SNPs	in	genes	encoding	immune	receptors	and	adaptor	molecules
Gene SNP ID Gene Region Nucleotide Amino Acid Change
   changea
TLR1 rs4833095 Exon 4 T > C S248N  
 rs5743611 Exon 4 G > C R80T
TLR2 rs111200466 5'UTR ins > del
 rs5743704 Exon 3 C > A P631H
 rs5743708 Exon 3 G > A R753Q
TLR4 rs4986790 Exon 3 A > G D299G
 rs1927911 Intron 1 C > T 
TLR6 rs1039559 Intron 1 T > C 
 rs5743818 Exon 2 T > G Synonymous (A644A)
TLR8 rs3747414 Exon 3 C > A Synonymous (I751I)
  rs3764880 Exon 1 A > G M1V affects protein start
NOD2 rs1077861 Intron 10 A > T
 rs2066847 Exon 11 – > C frameshift and stopcodon (L1007fsX1)
  rs2066844 Exon 4 C > T R702W
MYD88 rs4988453 Promoter C > A
 rs6853 3' UTR A > G
TIRAP rs8177348 Intron 1 C > T  
 rs8177374 Exon 5 C > T S180L
ITGAV rs3738919 Intron 17 C > A
 rs9333288 Intron 3 A > G
ITGB3 rs3809865 3' UTR A > T
 rs4642 Exon 10 G > A Synonymous (E511E) 
ITGAM rs1143679 Exon 3 G > A R77H
  rs1143678 Exon 30 C > T P1146S
Abbreviations: SNP, single nucleotide polymorphism; ID, identification number
a The first nucleotide is the most common nucleotide.
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Table	4:	Associations	of	polymorphisms	in	immune	receptors	and	adaptors	genes	and	susceptibility	
to chronic Q fever
Polymorphism Genotype distribution  Dominant model analysisb Recessive model analysis
    p valuea p valueb	 OR	(95%	CI)b p valueb	 OR	(95%	CI)b
TLR1 rs4833095 TT CT CC .60 .40 1.21 (0.78-1.87) .48 1.42 (0.53-3.77)
controls (%) 121 (57.6) 80 (38.1) 9 (4.29) 
patients (%) 71 (53.0) 55 (41.0) 8 (5.97)
TLR1 rs5743611 GG GC CC .21 .08 0.61 (0.35-1.06) .77 0.78 (0.14-4.30)
controls (%) 158 (75.6) 47 (22.5) 4 (1.91)
patients (%) 112 (83.6) 20 (14.9) 2 (1.49)
TLR2	rs111200466 ins/ins ins/del del/del .48 .67 0.90 (0.56-1.46) .36 1.64 (0.56-4.79)
controls (%) 145 (69.4) 57 (27.3) 7 (3.35) 
patients (%) 93 (71.5) 30 (23.1) 7 (5.38)
TLR2 rs5743704 CC CA AA .69 .67 1.19 (0.54-2.59) na
controls (%) 193 (92.3) 16 (7.66) 0   
patients (%) 122 (91.0) 12 (8.96) 0
TLR2 rs5743708 GG GA AA .89 .51 1.34 (0.56-3.18) .75 1.58 (0.10-25.46)
controls (%) 207 (94.5) 11 (5.02) 1 (0.46)
patients (%) 129 (92.8) 9 (6.47) 1 (0.72)     
TLR4	rs4986790 AA AG GG .19 .36 0.75 (0.41-1.38) 1.00 2.55E9 (0.0-∞)
controls (%) 174 (82.9) 36 (17.1) 0   
patients (%) 116 (86.6) 17 (12.7) 1 (0.75)  
TLR4 rs1927911 CC TC TT .48 .25 1.30 (0.83-2.01) .90 1.06 (0.46-2.43) 
controls (%) 130 (61.9) 65 (31.0) 15 (7.14)
patients (%) 74 (55.6) 49 (36.8) 10 (7.52)      
TLR6	rs1039559 TT TC CC .81 .50 1.18 (0.72-1.94) .90 1.03 (0.60-1.78)
controls (%) 60 (28.7) 108 (51.7) 41 (19.6)    
patients (%) 34 (25.4) 73 (54,5) 27 (20.1)
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Table 4: Continued
Polymorphism Genotype distribution  Dominant model analysisb Recessive model analysis
    p valuea p valueb	 OR	(95%	CI)b p valueb	 OR	(95%	CI)b
TLR6	rs5743818 TT TG GG .34 .19 0.75 (0.48-1.16) .24 0.62 (0.27-1.38) 
controls (%) 104 (49.5) 84 (40.0) 22 (10.5)      
patients (%) 76 (56.7) 49 (36.6) 9 (6.72)   
TLR8 rs3747414c allele C allele A  .74    
controls (%) 276 (66.3) 140 (33.7)      
patients (%) 173 (65.0) 93 (35.0) 
TLR8 rs3764880c allele A allele G  .15
controls (%) 319 (77.1) 95 (22.9) 
patients (%) 193 (72.0) 75 (28.0) 
NOD2 rs1077861 AA TA TT .89 .74 1.08 (0.70-1.67) .64 1.18 (0.58-2.40)
controls (%) 97 (46.6) 91 (43.8) 20 (9.62)
patients (%) 60 (44.8) 59 (44.0) 15 (11.2) 
NOD2	rs2066847 -/- -/C C/C .02 .02 3.34 (1.22-9.14) na  
controls (%) 204 (97.1) 6 (2.86) 0 
patients (%) 122 (91.0) 12 (8.96) 0
NOD2 rs2066844 CC CT TT .50 .48 1.27 (0.66-2.45) na  
controls (%) 196 (89.5) 23 (10.5) 0      
patients (%) 121 (87.1) 18 (12.9) 0      
MYD88 rs4988453 CC CA AA .04 .04 2.15 (1.05-4.39) na  
controls (%) 195 (92.9) 15 (7.14) 0      
patients (%) 115 (85.8) 19 (14.2) 0      
MYD88 rs6853 AA GA GG .52 .30 1.29 (0.80-2.07) .78 0.78 (0.14-4.32) 
controls (%) 155 (73.8) 51 (24.3) 4 (1.90)      
patients (%) 92 (68.7) 40 (29.9) 2 (1.49)
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Table 4: Continued
Polymorphism Genotype distribution  Dominant model analysisb Recessive model analysis
    p valuea p valueb	 OR	(95%	CI)b p valueb	 OR	(95%	CI)b
TIRAP	rs8177348 CC CT TT .23 .26 1.29 (0.83-2.01) .12 1.93 (0.84-4.45) 
controls (%) 128 (61.8) 68 (32.9) 11 (5.31)      
patients (%) 74 (55.6) 46 (34.6) 13 (9.77)    
TIRAP rs8177374 CC CT TT .77 .76 0.93 (0.58-1.50) .58 1.57 (0.31-7.91) 
controls (%) 156 (71.9) 58 (26.7) 3 (1.38)     
patients (%) 102 (73.4) 34 (24.5) 3 (2.16)      
ITGAV rs3738919 CC CA AA .70 .54 0.87 (0.56-1.36) .69 1.14 (0.60-2.19) 
controls (%) 82 (39.2) 102 (48.8) 25 (12.0)   
patients (%) 57 (42.5) 59 (44.0) 18 (13.4) 
ITGAV rs9333288 AA AG GG .88 .70 1.09 (0.71-1.67) .81 0.90 (0.37-2.20) 
controls (%) 123 (56.4) 81 (37.2) 14 (6.42)     
patients (%) 75 (54.3) 55 (39.9) 8 (5.80)     
ITGB3 rs3809865 AA TA TT .17 .07 0.67 (0.44-1.03) .27 0.68 (0.34-1.35) 
controls (%) 86 (39.4) 103 (47.2) 29 (13.3)      
patients (%) 68 (49.3) 57 (41.3) 13 (9.42)      
ITGAM rs1143679 GG GA AA .68 .65 0.88 (0.49-1.56) .57 1.60 (0.32-8.04) 
controls (%) 180 (82.2) 36 (16.4) 3 (1.37)     
patients (%) 116 (84.1) 19 (13.8) 3 (2.17)     
ITGAM rs1143678 CC CT TT .51 .49 1.19 (0.73-1.95) .27 1.87 (0.62-5.70) 
controls (%) 159 (75.7) 45 (21.4) 6 (2.86)     
patients (%) 97 (72.4) 30 (22.4) 7 (5.22)      
Abbreviations: na, not applicable
a Fisher's exact test 
b Logistic regression 
c X-chromosomal 
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Table	5:	Distribution	of	TLR1	(R80T),	NOD2	(L1007fsX1)	and	MYD88	(-938C>A)	genotypes	in	proven	
chronic	Q	fever	patients	(n=92)	compared	to	controls	(n=220)
Polymorphism Genotype distribution  Dominant model analysisb Recessive model analysis
    p valuea p valueb	 OR	(95%	CI)b p valueb	 OR	(95%	CI)b
TLR1	rs5743611 GG GC CC .047 .034 0.48 (0.24-0.95) .86 1.17 (0.21-6.48) 
controls (%) 158 (75.6) 47 (22.5) 4 (1.91)      
patients (%) 78 (86.7) 10 (11.1) 2 (2.22)      
NOD2	rs2066847 -/- -/C C/C     
controls (%) 204 (97.1) 6 (2.86) 0 .007 .007 2.87 (0.94-8.79) na na 
patients (%) 83 (92.2) 7 (7.78) 0      
MYD88 rs4988453 CC CA AA .121 .091 2.00 (0.89-4.5) na na 
controls (%) 195 (92.9) 15 (7.14) 0         
patients (%) 78 (86.7) 12 (13.3) 0
Abbreviations: na, not applicable
a Fisher's exact test 
b Logistic regression 
c X-chromosomal 
114  SNPS IN PRR GENES IN CHRONIC Q FEVER CHAPTER 5	 115
Figure	1:	Association	between	TLR1 R80T genotypes and cytokine production after 24 hours whole 
blood stimulation with C. burnetii 
IL-1β, interleukin 1β; IL-2, interleukin 2; IL-6, interleukin 6; IL-10, interleukin 10; TNF, tumor necrosis factor. 
Stimulation was performed for 24 hours with heat-killed C. burnetii Nine Mile phase I (RSA 493) (bacteria 
count, 1 × 107/mL). Data are presented as medians and interquartile ranges, and groups were compared 
with the Mann-Whitney U test.
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Figure	2:	Association	between	NOD2 and MYD88 genotypes and cytokine production after 24 hours 
whole blood stimulation with C. burnetii 
Subjects were stratified by genotype NOD2 1007fsX1 (A,	C,	E) and MYD88 -938C>A (B,	D,	F). IL-1β (A,	B), 
TNF (C,	D) and IL-10 (E,	F) cytokine productions are shown. Stimulation was performed for 24 hours with 
heat-killed C. burnetii Nine Mile phase I (RSA 493) (1x 107 bacteria/ml). Data are presented as medians 
± interquartile range. Groups were compared by Mann-Whitney U-test.
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of persistent presence of the bacteria in monocytes/macrophages. Deciphering 
genetic polymorphisms in immune genes of the innate response to C. burnetii may 
give more insight in the mechanism. 
When performing genetic association studies, the choice of the control group is 
of pivotal importance. We deliberately chose a control cohort of subjects living in 
the same Q fever endemic area, with past C. burnetii infection (as shown by posi-
tive anti-C. burnetii serology), as well as cardiovascular risk factors for chronic Q 
fever, who did not develop chronic Q fever. When observing a different distribution 
of genetic polymorphisms between patients and these controls, it indicates that 
these polymorphisms modify the risk for developing chronic Q fever, and not for 
contracting C. burnetii infection or any underlying predisposing factors. The control 
cohort, however, was somewhat younger, had significantly more often valvular risk 
factors and less often immunocompromised conditions than the patient cohort. 
Notably, antimicrobial drug treatment at the time of acute Q fever might decrease 
the risk of chronic Q fever. Although information on previous treatment for acute Q 
fever was not obtained from the controls in this study, we assume that the majority 
of these individuals did not receive antibiotic treatment for acute Q fever since they 
participated in screening programs to detect previous C. burnetii infection.
The patient cohort included patients with proven or probable diagnosis of chronic Q 
fever, while possible cases were left out. Since diagnosis of chronic Q fever is often 
difficult – because direct detection of the bacterium is not possible in many cases 
– a probable chronic Q fever diagnosis is based on indirect evidence of persistent 
C.  burnetii infection. These patients also receive long-term antibiotic treatment, 
and clinicians use identical treatment and follow-up schemes as for proven chronic 
Q fever patients, but a part of these patients may have no persistent infection. 
We, however, also performed an analysis in which only the subset of patients with 
proven chronic Q fever were included. The latter increased the level of diagnostic 
certainty of chronic Q fever in the case-patients, but had decreased power to detect 
associations.
We identified a significant association between the TLR1 R80T polymorphism and 
the risk for chronic Q fever. This TLR1 SNP is previously described to be a risk factor 
Discussion
In the present study we investigated whether genetic variants in pattern recog-
nition receptors and adaptor proteins were associated with chronic Q fever in 
C.  burnetii-infected individuals with vascular or valvular risk factors. Our results 
showed that TLR1 R80T (rs5743611), NOD2 L1007fsX1 (rs2066847) and MYD88 
-938C>A (rs4988453) are linked to the development of chronic Q fever. In addition, 
blood cells from individuals carrying the TLR1 80T variant that led to decreased 
susceptibility to chronic Q fever, showed lower IL-10 production upon C. burnetii 
stimulation. No influence of TLR2, TLR4, TLR6, TLR8, TIRAP, ITGAV, ITGB3 and 
ITGAM SNPs on the susceptibility to chronic Q fever was observed.
To our knowledge, this is the first genetic study that investigates the role of SNPs 
in PRR and adaptor molecule genes in development of chronic Q fever, the most 
severe complication of C.  burnetii infection. Our study comprises the largest 
chronic Q fever cohort ever described. Previous studies on genetic predisposition 
to Q fever concerned either small cohorts of patients or focused on other clinical 
Q fever manifestations (acute Q fever or Q fever fatigue syndrome). Everett et al. 
studied genetic susceptibility to acute Q fever by focusing on TLR2 and TLR4 SNPs, 
for which they demonstrated no correlation in 89 acute Q fever patients and 162 
controls[26]. Helbig and colleagues investigated association between genetic vari-
ants in HLA, IFNG, IL10 and TNFR genes and chronic Q fever or post-Q fever fatigue 
in 22 and 31 patients, respectively[27]. They described significant differences in 
the frequencies of IL10 promoter microsatellites in chronic Q fever compared to 
a control panel of 181 individuals without Q fever exposure. Vollmer-Conna and 
colleagues demonstrated that functional polymorphisms in IFNG and IL10 affect 
disease severity and duration after serologically-confirmed acute Q fever[28].
We focused on polymorphisms in immune genes involved in the initial recognition 
of C. burnetii based on the assumption that chronic Q fever will develop only after 
inefficient early recognition resulting in inadequate early clearance of the bacte-
rium. Previous studies have shown that chronic Q fever patients exhibit a differ-
ent cytokine response to C. burnetii[29-31]. It is, however, not clear whether this 
different response is specific for the myeloid cells of these individuals or a result 
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The role of the adaptor molecule MyD88 in C. burnetii infection has not been studied 
previously. We found that MYD88 -938C>A was significantly associated with 
susceptibility to chronic Q fever. In general, MyD88 plays a central role in innate 
immune responses, being downstream of all TLRs (except for TLR3) and the IL-1 
receptor. MyD88 deficiency leads to recurrent infections with pyogenic bacteria 
in early childhood but seems redundant for most other infections[15]. The MYD88 
-938C>A SNP has been shown to decrease promoter activity[44] and was found to 
be associated with development of sarcoidosis[45]. 
TLR2 is a receptor for bacterial lipopeptides, which are either recognized by TLR2/
TLR1 or TLR2/TLR6 heterodimers. Although multiple studies have shown that TLR2 
is involved in the host’s immune response against C. burnetii[5, 46-48], we found 
no association between the TLR2 SNPs included in this study and development of 
chronic Q fever. This could indicate that either TLR2 has no prominent role in elimi- 
nation of C. burnetii or the consequences of the genetic variants for the function of 
the protein in C. burnetii defense are limited. We did not observe any association 
of chronic Q fever with TLR4, TLR6, TLR8, TIRAP polymorphisms either. Genetic 
polymorphisms in the genes for the receptors αvβ3 integrin and CR3, which are 
described to be involved in C. burnetii uptake and TNF production[7, 49], were also 
not significantly different distributed among chronic Q fever patients compared to 
the control cohort.
Our study has some limitations that need to be taken into account. Although this 
is the largest cohort of chronic Q fever patients ever described, it is still relatively 
small for a study of genetic association of an infectious disease. We tried to over-
come this limitation by the use of a matched control group with respect to gender, 
age, presence of cardiovascular risk factors and exposition to the same virulent 
C. burnetii strain. Another important consideration is that no correction for multiple 
testing was performed. This was decided because candidate genes with a known 
or suspected role in C. burnetii recognition were investigated instead of randomly 
selected genes. It has to be taken into account that, when applying correction 
for multiple testing, statistical significance of the NOD2, MYD88 and TLR1 SNPs 
association with susceptibility to chronic Q fever is lost. To confirm the findings of 
the current study, these need to be replicated in another cohort of chronic Q fever 
patients. 
for invasive aspergillosis after hematopoietic stem cell transplantation[16], candi-
demia[32] and inflammatory bowel disease[33]. TLR1 S248N, which is not linked 
to TLR1 R80T, did not show association with development of chronic Q fever. We 
studied the functional consequences of the TLR1 R80T polymorphism in a subset 
of controls. Presence of TLR1 80T allele resulted in significantly lower produc-
tion of the anti-inflammatory cytokine IL-10, but did not affect TNF, IL-1β or other 
pro-inflammatory cytokines, as found before[5]. The TLR1 80T allele was present 
significantly less frequent in the proven Q fever patient cohort compared to the 
control cohort. This suggests that having lower IL-10 production upon contact with 
C. burnetii may protect against chronic Q fever. This finding is in line with the role of 
the anti-inflammatory cytokine IL-10 in the development of human chronic Q fever 
that has been extensively reported[29, 34-36]. In short, IL-10 induces C. burnetii repli-
cation in naive monocytes[34]. In addition, IL-10 production in unstimulated peri- 
pheral blood mononuclear cells was increased after C. burnetii infection in individu-
als who subsequently developed chronic endocarditis in comparison to individuals 
who did not develop endocarditis[35]. Moreover, transgenic mice that constitutively 
over-express IL-10 is the only efficient model for chronic Q fever so far[37].
NOD2 is a cytoplasmic receptor involved in bacterial peptidoglycan sensing. The 
intracellular cytoplasmic localization of NOD2 and the survival of C. burnetii in the 
intracellular PV may lead to ongoing interaction between them. The active secre-
tion of bacterial proteins by C. burnetii through the PV membrane, demonstrated to 
occur by a type IV secretion apparatus[38], may play a role in this process. Genetic 
variation in NOD2 has previously been linked to auto-inflammatory diseases such 
as Crohn’s disease and Blau syndrome[39]. In addition, association with suscepti-
bility to tuberculosis and leprosy has been described[40, 41]. The NOD2 L1007fsX1 
SNP, leading to a frameshift and a premature stopcodon, has a large effect on the 
protein. Its association with Crohn’s disease has been extensively described[42, 
43]. We previously showed that C. burnetii-induced cytokine production by human 
mononuclear cells is mediated through NOD2, with NOD2-deficient individuals 
having strongly decreased IL-1β and IL-6 responses[5]. In the present study, we 
were unable to show a significant effect on C. burnetii-induced cytokine responses 
when we stratified for the polymorphism NOD2 L1007fsX1. This is most likely due 
to the rare occurrence of heterozygotes for the allelic variant and absence of homo-
zygotes in this group.
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Introduction
Q fever is a zoonosis caused by the intracellular Gram-negative bacterium Coxiella 
burnetii. In humans, infection may remain unnoticed in approximately half of the 
infected individuals and causes disease, a short flu-like acute febrile disease, 
pneumonia or hepatitis, in the other half[1]. After infection, either unrecognized or 
symptomatic, 1 to 5% may develop chronic Q fever months to years later, which 
presents primarily as endocarditis or vascular infection and may be lethal when 
left untreated[1]. Infected goats, sheep and cattle are the main reservoir for human 
infections, these animals can excrete high numbers of C. burnetii into the environ-
ment during parturition[2, 3]. 
In contrast to human infections, infection in goats by C. burnetii does not lead to 
recognizable systemic disease in non-pregnant animals, while in pregnant animals 
infection will lead only to abortion, stillbirth or premature delivery explained by the 
high bacterial numbers in the placenta and severe local inflammation[4]. Although 
clinical symptoms are absent in goats, two weeks after infection a clear specific 
humoral immune response occurs with the appearance of IgM and IgG anti-Phase 
2 C. burnetii antibodies[3]. So far little is known about the early immune response 
in goats and the differences in the immune response to C. burnetii in man and goat.
Toll-like receptors (TLRs) are assumed to be the principal receptors involved in the 
early recognition and signalling of C. burnetii by innate immune cells. Upon recog-
nition, peripheral blood mononuclear cells (PBMCs) derived from healthy humans 
produce various cytokines including interleukin-1beta (IL-1β), tumour necrosis 
factor-alpha (TNF-α) and interleukin-10 (IL-10), but no interferon gamma (IFN-γ)
[5-7]. After infection, stimulation of human PBMCs with C. burnetii also leads to 
up-regulation of IL-1β[6, 8-10]. In patients with chronic Q-fever, the anti-inflamma-
tory cytokine IL-10 is up-regulated[7, 11]. 
It is generally assumed that the type and degree of the early innate immune 
response relates to the severity of early disease manifestations and determines 
the early outgrowth of the infection[12]. Therefore it may be hypothesized that 
this response is different in goats which do not develop disease after infection as 
Abstract
In humans, infection with Coxiella burnetii, the causative agent of Q fever, leads 
to acute or chronic infection, both associated with specific clinical symptoms. In 
contrast, no symptoms are observed in goats during C. burnetii infection, although 
infection of the placenta eventually leads to premature delivery, stillbirth and abor-
tion. It is unknown whether these differences in clinical outcome are due to the early 
immune responses of the goats. Therefore, peripheral blood mononuclear cells 
(PBMCs) were isolated from pregnant goats. In total, 17 goats were included in the 
study. Six goats remained naive, while eleven goats were infected with C. burnetii. 
Toll-like receptor (TLR) and cytokine mRNA expression were measured after in vitro 
stimulation with heat-killed C. burnetii at different time points (prior infection, day 
7, 35 and 56 after infection). In naive goats an increased expression of interleu-
kin (IL)-1β, tumor necrosis factor (TNF)-α, IL-10 and interferon (IFN)-γ mRNA upon 
C.  burnetii stimulation was detected. In addition, TLR2 expression was strongly 
up-regulated. In goats infected with C. burnetii, PBMCs re-stimulated in vitro with 
C. burnetii, expressed significantly more TNF-α mRNA and IFN-γ mRNA compared 
to naive goats. In contrast, IL-10 mRNA production capacity was down-regulated 
during C.  burnetii infection. Interestingly, at day 7 after inoculation a decreased 
IFN-γ protein level was observed in stimulated leukocytes in whole blood from 
infected goats, whereas at other time-points increased production of IFN-γ protein 
was seen. Our study shows that goats initiate a robust pro-inflammatory immune 
response against C. burnetii in vitro. Furthermore, PBMCs from C. burnetii infected 
goats show augmented pro-inflammatory cytokine responses compared to PBMCs 
from non-infected goats. However, despite this pro-inflammatory response, goats 
are not capable of clearing the C. burnetii infection.
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Coxiella burnetii strains
C. burnetii 3262 was used as infectious organism. This strain was isolated from 
the placenta from a goat that aborted on a farm during the Q fever outbreak in the 
Netherlands[13]. The strain was genotyped as CbNL01, which was the main 
C.  burnetii genotype during the Dutch Q fever outbreak[13]. Ex vivo stimula-
tion experiments were performed with the heat-killed C. burnetii Nine Mile (NM) 
reference strain. Both C.  burnetii NM and C.  burnetii 3262 were cultured at the 
Central Veterinary Institute as described previously[3]. The strains represent LPS 
phase I. LPS phase determination was performed by SDS-PAGE and silver staining, 
using purified phase I (RSA493) and phase II (RSA439) C. burnetii NM LPS (kindly 
provided by R. Toman) as controls[14, 15]. The number of Coxiella DNA copies was 
determined using Taqman (Quanta BioSciences, USA) real-time PCR as mentioned 
earlier[4]. MLVA typing was performed by using 12 of the 17 loci described by 
Arricau-Bouvery et al.[16]. A second series of stimulation experiments was simul-
taneously performed also with three heat-killed isolates, C.  burnetii 14160-001, 
C.  burnetii 3345937 and C.  burnetii 3262. Details of all strains are mentioned in 
Table 1. Bacteria were killed by heating for 30 minutes at 99°C.
Isolation and stimulation of peripheral blood mononuclear cells 
The PBMC fraction was obtained by density centrifugation of EDTA blood using a 
Ficoll-Paque gradient (Pharmacia Biotech, USA) or Leucosep tubes prefilled with 
Ficoll-Paque (Greiner, the Netherlands). After washing, the cells were re-suspended 
in RPMI 1640 Dutch modified (Gibco Invitrogen, USA) supplemented with 50 mg/L 
gentamycin (Centrafarm, the Netherlands), 2 mM L-glutamine, and 1 mM pyruvate 
(Gibco Invitrogen, USA). A volume of 100 µl containing 5x105 mononuclear cells 
was added to round-bottom 96-well plates (Costar, Corning, The Netherlands) and 
incubated at 37°C and 5% CO2 for both 4h and 24h with either 50 µl RPMI (medium 
control), C.  burnetii NM 1x107/ml, C.  burnetii 3262 1x106/ml, C.  burnetii 3345937 
3.2x104/ml, C. burnetii 14160-001 1x107/ml and E. coli LPS 10ng/ml in the presence 
of 50 µl 5% naive goat serum (in house). Following incubation, the supernatant was 
harvested and stored at -20°C. Subsequently Trizol (Invitrogen, USA) was added to 
cell pellet and stored at -80°C till further RNA isolation.
compared to humans. To test this hypothesis we evaluated the C. burnetii induced 
TLR and cytokine responses of PBMCs derived from naive and from infected preg-
nant goats in the last months of pregnancy. Furthermore, Roest et al. recently 
examined the circulating cytokine levels in naive and C.  burnetii infected goats. 
They observed an absence of a systemic cytokine mRNA response and hypothe-
sized that PBMCs might not have been in contact with C. burnetii during infection. 
To clarify this we focus on PBMCs and their ability to induce an immune response 
against heat-killed C. burnetii.
Material and Methods
Animals, Infection and Experimental Design
Seventeen pregnant healthy Alpine yearling goats were included in the study. The 
experimental setup has been published in detail by Roest et al.[3]. In short, on day 
76 of the pregnancy eleven goats were intranasally inoculated with 1ml of 1x106/
ml C.  burnetii X09003262-001 (C.  burnetii 3262) in culture medium. As a nega-
tive control, six goats were inoculated with 1 ml of culture medium only. Serum 
samples were taken weekly to measure antibody titers against C. burnetii (LSIVET 
RUMINANT milk/serum Q-fever ELISA kit, LSI, France). EDTA and heparin blood 
samples for stimulation experiments were taken from each goat; at day 0 (before 
inoculation) and at day 7, 35 and 56. To prove successful C. burnetii infection of 
the infected goats, the placenta was sampled after parturition from each goat for 
immunohistochemistry (IHC) and vaginal mucus was sampled for detection of 
C. burnetii DNA by PCR. 
Ethics Statement
All animal experiments were approved by the Animal Experiment Commission of 
the Central Veterinary Institute, part of Wageningen UR, in accordance with the 
Dutch regulations on animal experimentation (registration number 2011111.c). 
Everything possible was done to minimise animal suffering. Humane endpoints 
were defined in advance. Whenever these endpoints were reached, animals were 
euthanized.
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Table	1:	List	of	C. burnetii isolates used in this study
Table	2:	Primer	sequences	for	TLR1,	TLR2,	TLR4	and	TLR6
Name	 Country	of	origin	 Source	 LPS	Phase	 MLVA	marker	and	number	of	repeats
	 	 	 	 01	 03	 20	 21	 22	 28	 24	 30	 31	 34	 27	 36
C. burnetii 3262 The Netherlands Goat placenta I 4 7 19 6 6 3 11 5 3 7 3 13
C. burnetii 3345937 The Netherlands Human heart valve I 4 7 19 6 6 3 11 5 3 7 3 13
C. burnetii 14160-001 The Netherlands Goat placenta I 3 6 15 6 6 7 13 6 3 9 2 4
C. burnetii Nine Mile USA Tick I 4 7 15 6 6 6 27 6 5 5 4 4
Name	 Primer	sequence	5’-3’	Forward/reverse	 Accession	no.	 Annealing	Temperature
TLR1 GGGTTGAGTGCCACACAGTTACCCCATAAGTATCTCCTAAGACCAATAAAA HQ263209.1 60°C
TLR2 ACTGGGTGGAGAACCTCATGGTCATTTGCCAGGGACGAAGTC HQ263214.1 60°C
TLR4 TCTGCCTTCACTACAGGGACTTTATGGCTCTTGTGGAAACCTTCCT HM627213.2 60°C
TLR6 TCTCAAGCATTTAGACCTCTCATTCACTGGGTCAAGTTGCCAAATTC HQ263211.1 60°C
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Statistical analysis 
Statistics regarding mRNA expression and cytokine production were performed 
using GraphPad Prism 5 software (Graphpad). Differences between experimental 
groups were tested using the Mann-Whitney U test, and differences with a p-value 
≤0.05 were considered statistically significant. Samples with values lower or 
higher than two times the standard deviation were defined as outliers and excluded 
from the statistical analysis. These outliers are indicated in the figures as an open 
circle. In case the value of the outlier exceeded the y-axis of the graph, its value 
is mentioned. The PCR efficiency was determined for all TLRs and SDHA using a 
standard curve generated with different dilutions of a mixture of the cDNA of all 
samples.
Results 
Experimental C. burnetii infection in goats
The experimental infection of the goats with C. burnetii 3262 was successful in 
all infected goats as shown by a positive IHC of the cotyledon with adjacent allan-
tochorion of the placenta and by positive PCR of vaginal swabs. All naive goats 
remained negative in both tests. The IHC pictures of a C. burnetii positive and nega-
tive cotyledon can be found in the article of Roest et al.[4] in which the goats from 
experiment III resemble the goats in our study. Three infected goats gave birth to 
dead lambs, the lambs of the remaining six infected goats were alive. The offspring 
of the naive goats were all alive and healthy. 
The weekly antibody response of all goats against C. burnetii during the infection 
period is shown in Figure 1. The antibody response in the infected goats increased 
strongly 21 days after infection, whereas the antibody response of the naive goats 
did not alter. The average pregnancy of the infected goats was 143 days (range 
128-146 days), significantly shorter (p<0.001) than the 153 days (range 149-157 
days) of the naive goats.
mRNA expression of Toll-like receptors and cytokines
RNA was isolated from the Trizol samples using the manufacturer's guidelines. In 
the end, the pellet was re-suspended in 25 µl RNAse free water (Sigma–Aldrich, 
USA) with 0.5µl RNAseOUT Recombinant ribonuclease Inhibitor (Invitrogen, USA). 
Further purification of the samples was performed with the DNA-free kit (Ambion, 
USA) and the concentration of the RNA samples was determined using the Nanodrop 
(ND1000, NanoDrop Technologies, Inc, USA). Reverse transcription was performed 
using random primers and SuperScript III Reverse Transcriptase (Invitrogen, USA). 
PCR on the cytokines mRNA (TNF-α, IL-1β, IL-10 and IFN-γ) was performed using 
specific goat primers[3] and SYBR Green PCR Master Mix (Applied Biosystems, 
USA) in an ABI 7500 Real-time PCR system (PE Applied Biosystems, USA). Results 
were normalized according to the Succinate dehydrogenase complex subunit A 
(SDHA) gene of the same sample (Bos Taurus, Primerdesign Ltd, United Kingdom). 
Data was not corrected for the medium control, hereby the influences of the preg-
nancy on the cytokine mRNA expression remain visible. The primer sets for TLR1, 
TLR2, TLR4 and TLR6 were designed using PrimerExpress (Invitrogen, USA) (Table 
2). The Livak method (2^ΔΔCt) was used to represent the TLR expression data.
Whole blood stimulation
Undiluted heparin blood (500 µl) was stimulated with either nothing or 25 µl heat-
killed C. burnetii NM 1x107/ml. As control, samples were stimulated with conca-
navalin A (ConA) and/or phytohemagglutinine (PHA). After 24h incubation at 
37°C, the samples were centrifuged and the supernatant was stored at -20°C till 
further investigation. The production of IFN-γ protein by the leukocytes in the whole 
blood samples was analysed with the Bovigam IFN-γ test kit for cattle (Prionics, 
Schileren-Zurich, Switzerland) which was evaluated for goats. ELISA results were 
obtained as Optical Density determined at 450nm (OD450) with a 635nm reference 
filter (EL 808 Ultra micro plate reader, Bio-tek instruments, USA). Recombinant goat 
IFN-γ was purchased from Cusabio to invest to proportion between the measured 
OD values and the IFN-γ concentration. Hereto, a dilution series of IFN-γ was made 
with a maximum concentration of 25 ng/ml. The IFN-γ concentration and the corre-
sponding OD values are proportional. Because the Bovigam IFN-γ test kit is able to 
measure goat IFN-γ in a dose-dependent manner, we decided to use this kit in our 
study.
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In PBMCs stimulated for 24 hours, the expression of the anti-inflammatory cyto-
kine IL-10 strongly increased. Furthermore, the mRNA expression of the T-cell or 
NK-cell derived cytokine IFN-γ also showed an increase (Figure 2B), although this 
did not lead to increased IFN-γ protein concentrations in the supernatants of these 
cells (Figure 2C). 
PBMC stimulation experiments from naive and infected pregnant goats during the 
course of pregnancy
The course of the cytokine mRNA expression of PBMCs was investigated in unstim-
ulated PBMCs, derived from naive and infected goats during the study period of 
56 days (Figure 3A). IL-1β mRNA was not up-regulated in PBMCs from both naive 
and infected pregnant goats. At day 56 of the study TNF-α mRNA expression was 
increased in PBMCs derived from both naive and infected goats compared to TNF-α 
mRNA expression at the start of the study. In the infected goats this increase of 
TNF-α mRNA was significantly higher than in non-infected goats. In contrast, the 
IL-10 mRNA expression at day 56 was increased in the PBMCs from non-infected 
goats, while this increase was not observed in the PBMCs of infected goats. Both 
IFN-γ mRNA and IFN-γ protein levels were not up-regulated in respectively unstimu-
lated PBMCs and unstimulated whole blood from both naive and infected pregnant 
goats during the study period (Figure 3A and 3C).
To investigate whether stimulation with C. burnetii resulted in different TLR up-reg-
ulation and cytokine responses of PBMCs derived from naive or infected goats 
we stimulated these cells in vitro with C.  burnetii NM. The mRNA expression of 
TLR1, TLR2, TLR4 and TLR6 of C. burnetii NM stimulated PBMCs derived from naive 
and infected goats at day 35 equalled the expression as prior infection (data not 
shown). The expression of IL-1β and TNF-α mRNA of the infected goats was signifi-
cantly higher at day 56 of the study than at the start of the study (Figure 3B). In 
contrast, C. burnetii stimulated PBMCs from naive goats did not show an increased 
IL-1β and IFN-γ mRNA expression. The expression of TNF-α mRNA at day 56 of the 
study was significantly higher in the infected goats compared to the naive goats. 
Compared to day zero, IL-10 mRNA expression increased within the 56 days of 
the study in the naive goats. In contrast, no significant difference in IL-10 mRNA 
expression between day zero and day 56 was observed in the infected goats. In 
addition, the expression of IL-10 mRNA was lower in the infected goats compared 
TLR	 up-regulation	 and	 cytokine	 responses	 in	C.  burnetii stimulated PBMCs from all 
goats	at	day	0
Stimulation of PBMCs from all pregnant goats at day 0 (prior to infection) with 
C. burnetii NM for 4 hours resulted in a slightly lower mRNA expression of TLR4, 
the mRNA expression of TLR1 and TLR6 was slightly up-regulated, and the expres-
sion of TLR2 mRNA was strongly up-regulated in comparison with unstimulated 
PBMCs (Figure 2A). In general, a fold induction of factor 2 indicates biological rele-
vance. Despite the significantly increased TLR1, TLR2 and TLR6 mRNA expression 
after C. burnetii stimulation, the fold induction remained below factor 2. The mRNA 
expression of IL-1β and IFN-γ was up-regulated after stimulation of PBMCs from 
naive goats with the positive control E. coli LPS (data not shown), showing the reli-
ability of the experimental approach to measure cytokine mRNA expression in goat 
PBMCs. Stimulation of goat PBMCs with C. burnetii NM resulted in an increased 
mRNA expression of IL-1β and the same trend was observed for TNF-α (Figure 2B). 
Figure	1:	Successful	experimental	infection	of	goats	with	Coxiella burnetii	3262	
Eleven out of seventeen goats were intranasally infected with C. burnetii 3262. The remaining six were 
kept naive. During the infection, antibodies against C. burnetii were measured weekly in the serum of all 
goats using the LSIVET RUMINANT milk/serum Q-fever ELISA kit. Grey squares represent naive goats, 
black squares represent infected goats. Median values with SEM are shown. Parturition is indicated 
for each individual goat using an arrow. Abortion, defined as birth of dead lambs, is indicated with an 
asterisk. The final two remaining pregnant infected goats were culled for other purposes, and therefore 
not included in this graph.
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with the naive goats at day 7. The infected goats expressed more IFN-γ mRNA after 
PBMC stimulation starting from day 7 onwards (Figure 3B). Furthermore, at day 
56 we found that in infected goats IFN-γ protein in the supernatants was higher 
compared to naive goats (Figure 3D) and unstimulated PBMCs (P<0.0017). At 
other time points, IFN-γ protein in the C. burnetii stimulated samples did not exceed 
that of the unstimulated samples, but the IFN-γ protein level was significantly lower 
in the PBMCs obtained of infected goats compared to PBMCs of naive goats at day 
7 and higher at day 35. The increased IFN-γ mRNA expression found in the infected 
goats at day 35 and 56 after C. burnetii NM stimulation was not observed when 
PBMCs of these infected goats were stimulated with E. coli LPS (Figure 3E).
Whole blood stimulation experiments from naive and infected pregnant goats during 
the course of pregnancy
The role of whole blood components on the early immune response against 
C. burnetii was investigated by stimulation of whole blood from naive and infected 
goats with nil or C.  burnetii NM. In non-stimulated blood from both naive and 
infected goats, IFN-γ production did not significantly alter at day 7 and day 35 of the 
study. However, at day 56, IFN-γ concentration increased in both naive as infected 
goats (Figure 4A). Figure 4B shows that in vitro stimulation of whole blood with 
C.  burnetii NM does not lead to changes in the IFN-γ production in naive goats 
during the 56 days. In whole blood of the infected goats, the IFN-γ protein level 
is decreased at day 7 which was not observed in the naive goats. At day 35 of 
the study, the IFN-γ level is significantly higher in whole blood of infected goats 
compared to naive goats after stimulation with C. burnetii NM.
Figure	2:	TLR	up-regulation	and	cytokine	responses	of	C. burnetii stimulated PBMCs from naive 
goats
2A/B) PBMCs were incubated 4h (TLRs, IL-1β, TNF-α) or 24h (IL-10, IFN-γ) with either medium (grey bars) 
or heat killed C. burnetii NM 1x107/ml (dark grey bars). mRNA expression of TLR1, 2, 4, 6 and IL-1β, TNF-α, 
IL-10 and IFN-γ was determined using qPCR. 
2C) IFN-γ protein was measured in the supernatant of PBMCs stimulated for 24h with nil or C. burnetii 
NM 1x107/ml. IFN-γ was measured using the Bovigam Elisa kit. Box and Whisker plots are shown. Outliers 
are indicated as open circles. NS not significant; *p<0.05; **p<0.01; ***p<0.001, Mann-Whitney U-test. 
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Figure	3:	Cytokine	profile	of	C. burnetii stimulated PBMCs from naive and C. burnetii infected goats 
3A/B) EDTA blood was sampled at day 7, 35 and 56 of the study from six naive goats (grey bars) and 
eleven infected goats (dark grey bars). The white bars show the mRNA expression at day zero. PBMCs 
were isolated and incubated for 4h or 24h with either medium (3A), heat killed C. burnetii NM 1x107/ml 
(3B) or E. coli LPS 10ng/ml (3E). mRNA expression of TNF-α, IL-1β, IL-10 and IFN-γ was determined using 
qPCR. 
3C/D) IFN-γ protein was measured in the supernatant of PBMCs stimulated for 24h with nil (3C) or 
C. burnetii NM 1x107/ml (3D). IFN-γ was measured using the Bovigam Elisa kit. Grey bars represent six 
naive goats, dark grey bars represent eleven infected goats. Box and Whisker plots are shown. Outliers 
are indicated as open circles. NS; not significant *p<0.05; **p<0.01; ***p<0.001, Mann-Whitney U-test.
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In vitro stimulation of PBMCs from naive and infected pregnant goats with different 
C. burnetii strains
PBMCs from naive and infected goats were stimulated in vitro with four different 
C. burnetii strains to investigate whether all strains were able to induce up-regu-
lation of cytokine mRNA levels. At day zero, only C.  burnetii 14160-001 induced 
significantly more TNF-α mRNA compared to unstimulated PBMCs. The IFN-γ 
mRNA levels increased after PBMC stimulation with C.  burnetii NM, C.  burnetii 
3262 and C.  burnetii 14160-001. C.  burnetii 3345937 stimulation did not induce 
either TNF-α and IFN-γ mRNA (Figure 5A). At day 35, PBMCs re-stimulated with 
all strains, except C. burnetii 3262, showed a trend towards an increased TNF-α 
mRNA expression in PBMCs of infected goats than PBMCs of naive goats. IFN-γ 
mRNA expression was significantly increased in PBMCs from infected goats after 
encounter with all four C. burnetii strains compared to naive goats (Figure 5B).
Figure	5:	Stimulation	of	C. burnetii infected PBMCs results in an increased cytokine expression
EDTA blood was sampled at day zero (5A) and day 35 (5B) of the study. Peripheral blood mononuclear 
cells were isolated and incubated for 4h or 24h with either medium, heat killed C. burnetii NM 1x107/ml, 
heat killed C. burnetii 3262 1x106/ml, heat killed C. burnetii 3345937 3.2x104/ml, heat killed C. burnetii 
14160-001 1x107/ml. mRNA expression of TNF-α and IFN-γ was determined using qPCR. Grey bars repre-
sent six naive goats, dark grey bars represent eleven infected goats. Box and Whisker plots are shown. 
Outliers are indicated as open circles. NS not significant; *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001, 
Mann-Whitney U-test.
Figure	 4:	 Increased	 Interferon-γ	 production	 in	C.  burnetii infected goats after stimulation with 
C. burnetii 
Stimulation of undiluted heparin blood with nil (4A) or heat killed C. burnetii NM 1x107/ml (4B). Grey bars 
represent six naive goats, dark grey bars represent eleven infected goats. Blood was sampled at day zero 
and at day 7, 35 and 56 of the study. IFN-γ was measured after 24h incubation using the Bovigam IFN-γ 
ELISA kit. Box and Whisker plots are shown. Outliers are indicated as open circles. NS; not significant 
*p<0.05; **p<0.01; ***p<0.001, Mann-Whitney U-test.
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rance and anti-inflammatory responses, permits persistence of C.  burnetii. This 
specific compartmentalized infection is also observed in chronic Q fever patients, 
as in these persons C. burnetii is mainly localised in the heart valve and vessels[1]. 
At day 56 of our study TNF-α mRNA expression was increased in all goats compared 
to the initial level, but a significantly higher TNF-α mRNA expression was seen in the 
infected goats. This suggests that, besides the influence of the pregnancy, infec-
tion with C. burnetii also increases expression of TNF-α mRNA. We also showed a 
clear increase in IL-1β and IFN-γ mRNA expression in the C. burnetii NM stimulated 
PBMCs derived from infected goats from day zero till day 56 of the study. However, 
at day 56, only IFN-γ mRNA expression was significantly higher in the PBMCs 
from infected goats. The fold induction (C. burnetii stimulated PBMCs divided by 
unstimulated PBMCs) of naive and infected goats at day 56 was respectively 1.96 
and 24.21, indicating the large effect on IFN-γ mRNA expression of C. burnetii stimu- 
lated PBMCs from infected goats.
The fold induction at day 56 in C. burnetii stimulated PBMCs from naive and goats 
was respectively 1.96 and 24.21. Besides the observed mRNA up-regulation, IFN-γ 
protein levels were increased in C. burnetii stimulated PBMCs and whole blood from 
infected goats compared to naive goats. Thus although no systemic response in 
goats could be observed, PBMCs of C. burnetii infected goats respond differentially 
to C. burnetii stimulation compared to PBMC of uninfected goats. Stimulation with 
E. coli LPS did not lead to increased up-regulation of IFN-γ mRNA expression in the 
C. burnetii infected goats, which demonstrates that the observed IFN-γ response 
is specific for C. burnetii. Even though we hypothesized that C. burnetii infected 
PBMCs are translocated to the placenta, we assume that remaining memory T-cells 
in the peripheral blood can be activated and play a role in this immune response 
and increased IFN-γ mRNA expression.
The importance of TNF-α and IFN-γ during C. burnetii infection has been shown by 
Andoh et al.[24]. These authors demonstrated that IFN-γ-/- and TNF-α-/- mice have 
respectively high and modest susceptibility to C. burnetii NM infection and that the 
disease progressed rapidly in these mice[24]. In humans, much research has been 
performed on the cytokine expression in chronic Q fever patients, a condition that in 
our opinion mostly resembles the C. burnetii re-stimulation of PBMCs from infected 
Discussion
PBMCs from pregnant goats have a clear cytokine response upon contact with 
C. burnetii. This response is observed both in goats without any previous contact 
with the bacterium as well as in goats who where recently infected. This latter 
observation is interesting because infections of pregnant goats do not lead to 
systemic disease of the animal except for stillbirth of the lamb. In PBMCs of healthy 
pregnant goats we observed that the mRNA expression of IL1-β, TNF-α, IL-10 and 
IFN-γ were up-regulated after C.  burnetii stimulation. These findings correspond 
with other studies in which increased TNF-α protein levels were found in human 
monocyte-derived dendritic cells stimulated with the C. burnetii outer membrane 
protein 1, and THP-1 cells which showed increased TNF-α and IFN-γ expression 
after C. burnetii stimulation[17, 18]. Recently, Graham et al.[19] demonstrated that 
stimulation of human alveolar macrophages with C. burnetii skewed towards a Th1 
response. Increased TNF-α and IFN-γ protein levels were also found in serum from 
mice challenged with C. burnetii, and TNF-α mRNA expression increased in mice 
of which bone marrow derived macrophages were stimulated with C. burnetii[20, 
21]. Thus, our results show that PBMCs of goats do not differ from humans and 
mice in their augmented TNF-α and IFN-γ mRNA response after in vitro stimulation 
with C. burnetii. During C. burnetii infection increased IFN-γ protein was measured 
in C. burnetii stimulated whole blood of goats which corresponds with the higher 
IFN-γ protein levels found in infected mice and chronic Q fever patients[20, 22]. 
The expression of IL-1β, IL-10 and IFN-γ mRNA was not up-regulated in the PBMCs 
of pregnant goats who were infected with C. burnetii. The observed up-regulation 
of TNF-α mRNA expression in PBMCs derived from infected goats may be seen 
as a consequence of pregnancy because this pattern was also found in PBMCs 
from naive goats. A possible explanation for the absence of an increased cytokine 
mRNA expression is that the non re-stimulated PBMCs did not respond to a nasal 
infection of C. burnetii. One of the reasons can be that in goats the C. burnetii infec-
tion is localised specifically in the placenta, and therefore no persistent systemic 
mRNA up-regulation was observed in the PBMCs from infected goats. Ben Amara 
et al.[23] indeed found that C. burnetii replicates in vitro in placental derived tropho-
blasts and induces an up-regulation of cytokine mRNA. Therefore, they assumed 
that the specific inflammatory environment in the placenta, skewed towards tole-
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profile as chronic Q fever patients, while the IL-10 mRNA expression in infected 
goats is not up-regulated as found in the chronic Q fever patients. These differences 
in IL-10 expression could be an explanation for the divergent clinical outcomes in 
humans and goats during C. burnetii infection. Yet, is should be taken in to account 
that, in contrast with the human study subjects, the infected goats are pregnant 
which can influence the cytokine responses in general and upon encounter of 
micro-organisms. Furthermore, possible differences in experimental approaches 
should be considered, i.e. our conclusions are based on mRNA expression levels, 
while other studies rely on protein levels in particular. 
An interesting finding is the decreased IFN-γ protein level in C. burnetii stimulated 
PBMCs and whole blood from infected goats at day 7 of the study. This reduction 
was not observed in the PBMCs and whole blood of naive goats and is inconsis-
tent with the increased IFN-γ protein levels observed in the PBMCs obtained from 
infected goats later in the infection. It can be hypothesized that the initial C. burnetii 
infection in the goats is capable to immune modulate PBMCs to produce less 
IFN-γ. Other microorganism infections, like Legionella pneumophila, Leishmania 
and Mycobacterium tuberculosis are also capable of modulating the Th1 response 
during early phases of infection[26-28]. Modulation of the IFN-γ response early 
during the infection, could create a favorable situation for C. burnetii to escape the 
early immune response of the goats, and might therefore be a strategy to pass over 
to the placenta without being eliminated. PBMCs obtained from infected goats 
later in the infection did not show the IFN-γ decrease after re-stimulation in vitro. 
This could mean that the immune modulation of PBMCs in vivo only occurred early 
in infection and once the Coxiella bacteria have reached the placenta, no systemic 
immune modulation is needed, or all systemic Coxiella bacteria are eliminated. 
Antigen specific lymphocyte sequestration can also be an explanation for the lower 
IFN-γ levels in infected goats up to 7 days after the infection. However, our results 
suggests that the effector T-cell population (Th1) remained in the PBMC fraction 
during Coxiella infection, as the mRNA expression of IFN-γ increased. However, 
based on the results of IL-10 mRNA expression, we can hypothesize that the regula-
tory T-cells (Th2) could be transferred to the lymph nodes during Coxiella infection.
During first contact with C. burnetii, PBMCs of healthy pregnant goats are capable 
of recognizing C. burnetii and activate their early immune response in vitro. Further-
goats. TNF-α mRNA and TNF-α protein levels are increased in C. burnetii re-stimu-
lated monocytes of chronic Q fever patients compared to healthy controls[9]. Simi-
larly, blood cells of chronic Q fever patients respond to C. burnetii stimulation with 
higher IFN-γ production[10, 22]. 
The observed up-regulation of IFN-γ mRNA expression after C. burnetii NM stimula-
tion was also found for the inoculum strain C. burnetii 3262 and the other C. burnetii 
strains which indicates that the different C.  burnetii strains contain correspond-
ing antigens on their surfaces which are recognized by goat PBMCs. Similar cross 
reactivity was demonstrated by Arricau-Bouvery et al. in a vaccination study in 
goats[25]. Based on these results we decided to perform our stimulation experi-
ments with C.  burnetii Nine Mile. The concentrations of the different C.  burnetii 
strains used in this experiment were not identical, due to time restrictions and 
culture difficulties. Therefore, it is not possible to compare the strains and the cyto-
kine mRNA expression they induce. Further studies have to be performed to inves-
tigate the possible divers immune response against C. burnetii strains by goats. 
PBMCs derived from goats infected with C. burnetii expressed significantly less or 
equal amounts of IL-10 mRNA compared to the PBMCs of non-infected goats. We 
did not expect this, as in humans high IL-10 protein levels are related to chronic 
Q fever infection, and in acute Q fever patients a slight increase of IL-10 produc-
tion was observed compared to healthy controls[7, 11]. The lower expression of 
IL-10 mRNA in the infected goats can be explained by the higher levels of IFN-γ 
mRNA and IFN-γ protein, as these two cytokines have an antagonistic effect on 
each other. Our results indicate that PBMCs from infected goats actually did inter-
act with C. burnetii, leading to an augmented cytokine mRNA expression after a 
second C.  burnetii encounter. The amount of IL-10 mRNA exceeded the mRNA 
levels of the housekeeping gene much more (up to 400 fold) than for IL-β and 
IFN-γ. However, the fold induction of IL-10 (C. burnetii stimulated PBMCs divided by 
unstimulated PBMCs) did not differ from the IL-1β fold induction or was even lower 
in the infected goats at day 35 and 56 when compared with IFN-γ. For example, at 
day 56, the fold induction of IL-1β, IL-10 and IFN-γ in the infected goats was respec-
tively 5.89, 5.04 and 24.21. 
We can speculate that regarding the pro-inflammatory cytokines, TNF-α and IFN-γ, 
PBMCs of infected goats re-stimulated with C. burnetii show the same cytokine 
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Introduction
The zoonotic bacterium Coxiella burnetii caused a large outbreak in the Neth-
erlands between 2007 and 2010. More than 4.000 acute Q fever cases were 
reported, but seroprevalence studies estimated at least >40.000 individuals 
infected with C. burnetii[1, 2]. Besides acute Q fever, C. burnetii infection can lead 
to chronic Q fever in 1-5% of the individuals after an initial infection[3]. The main 
source for Q fever in humans are sheep and goats. In contrast to the observed 
clinical symptoms in humans during C.  burnetii infection, infection in ruminants 
is mostly asymptomatic. However, in pregnant sheep and goats infection may 
cause abortion, premature birth, dead or weak offspring and it may cause repro-
ductive disorders in cattle[4, 5]. In 2012 a large review study was conducted in 
which, among others, the seroprevalence of C. burnetii-antibodies in goats, sheep 
and cattle was investigated[6]. Within-herd prevalence estimates for cattle, goat 
and sheep were respectively 20.8%, 40.0%, 56.9% (Bulgaria), 15.0%, 88.1%, 20.0% 
(France), 19.3%, 2.5%, 8.7% (Germany), and 21.0%, 7.8%, 3.5% (the Netherlands)[6]. 
The herd prevalence (a herd is considered positive when at least one animal in the 
herd was serologically confirmed) in the Netherlands was up to 37.0% in cattle, 
17.8% in goats and 14.5% in sheep. In France, the herd prevalence for cattle, goats 
and sheep was respectively 73.0%, 40% and 89%[6]. More specifically for cattle in 
the Netherlands, Muskens et al.[7] identified that 268 of 341 cattle herds (78.6%) 
tested positive for C. burnetii antibodies and at 56.6% of the herds C. burnetii DNA 
was detected.
Despite the high percentage of (herd) seroprevalence of C. burnetii in cattle, only 
a minority of the human Q fever outbreaks are attributed to cattle[6]. In addition, 
while almost all commercial milk products from cattle contain C. burnetii DNA, to 
our knowledge no reports are available indicating that these farmers, their family or 
milk consumers developed Q fever[8]. Several studies indicate that specific geno-
types of C. burnetii are associated with cattle[8-10]. However, cattle can also be 
infected with other genotypes, when more animal species are present on the same 
farm[11]. It can be hypothesized that humans can become infected by C. burnetii 
isolates originating from both cattle and goat, but infection with cattle isolates 
results in fewer, milder or no clinical symptoms compared with infections by goat 
Abstract
The zoonotic bacterium Coxiella burnetii is the causative agent of Q fever. Goats and 
sheep are the main source for human Q fever outbreaks. Interestingly, although the 
prevalence of C. burnetii in cattle is much higher than in goats and sheep, infected 
cattle are only rarely associated with human outbreaks. In the present study we 
investigated whether the immune response of humans differs after contact with 
C.  burnetii isolates originating from different host species. In addition, cytokine 
responses against C. burnetii isolates from acute and chronic Q fever patients were 
compared with C. burnetii isolates from animal origin.
Human peripheral blood mononuclear cells (PBMCs) were stimulated with 16 
C. burnetii isolates with known MLVA genotype from goats, sheep, cattle, acute and 
chronic Q fever patients. Subsequently, IL-1β, TNF-α, IFN-γ, IL-1Ra, IL10, IL-17 and 
IL-22 were measured.  
C. burnetii isolates originating from cattle induce significantly more IL-1β, TNF-α 
and IL-22 than the isolates from goats, sheep or chronic Q fever patients. A trend 
was observed of a higher cytokine induction by acute isolates than those from 
chronic Q fever patients. Comparing the cytokine induction of the isolates based 
on their MVLA genotype, instead of their origin, did not reveal any differences in 
response between the different MLVA genotypes. 
The high pro-inflammatory cytokine response induced in human PBMCs by 
C. burnetii isolates from cattle may explain the low incidence of human Q fever 
outbreaks caused by cattle. The cytokine profile of PBMCs from healthy individuals 
stimulated with C. burnetii isolates derived from chronic Q fever patients resem-
bles isolates from goats, while the acute human isolates induce a similar cyto-
kine pattern as cattle isolates. Furthermore, cytokine responses seem to be more 
depending on host origin than on MLVA genotype.
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tute for Microbiology (Munich, Germany). These isolates were retrieved from acute 
Q fever patients, however they were not obtained in the Netherlands during the 
outbreak, and background information about the assumed origin (infection via 
goat, sheep or cattle) is missing. Four isolates were obtained in France from goats 
(1683CbC2 and CbG15D6), sheep (736Cb01) and cattle (701CbB1) and were kindly 
provided by A. Rodolakis (INRA, France). The second cattle isolate (CbBEB1) came 
from Belgium and was a kind gift from D. Fretin (Coda Cerva, Bruxelles). All isolates 
represent LPS phase I. LPS phase determination was performed by SDS-PAGE and 
silver staining, using purified phase I (RSA493) and phase II (RSA439) C. burnetii 
NM LPS (kindly provided by R. Toman) as controls[12, 13]. More details of the 
isolates, like origin of the host (referred throughout the article as ‘origin’), country 
and MLVA genotype is described in Table 1. All isolates were cultured on Buffalo 
Green Monkey (BGM) cells as described previously and heat inactivated at 99 °C 
for 30 min[14]. All isolated were quantified by qPCR as described in detail by Roest 
et al.[15]. In short, the qPCR targets a single copy gene encoding a C. burnetii-spe-
cific hypothetical protein (gene bank number AY502846) using the forward primer 
5’-ATAGCGCCAATCGAAATGGT-3’, the reverse primer 5’- CTTGAATACCCATC-
CCGAAGTC-3’, and the NED-labelled probe 5’-CCCAGTAGGGCAGAAGACGTTC-
CCC-3’. qPCR was performed on a 7500 Fast Real Time PCR system (Applied 
Biosystems, USA),
MLVA	genotyping		
MLVA genotyping was performed by using a selection of 12 loci: ms01, ms03, 
ms20, ms21, ms22, ms24, ms27, ms28, ms30, ms31, ms24 and ms36. The method 
of MLVA genotyping is described in detail by Roest et al. and Arricau-Bouvery et 
al.[10, 16]. A dendrogram based on the MLVA genotype of the isolates was made 
using BioNumerics 7.5. 
Isolation of human peripheral blood mononuclear cells and stimulation with C. burnetii 
PBMCs from healthy individuals were isolated according to standard proto-
cols (Invitrogen, USA) as described previously[17]. 5x105 cells were added to a 
round-bottom 96-well plate (Corning, The Netherlands) and incubated with RPMI 
medium and the 16 C. burnetii isolates (1x107/ml) in the presence of 10% human 
serum. After 24 hours, 48 hours and 7 days supernatants were harvested, depend-
ing on the cytokine to be measured, and stored at -20°C. 
isolates. We hypothesize that the cattle C. burnetii isolates induce a more profound 
immune response in humans, which can eventually result in more effective elimi-
nation of the bacteria leading to absence of clinical disease.
To our knowledge, the current literature does not comprise studies focusing on the 
human immune response against different C. burnetii isolates. In order to check 
our hypothesis, we conducted the present study in which we used 16 C. burnetii 
isolates with either a different origin according to the host species and/or different 
MLVA genotype to investigate their cytokine induction upon stimulation of human 
peripheral blood mononuclear cells (PBMCs). As humans can get infected via 
either goat, sheep or cattle, C. burnetii isolates retrieved from these animals were 
included in the study. In addition, isolates from both acute and chronic Q fever 
patients were included to examine whether they induced a comparable cytokine 
pattern as the animal isolates. Our findings reveal that the origin of the C. burnetii 
isolates has a greater influence on the cytokine production by human PBMCs, 
compared to the MLVA genotype. Here we provide a possible immunological expla-
nation why C. burnetii transmission from infected cattle are less likely to induce 
infection in humans, which can relate to the minimal numbers of human Q fever 
outbreaks caused by cattle as stated in the current literature. 
Material and methods
C. burnetii isolates 
The C.  burnetii isolates X09003262-001 (3262), CbCVIC1, 8014160-001 (14160-
001), 8014160-002 (14160-002) and 18430 were isolated from the placenta of 
goats or sheep that aborted at different farms during the Q fever outbreak in the 
Netherlands. The human C. burnetii isolates from the Netherlands, 42785537 and 
334937 were isolated from the heart valve from two individual chronic Q fever 
patients from the Radboud University Medical Centre and Canisius Wilhelmina 
Hospital respectively. The other human isolates, Schperling, Henzerling, Herzberg 
and Scurry were a kind gift from Dimitrios Frangoulidis of the Bundeswehr Insti-
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Statistics
PBMCs of 11 healthy individuals were stimulated with the different C.  burnetii 
isolates. The average cytokine production for each isolate was used in a one-way 
Anova to identify the differences between the groups. In case of IL-1β, TNF-α, IL-10, 
IL-1Ra, IL-17 and IL-22 the homogeneity of variances was ≥ 0.05, therefore the 
Bonferonni Post-Hoc test was used to compare the different groups. For IFN-γ, 
difference between the variances in the groups (<0.05) was calculated and the 
Dunnett T3 Post-Hoc test was used. The data are expressed as mean ( ± standard 
error of the mean). IBM SPSS 18 software was used to perform the statistical anal-
yses and GraphPad Prism 5 software was used generate the graphs. Differences 
with a P value of < 0.05 were considered statistically significant.
Cytokine measurements
Cytokine production was measured in the cell supernatants using ELISA accord-
ing to the manufacturer’s protocols. The following kits were used: IL-10 and IFN-γ 
(Sanquin, the Netherlands), TNF-α, IL-1β, IL-1Ra, IL-17 and IL-22 (R&D Systems, 
USA). Absorption was measured at 450 nm using a microplate reader (Bio-Rad 
Laboratories, the Netherlands). TNF-α and IL-1β were measured after 24h, IL-10 
and IL-1Ra after 48h and IFN-γ, IL-17 and IL-22 were measured after 7d incuba-
tion.  
Table	1:	Characteristic	of	the	C. burnetii isolates used in this study 
Isolate	 Country	 Origin	 Passage	 MS	 MS	 MS	 MS	 MS	 MS	 MS	 MS	 MS	 MS	 MS	 MS	 MLVA
	 	 	 (in	house)	 01	 03	 20	 21	 22	 24	 27	 28	 30	 31	 34	 36	 genotype
Schperling Kyrgyzstan Human Acute Q fever 2 4 6 18 7 6 15 3 8 6 3 2 11
Henzerling Italy Human Acute Q fever 3 4 7 19 6 6 7 3 3 5 2 3 13 
Herzberg Greece Human Acute Q fever 2 4 7 19    3 3 5 2 3
Scurry America Human Chronic Q fever 4 4 6 15 6 6 9 3 4 6 4 2 4
42785537 The Netherlands Human Chronic Q fever 4 4 7 19 6 6 11 3 3 5 3 7 13 CbNL01
3345937 The Netherlands Human Chronic Q fever 11 4 7 19 6 6 11 3 3 5 3 7 13 CbNL01
3262 The Netherlands Goat 4 4 7 19 6 6 11 3 3 5 3 7 13 CbNL01
CbCVIC1 The Netherlands Goat 13 4 7 19 6 6 11 3 3 5 3 7 13 CbNL01
14160-001 The Netherlands Goat 14 3 6 15 6 6 13 2 7 6 3 9 4 CbNL12
1683CbC2 France Goat 3 4 7 19 6 6 11 3 3 5 3 7 13 CbNL01
14160-002 The Netherlands Goat 12 4 7 19 6 6 11 3 3 5 3 7 13 CbNL01
CbG15D6 France Goat 3 3 6 15 6 6 13 2 7 6 3 9 4 CbNL12
18430 The Netherlands Sheep 11   6   6 6 13 2 7 6 3 9 4 CbNL12
736Cb01 France Sheep 5  6  7 7 11 4 5 6 3 2 2
701CbB1 France Cattle 5 3 6 15 6   13 2 7 6 3 9 4 CbNL12
CbBEB1 Belgium Cattle 4  6 15 6 6 13 2 7 6 3 9 4 CbNL12
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revealed that all isolates contained phase I LPS. Furthermore, statistical analyses 
between the low and high passage number goat isolates showed no significant 
difference in IL-1β and TNF-α production by human PBMCs upon stimulation (data 
not shown).
The	MLVA	genotype	of	C. burnetii isolates does not influence the cytokine production 
of human PBMCs
Besides analyzing the isolates based on their origin, the isolates were discrimi-
nated based on their MLVA genotype. Two main genotypes can be distinguished 
among our isolates. First the genotype, named CbNL01 by Roest et al.[10], was the 
dominant genotype found during the Dutch Q fever outbreak. In total six isolates 
from our study belong to this genotype, four goat and two isolates from chronic 
Q fever patients. The second main genotype in our study, referred to as CbNL12, 
contained two goat, one sheep and the two cattle isolates. The third group consist 
of the remaining individual genotypes, including the three acute human strains, one 
chronic human strain and a second sheep strain. The differences in MLVA genotype 
are visualized in Figure 2, which shows the minimal spanning tree of all C. burnetii 
isolates included in this study. Genotype CbNL12 differs 9 micro satellite (ms) loci 
from CbNL01 and is situated in a separate genotype. From three isolates, 701CbB1, 
CbBEB1 and 18430, one or two ms loci were missing. Based on the 10 known ms 
loci, these isolates belong to the CbNL12 MLVA genotype.
Comparison of the cytokine induction between the diverse genotypes showed 
no significant differences in the pro-inflammatory cytokines (IL-1β, TNF-α, IFN-γ) 
(Figure 3A) and other cytokines (IL-10, IL-1Ra, IL-17 and IL-22) (Figure 3B and 3C). 
Among the isolates with the CbNL12 MLVA genotype, the isolates originated from 
infected cattle produced more TNF-α, IL-1β, IL-10 and IL-1Ra (data not shown).
Results
C. burnetii isolates from cattle induce a pro-inflammatory cytokine response
PBMCs stimulated with cattle isolates produced significantly more of the pro-in-
flammatory cytokines IL-1β and TNF-α, compared to the sheep, goat or isolates 
from patients with chronic Q fever (Figure 1A). In contrast, no significant differ-
ences were found between the cattle and the isolates from acute human cases. In 
case of IFN-γ, human PBMCs produced similar IFN-γ levels after stimulation with 
all different C.  burnetii isolates. The general induction of IFN-γ was much lower 
than for IL-1β and TNF-α. The fold induction of IL-1β ranged from 10x in sheep and 
more than 40x in cattle isolates compared with no stimulation, whereas, the fold 
induction for IFN-γ was only 1.44x and 2.6x in sheep and cattle isolates respec-
tively. Besides the high pro-inflammatory cytokine induction of cattle isolates, the 
isolates from acute human cases also produced high amounts of IL-1β and TNF-α. 
In case of IL-1β there was a significant difference between isolates from patients 
with acute Q fever compared to isolates derived from chronic Q fever patients 
(p=0.038) and sheep isolates (p=0.035) (Figure 1A).
In addition to the pro-inflammatory cytokines, the anti-inflammatory cytokines 
IL-10 and IL-Ra were measured. Isolates from acute Q fever patients induced the 
highest IL-10 and IL-1Ra in human PBMCs, followed by the cattle isolates (no signif-
icant differences). Comparing the isolates from chronic and acute Q fever patients 
shows a trend for a lower IL-10 (p=0.072) and IL-1Ra (p=0.051) in the isolates 
from chronic Q fever patients (Figure 1B). Finally the Th17 cytokines, IL-17 and 
IL-22 were measured. For IL-17, no differences were observed between the groups. 
In contrast, the IL-22 response was significantly higher in human PBMCs stimu-
lated with cattle isolates compared to the other groups, the differences are signif-
icant for sheep (p=0.002) goat (p=0.004) and isolates from acute and chronic 
Q fever patients(both p=0.001) (Figure 1C). Comparison of the isolates derived 
from infected cattle and the isolates from individuals with acute Q fever shows 
that except for IL-22, there are no significant differences in cytokine responses in 
human PBMCs.  
Three of the six goat isolates have a low passage number (3-4 times), while the 
other three isolates have been passed on BGM cells 12 to 14 times. Despite these 
differences in passage number, examination by SDS-PAGE and silver staining 
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Figure	1:	Cytokine	profiles	of	the	C. burnetii isolates grouped on their origin
PBMCs of 11 healthy individuals were stimulated with RPMI medium (striped bar) and 16 different 
C. burnetii isolates, see Table 1 for the details of the isolates. The following cytokines were measured 
using ELISA: IL-1β, TNF-α, IFN-γ (1A), IL-Ra, IL-10 (1B), IL-17 and IL-22 (1C). The color of the bars match 
the following isolates; white (3x chronic human), light grey (3x acute human), medium grey (6x goat), dark 
grey (2x sheep), black (2x cattle). Statistical differences were tested using one-way ANOVA. In case of 
all cytokines, except IFN-γ, the Bonferonni Post-Hoc test was used. For IFN-γ, differences were calculates 
using Fishers Least Significant Difference (LSD). NS: Not Significant, *p<0.05, **p<0.01, ***p<0.001. Data 
is presented as mean ±SEM.
Figure	2:	Minimum	spanning	 tree	analysis	of	MLVA	genotypes	 from	C. burnetii isolates used in 
the study
A total of 12 micro satellite loci (Table 1) were used to construct a dendrogram of 16 C. burnetii isolates. 
Numbers on the connecting lines refer to the distance between the nodes, e.g. 4 means four different 
loci. The size of the circles is proportional to the number of strains bearing the same genetic profile. 
Colors indicate the origin from which the isolates originate; goat (dark grey), human acute Q fever (black), 
human chronic Q fever (light grey), sheep (dashed) and cattle (white). Branch labels and connecting lines 
correspond to the number of different markers between the genotypes. Clustering by minimum spanning 
tree (MST, hypothetical, non-rooted) was performed with Bionumerics 7.5.
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Discussion 
C.  burnetii causes Q fever in humans and a broad range of animals throughout 
the world. In the majority of the examined cases, goats and sheep are the most 
likely source for human Q fever outbreaks[6]. Interestingly, in the Netherlands 
and Germany, the herd prevalence of C. burnetii in cattle is much higher than in 
goat and sheep. This could suggest that infected cattle are a large threat for the 
human population[6]. However, in the Netherlands and other countries with known 
human Q fever outbreaks, cattle are scarcely the source of the outbreak[6]. We 
hypothesized that these cattle C. burnetii isolates induce a more profound immune 
response in humans, which can eventually result in more effective elimination of 
the bacteria, resulting in less clinical disease.
Our study revealed that the cytokine patterns induced in human PBMCs depends 
on the C. burnetii isolate host origin. Namely, the two cattle isolates induced higher 
amounts of IL-1β, TNF-α, and IL-22 in human PBMCs than the goat and sheep 
isolates. In addition, we observed that the MLVA genotype of the C. burnetii isolates 
is not related to the cytokine induction by PBMCs. As the cytokine patterns induced 
in human PBMCs by C. burnetii isolates (grouped on base of their MLVA genotype), 
revealed no significant differences between the groups. 
There are several explanations for the observed differences in cytokine response 
of human PBMCs against C.  burnetii isolates originating from different animal 
hosts, and for the observation that the MLVA genotypes used in this study do not 
effect these cytokine responses.
Figure	3:	Cytokine	profiles	of	the	C. burnetii	isolates	grouped	on	their	MLVA	genotype
PBMCs of 11 healthy individuals were stimulated with RPMI medium (striped bar) and 16 different 
C. burnetii isolates, see Table 1 for the details of the isolates. The following cytokines were measured 
using ELISA: IL-1β, TNF-α, IFN-γ (3A), IL-Ra, IL-10 (3B), IL-17 and IL-22 (3C). The color of the bars match 
the following isolates; white (6x CbNL01), grey (5x CbNL12), black (5x remaining MLVA genotypes). 
Statistical differences were tested using one-way ANOVA. In case of all cytokines, except IFN-γ, the 
Bonferonni Post-Hoc test was used. For IFN-γ, differences were calculates using Fishers Least Signifi-
cant Difference (LSD). NS: Not Significant. Data is presented as mean ±SEM.
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genotype. There is evidence that insufficient induction of pro-inflammatory cyto-
kines result in defective activation of the host immune response on invasion of the 
organism by pathogenic microbes, resulting in increased susceptibility to infec-
tions[21]. Of course, the virulence factors of the C. burnetii isolates, as mentioned 
above as a second explanation, and the responsiveness of the human immune 
system are linked to each other. The Q fever outbreak in the Netherlands can be 
explained by the fact that, besides possible differences in virulence of the isolate, 
the human immune system is not able to induce an optimal response, leading to a 
higher susceptibility to infection. 
A stronger immune response by human PBMCs could lead to a more effective elim-
ination of the bacteria and protection of the host, hence the infection does lead to 
minimal of no clinical symptoms. Which can explain the low incidence of Q fever 
outbreaks among humans caused by infected cattle. However, the more profound 
cytokine response against C.  burnetii isolates from cattle is most likely not the 
only reason for the lower incidence of human infections. One can hypothesize that 
there is no or only limited exchange of genetic material between the niche of the 
goats and the niche of the cattle. Meaning that the niche of C. burnetii from cattle is 
separated from the niche of C. burnetii from goats, and potential virulence factors 
do not interchange. This hypothesis is strengthened by a study on the prevalence 
of C.  burnetii DNA in cow milk and milk products from 18 countries throughout 
Europe and 10 non-European countries, which revealed the presence of only one 
predominant genotype[8]. It can be suggested that within this cattle population 
studied, which covers a widespread geographic area, there is exchange of the same 
C. burnetii isolate. It is possible that the infectious material of cattle does not come 
in contact with humans or goats, or the infective route of the infected material is 
not effective. In case the two niches are not in contact with each other, it allows 
genetic drift among the diverse populations. The route of infection is considered to 
play a role in the infectiveness of the strains. Infected goats and sheep suffer from 
abortion and large amounts of C. burnetii are shed during the delivery. Due to this 
large shedding of these infected particles, inhalation is the main infection route in 
humans. Infected cattle on the other hand, only incidentally show signs of abortion, 
but their milk products do contain C. burnetii which is consumed by humans[8]. 
Although most of the consumed cattle milk nowadays is pasteurized, Cerf et al. 
concluded in their study that ingestion of C. burnetii-contaminated milk may result 
First is the common principle of the MLVA genotyping of the C. burnetii isolates. 
We observed that the two cattle isolates with MLVA genotype CbNL12 induced 
more pro- and anti-inflammatory cytokines in human PBMCs than the two goat and 
sheep isolates with the same MLVA genotype (data not shown). However, it is not 
possible to predict the cytokine induction by human PBMCs against a C. burnetii 
isolates based on its MLVA genotype. MLVA genotyping depends on a selection 
of loci containing tandem repeats are targeted. These loci do probably not code 
for antigens that are involved in the innate immune response. So, even though the 
MLVA genotype of the C. burnetii isolates is the same, other parts of the genome 
can differ which might result in diverse responses from host[18].  
A second explanation for the observed differences in cytokine response upon 
stimulation by C. burnetii isolates coming from different host, is the expression of 
diverse virulence factors. Recently, D’Amato et al. indicated that C. burnetii Z3055, 
a clone linked to the Dutch Q fever outbreak isolate 3262, contains significantly 
more non synonymous gene mutations for proteins belonging to the categories 
of membrane proteins, ankyrin repeat domain-containing proteins, transcription 
factors and translational proteins[19]. They hypothesized that the epidemic poten-
tial of this isolate is based on modifications in the in antigenic surface proteins and 
growth rate, which results in a new serotype (classification of micro-organisms 
based on the cell surface antigens)[19]. Differences in membrane proteins or other 
virulence factors of C. burnetii can make individuals less or more susceptible for 
infection, in addition it could result in fewer or more clinical symptoms depend-
ing on the responsiveness of the immune system. It can be hypothesized that the 
C.  burnetii isolates from cattle possess specific virulence factors, to which the 
human immune system is more profound to react.  
The responsiveness of the human immune system is the third factor which can 
explain the induced cytokine differences between PBMCs stimulation with cattle 
isolates or goat and sheep isolates. This difference in cytokine induction may be 
explained by the ability of our immune system to mount an adequate pro-inflamma-
tory response to these different strains. This was recently shown for Cryptococcus 
by Schoffelen et al.[20], as they concluded that PBMCs from healthy individuals 
induced a more pronounced inflammatory response against clinical heat-killed 
C. gattii isolates then to other Cryptococcus species and non-clinical C. gattii[20]. 
From our study we conclude that human PBMCs are able to induce a cytokine 
response against all C.  burnetii isolates tested, independent the origin or MLVA 
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fore, identification of C. burnetii infection in these individuals, based on serology, 
cannot be made and leads to less documented human Q fever cases.  
The cytokine pattern of PBMCs stimulated with isolates from chronic Q fever 
patients were similar to that of goat isolates. Based on these findings it is possible 
to speculate that some C. burnetii isolates are inducing acute Q fever, while other 
C.  burnetii isolates are responsible for chronic Q fever infections. This hypothe-
sis is strengthened by several studies demonstrating that C.  burnetii isolates 
originating from humans with acute Q fever differ in plasmid type[24], lipopoly-
saccharide profiles[25], and chromosomal DNA restriction endonuclease frag-
ment patterns[26] from many isolates originating from chronic Q fever. In addi-
tion, a 28-kDa membrane-associated protein was identified and demonstrated that 
the acute disease antigen A (adaA) gene is expressed in acute isolates but not 
carried by chronic isolates, suggesting that adaA may be a virulence factor related 
to acute Q fever[27]. In contrast, other studies indicated that no specific gene(s) 
on plasmids are responsible for a specific virulence phenotype[28, 29]. Moreover, 
during the Dutch Q fever outbreak we assume that the majority of the infected 
individuals, both acute as chronic, are infected with the same C.  burnetii MLVA 
genotype originating from goats. Meaning that one C. burnetii MLVA genotype can 
induce either acute or chronic Q fever infections in humans. In our opinion, the 
disease outcome of C. burnetii infections in humans is multi-factorial. Besides the 
findings presents in this study, we recently also described that single nucleotide 
polymorphisms in specific pattern recognition receptors increase the chance to 
develop chronic Q fever[30]. Taking all this into account, the severity of the infection 
is influenced among others by the origin and virulence of the C. burnetii isolate, as 
well as the immune status and genetic background of the infected individual. This is 
strengthened by the fact that many diverse C. burnetii isolates are found in goats, 
which are not detected in human samples. It implies that only the origin of the 
isolate does not predict the possibility for human infection and disease outcome. 
In conclusion, in the present study we investigated the potential of C.  burnetii 
isolates from different species of origin and MLVA genotypes to induce cytokine 
production in human PBMCs. We demonstrated that isolates derived from cattle 
and from acute Q fever patients induced higher amounts of the pro-inflammatory 
cytokines TNF-α, IL-1β and IL-22 compared to isolates from other sources and 
patients with chronic Q fever. Interestingly, this could not be related to differences 
in serological conversion potentially indicating infection but not necessarily clinical 
disease[22]. Some studies do mention that infection via the oral route is possible, 
but it is infrequent and the doses of C. burnetii has to be very high[22]. 
IFN-γ induced by the cattle isolates was not significantly higher than in the isolates 
from either goats or sheep. This is an unexpected result as the other pro-inflam-
matory cytokines IL-1β and TNF-α were significant higher in the cattle isolates 
than in the isolates from either goats or sheep. One explanation for the observed 
difference could be the larger variation of IFN-γ production among the PBMCs 
of healthy individuals, resulting in less mutual differences between isolates of 
different origin (data not shown). PBMCs of 11 individuals were stimulated with the 
different isolates and we deliberately choose not to exclude the outliers in order to 
visualize the variance in cytokine responses. For example, our data shows, that 
there is a reasonable variation in IFN-γ, Il-17 and IL-22 induction per person. 
Secondly, as mentioned in the results, the general induction of IFN-γ was much 
lower than for IL-1β and TNF-α. Besides the significant differences in IL-1β and 
TNF-α induction of the cattle isolates, IL-22 was significant higher in these isolates 
than in the goat and sheep isolates. IL-22, in part synergistically with other cytokines 
such as TNF-α, activates the expression of antimicrobial proteins like defensins. 
Furthermore, IL-22 promotes the production of inflammatory mediators, such as 
granulocyte colony-stimulating factor, IL-1β and lipopolysaccharide-binding protein 
(LBP)[23]. The initiation of these immune responses by IL-1β, TNF-α and IL-22 can 
explain the better clearance of C. burnetii originating from cattle by humans. 
The isolates from acute Q fever cases showed the same cytokine profile as the 
cattle isolates except for Il-22. Whoever these isolates were not retrieved from 
Dutch patients during the Q fever outbreak but from Kyrgyzstan, Italy and Greece. 
Unfortunately, there is only limited information on the background of these isolates, 
and we do not know whether these individuals were infected via cattle, sheep or 
goat. Although C. burnetii infection of human via cattle is less common, based on 
our study, we speculate that these acute human isolates originated from infected 
cattle. As they showed similar cytokine responses upon stimulation in human 
PBMCs and the symptoms of acute Q fever are mild and self-limiting. An incon- 
venience is that individuals with a possible C. burnetii infection via cattle may not 
see their general practitioner, as they don’t experience clinical symptoms. There-
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Summary and 
general discussion
First there was the Q fever outbreak in the Netherlands, 
secondly an outbreak of researchers occurred.
Maarten	van	Calmhout	(KennisCafé	–	Ziek	van	een	dier)
08
We demonstrated that in healthy, seronegative individuals the alternative pathway 
was activated by C. burnetii, while both the classical and lectin pathway were not 
involved. In the presence of C. burnetii antibodies both classical and alternative 
pathways were activated. Production of monocyte-derived cytokines such as IL-1β, 
TNF-α and IL-6 was in part dependent on the activation of the complement system. 
This was mediated by the anaphylatoxin C5a, which was formed after activation 
of the alternative pathway by C. burnetii. Although C. burnetii expresses sugars on 
its LPS that can be recognized by MBL (D-mannose and N-acetyl-D-glucosamine), 
no role was observed for MBL in complement activation and induction of mono-
cyte-derived cytokines[3, 4]. Of interest, we did find that MBL augmented induction 
of T-cell-derived cytokines. This suggest that in case of C. burnetii stimulation, MBL 
interacts predominantly with T-cells to induce T-cell-derived cytokines. 
Next to the complement system, recognition of micro-organisms by pattern 
recognition receptors (PRRs) is very important to initiate a proper innate immune 
response. PRRs recognize unique pathogen-associated molecular patterns 
(PAMPs) on the surfaces of microorganisms and activate host-defense mecha-
nisms, such as phagocytosis and cytokine signaling[5]. The main PRRs involved in 
recognition of bacteria are Toll-like receptors (TLRs; TLR1, TLR2, TLR4, and TLR6) 
and nucleotide-binding oligomerization domain receptors 1 (NOD1) and NOD2. 
In Chapter 3 we showed that both the C. burnetii Nine Mile (NM) strain and the 
Dutch outbreak isolate C. burnetii 3262 were able to induce cytokine production 
via TLR2 signaling, which suggests that both strains have PAMPs that can activate 
TLR2. This also accounts for NOD2, which was also identified to be important for 
the recognition of both strains. Besides these similarities, we also detected some 
differences between the two strains. Analyses of human PBMCs suggested that 
C. burnetii 3262 was recognized by TLR6, while this was not the case for C. burnetii 
NM. This may be explained by a different binding site of C. burnetii 3262 to TLR6, 
compared with C. burnetii NM. Our study showed that in humans both C. burnetii 
NM and C. burnetii 3262 were recognized by TLR1, TLR2, and NOD2 and induced a 
robust pro-inflammatory cytokine response.
In Chapter 4 we discussed the role of TLR10, which recently has been found to 
suppress cytokine induction by TLR2 ligands[6]. We showed that HEK293 cells, 
Summary
The aim of this thesis was to answer the following questions: how is C. burnetii 
recognized and initiates immune responses in goats versus humans? And how 
does C. burnetii lead to persistence and abortion in goats and chronic disease in 
humans? Understanding the immunological host response to C.  burnetii could 
eventually result in better diagnostic tests for humans and animals, and treatment 
for patients with Q fever. 
Chapter 1 provides background knowledge of Q fever and Coxiella burnetii. The 
zoonotic bacterium Coxiella burnetii is the causative agent of Q fever, causing 
acute or chronic infections in humans and abortions in infected pregnant goats. 
The Q in Q fever stands for query, as in 1935 the discoverers of the disease did not 
know what kind of organism caused the illness among humans. Eighty years later 
much more is known about the C.  burnetii and the disease it causes. Research 
increased exponentially when the Netherlands experienced the world largest Q 
fever outbreak worldwide from 2007 till 2010. The Dutch Q fever outbreak led to 
many projects investigating all different fields of C. burnetii, such as epidemiology, 
Q fever fatigue syndrome, Q fever in domestic animals, optimizing diagnostics test 
and so on. Throughout this thesis, the reference strain C. burnetii Nine Mile and the 
Dutch outbreak isolate C. burnetii 3262 were mostly used. These two C. burnetii 
strains, and all other C. burnetii isolates implemented in the studies, were heat inac-
tivated prior usage. 
In Chapter 2 we examined the involvement of the complement system in the 
immune response towards C.  burnetii. The complement system is part of the 
humoral innate immune response and plays an important role in the elimination 
of bacteria. The complement system can be activated via three different path-
ways; the classical pathway, the lectin pathway and the alternative pathway. The 
classical pathway is initiated by antibodies, the lectin pathway is activated via 
mannose-binding lectin (MBL), and many bacteria, viruses and fungi can initiate 
the alternative pathway. Activation of all three pathways eventually leads to the 
formation the opsonin C3b, the anaphylatoxins C3a and C5a and the terminal 
complement complex (TCC)[1, 2].  
180  SUMMARy AND GENERAL DISCUSSION CHAPTER 8	 181
C.  burnetii infection than the human immune system. In Chapter 6 we showed 
that naive goats have an increased mRNA expression of IL-1β, TNF-α, IL10 and 
IFN-γ upon C. burnetii stimulation. In addition, TLR2 expression was also strongly 
up-regulated which corresponds with our findings in humans. During experimen-
tal C. burnetii infection of the goats, we observed an increase in TNF-α and IFN-γ 
in C.  burnetii-infected goats compared to naive goats. Goat PBMCs initiated a 
robust pro-inflammatory immune response against C. burnetii in vitro. Furthermore, 
PBMCs from C. burnetii-infected goats showed augmented pro-inflammatory cyto-
kine responses compared to PBMCs from non-infected goats. However, despite 
this pro-inflammatory response, goats were not capable of clearing the C. burnetii 
infection. 
In the previous chapters we used the Dutch outbreak isolate C. burnetii 3262 and 
the reference strain C.  burnetii NM. We observed some differences in recogni-
tion, as C.  burnetii 3262 was recognized by TLR6 while C.  burnetii NM was not, 
and the inhibitory effect of TLR10 on cytokine induction was more prominent after 
C. burnetii 3262 than C. burnetii NM stimulation. During the Q fever outbreak many 
C. burnetii isolates derived from goats, sheep and in a lesser extent from cattle 
were collected by the Central Veterinary Institute, part of Wageningen University 
and Research Centre. These isolates and the isolates obtained from chronic Q 
fever patients collected by the Radboud University Medical Centre and the Canis-
ius-Wilhelmina Hospital were cultured in-house. In Chapter 7 we used these strains 
to answer the question whether strains with a diverse origin induced a different 
cytokine profile upon stimulation of human PBMCs. C. burnetii isolates from cattle 
induced significant more of the pro-inflammatory cytokines, IL-1β, TNF-α and IL-22 
than the isolates from goat, sheep or acute Q fever patients. Furthermore, a trend 
was observed of a higher cytokine induction by acute isolates than those from 
chronic Q fever patients. When the cytokine profile of the different isolates was 
distinguished based on their MLVA genotype, no differences in cytokine induction 
was observed. Literature showed that most human Q fever outbreaks came from 
infected sheep or goats, and not or in lesser extent from infected cattle[8]. Based 
on our findings, we can suggest that the reduced pathogenic potential of cattle 
isolates may be caused by a stronger initial immune response from the human 
host. 
transfected with TLR2, TLR10 or TLR2/TLR10, and human PBMCs in the pres-
ence of anti-TLR10, showed higher cytokine responses in the absence of TLR10 
upon C. burnetii stimulation. The function of C. burnetii as strong TLR2 ligand was 
confirmed in this study, as well as the suppressive effect of TLR10.
The findings described in the above chapters were based on in vitro studies, 
using cell lines, human PBMCs or knockout mice. The next step was to investi-
gate whether these findings could be linked to the development of chronic Q fever 
in humans. In Chapter 5 we focused on the genetic variation within the TLRs, 
NLRs and downstream signaling pathways. In total, 25 SNPs in TLR1, TLR2, TLR4, 
TLR6, TLR8, TIRAP, MYD88, NOD2, ITGAV, ITGB3, and ITGAM were genotyped. It 
showed that among 139 chronic Q fever patients and 220 controls specific SNPs 
in NOD2 (1007finsC), TLR1 (R80T) and MyD88 (−938C>A) were associated with 
the development of chronic Q fever. Besides that TLR1 (R80T) was significantly 
less frequently present in the patients with proven chronic Q fever than in the 
control cohort, the presence of this SNP also resulted in lower IL-10 production. 
This suggests that having lower IL-10 production upon contact with C. burnetii may 
protect against chronic Q fever[7]. The same chronic Q fever and control cohort 
was used to investigate the effect of SNPs in MBL2 and TLR10. In Chapter 4 the 
distribution of two common SNPs in TLR10 was examined, but both were not asso-
ciated with the development of chronic Q fever. In Chapter 2 we showed that the 
distribution of five SNPs in MBL2 did not differ between the chronic Q fever patients 
and the control group. Also, the different MBL haplotypes, which are depending on 
the genetic background and have a direct effect on MBL serum levels, did not differ 
between the two groups. To summarize, we identified that individuals with specific 
SNPS in NOD2, TLR1 and MyD88 have a higher chance to develop chronic Q fever. 
In contrast, even though in vitro studies on these gene show effect concerning 
C. burnetii recognition, no role for was found for SNPs in TLR2, TLR6, TLR10 and 
MBL2.
Much of the Q fever research focused on the immune response against C. burnetii in 
humans, while less is known about the responses in goats. More knowledge about 
this can be useful, as goats are one of the main sources of human Q fever infec-
tions. Furthermore, they do not show any symptoms during the C. burnetii infection 
itself, which could indicate that their immune system reacts differently towards 
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Netherlands. Therefore, we can conclude that an efficient response of C. burnetii 
3262 via PRRs does not prevent initial infection in humans. We can hypothesize 
that the additional recognition of C. burnetii 3262 by TLR6 and the induced cyto-
kine response can lead to a higher phagocytosis of the bacteria by macrophages. 
The engulfment of C. burnetii by these immune cells can be in favor of the bacte-
ria, as it replicates in macrophages. The advanced uptake by macrophages which 
facilitates the replication of C. burnetii can lead to more intense infection in the 
individual.
The next question we asked ourselves was whether either TLR1, TLR2 or TLR6 are 
involved in the development of chronic Q fever. Our findings indicate that individ-
uals with a SNP in TLR1, but not in TLR2 or TLR6 have a higher chance to develop 
chronic Q fever infection (Chapter 4). In healthy goats, we observed an increased 
mRNA expression of TLR1, TLR4, TLR6 and especially TLR2 in C. burnetii stimu-
lated PBMCs (Chapter 6)[13]. Next to the up-regulated mRNA expression of TLRs, 
we examined the cytokine response induced by C. burnetii in humans and goats. 
Human as well as goat PBMCs are able to induce a cytokine response, specifically 
TNF-α and IFN-γ, upon encounter with C. burnetii. Regardless of the present recog-
nition by PRRs and the initiation of a cytokine response, a small proportion of the 
infected humans develop chronic Q fever and infected goats suffer from adverse 
pregnancies. An explanation is that other parts of the host immune response 
are less activated during C. burnetii infection, for example the adaptive immune 
response which includes T-cells and B-cells. In addition, as we described in Chapter 
5, individuals can bear polymorphisms in genes involved in C. burnetii recognition, 
which can lead to a higher chance to develop chronic Q fever infection. Further-
more, C. burnetii itself can possess strategies to avoid the immune responses of 
the host, as this has been characterized in many other micro-organisms[14].  
The whole blood IFN-γ assay in goats showed a higher IFN-γ response in pregnant 
goats experimentally infected with C. burnetii than naive goats (Chapter 6). Simi-
lar findings were observed in humans by Schoffelen et al., as the IFN-γ response 
was significantly higher in individuals with a chronic infection compared to indi-
viduals with a previous Q fever infection[15, 16]. However, we do not know how the 
C.  burnetii-induced IFN-γ production relates to the IFN-γ induction by viruses or 
other bacteria in these chronic Q fever patients. It is possible that the IFN-γ produc-
General discussion
The goal of this thesis was to elucidate the recognition and responses of C. burnetii 
by the immune system of healthy individuals and pregnant goats. After this funda-
mental understanding of the role of important innate immune processes, we imple-
mented our findings to answer the question why only a small proportion of the indi-
viduals with an initial infection developed chronic Q fever and whether C. burnetii 
isolates origin from different hosts, such as goat, sheep and cattle, induce a diverse 
immune response in human PBMCs. 
Only very few publications focused on the recognition of C.  burnetii by PRRs. A 
few studies showed the important role of TLR2 and NOD2 in the recognition of 
C. burnetii NM and the induction of immune responses in humans and mice[9-11]. 
A weakness of these studies, for example in the case of NOD2, was that the results 
were based on mice studies alone. In addition, no literature was available regarding 
other PRRs like TLR1, TLR6 and TLR10. In goats, only one study examined the cyto-
kine expression upon C. burnetii infection and no literature is available on the role 
of TLRs[12]. The advantage of our research was the comparison between human, 
mice and goat using in vitro experiments as well as examining the effects of SNPs 
in the concerned PRRs in humans. This enabled us to identify whether C. burnetii 
induces a generic immune response in different hosts. Furthermore, we tackled 
existing knowledge gaps in literature by investigating the role of TLR1, TLR6 and 
TLR10 in humans (Chapter 3 and 4). We examined the cytokine response and the 
upregulation of TLR1, TLR2, TLR4 and TLR6 during C. burnetii infection in pregnant 
goats (Chapter 6). In addition, we were the first to examine the cytokine induction 
in human PBMCs upon stimulation with C. burnetii isolates coming from different 
animal species (Chapter 7). 
Combining our findings with the existing literature, we conclude that the TLR1/
TLR2 heterodimer and NOD2 play an important role in the induction of cytokine 
responses in healthy individuals by both C.  burnetii NM and C.  burnetii 3262. In 
addition, TLR6 is involved in the recognition of the Dutch outbreak strain C. burnetii 
3262 as well (Chapter 3). Despite the proper recognition of C.  burnetii 3262 by 
these TLRs, it was able to cause a large outbreak of Q fever among humans in the 
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not always reflects the actual amount of proteins produced. Furthermore, the goats 
in the study were pregnant. Pregnancy is a necessity for goats to develop clinical 
Q fever, as non pregnant goats do not show any symptoms of the infection. Until 
recently, pregnancy in humans was considered a risk factor to develop chronic Q 
fever. However, studies performed during the Dutch Q fever outbreak did not show 
clear evidence for an increased probability to develop chronic Q fever during preg-
nancy[20, 21]. Based on the above mentioned differences and similarities between 
the goats and human immune response against C. burnetii, it is difficult to give an 
answer on the question whether the immune response is comparable. They are 
two independent models, which should be used to answer questions related to 
their own environmental background and situation. Though, with our approach to 
investigate the response in both models, we can conclude that C. burnetii itself is 
able to induce an innate immune response, and can be recognized in both humans 
and goat. We recommend that future studies on the C. burnetii-induced immune 
response in humans focus on in vitro studies using human immune cells, and we 
expect that much more information can be obtained from genetic studies among 
Q fever patients. Studies that focus on the C. burnetii infections and the immune 
responses in goats and other animal hosts are important and should not be 
neglected. Because of the current intensive herding, and the fact that humans and 
ruminants live close together, possible future outbreaks can be expected, when the 
protective vaccination of goats is abandoned. More knowledge on the epidemio- 
logy, transmission and immune responses in the animals hosts is always appreci-
ated and useful to prevent new outbreaks, find better diagnostics or treatments.  
As C. burnetii is been classified as a group B bioterrorism agent, experiments with 
the live bacteria need to performed in a level 3 laboratory. To our knowledge, no 
studies are published comparing both live and heat killed C. burnetii and the effect 
on cytokine induction and recognition by PRRs. We decided to use heat inactivated 
C. burnetii in our studies for two reasons. First, we investigated the initial recog-
nition of C. burnetii: does stimulation of human and goat PBMCs with C. burnetii 
induce a cytokine response, and which PRRs of these PBMCs are involved. We 
did not examine the replication or trafficking inside the immune cells. Secondly, it 
was a practical consideration: we were able to use one single batch of heat inac-
tivated C. burnetii for all experiments in this thesis. There might be a possibility 
that our findings do not apply to live C. burnetii as heat inactivation may influence 
tion in chronic Q fever patients is not sufficient to effectively clear the bacterium, 
and not all chronic Q fever patients induced these large amounts of IFN-γ upon 
C. burnetii stimulation. Treatment of chronic Q fever patients with additional IFN-γ 
may therefore result in regression of the disease. To test this hypothesis, a chronic 
Q fever patient (with a low IFN-γ response) recently underwent IFN-γ treatment in 
the Radboudumc. We hypothesize that an IFN-γ treatment could also potentially 
resolve C. burnetii infection in goat. However, in contrast to humans, IFN-γ treat-
ment of C. burnetii infected goats would not be cost-effective.  
In literature, it is often mentioned that 1-5% of the individuals with an initial infection 
will develop chronic fever. We know that individuals with preexisting cardiac valv-
lo-pathy, vascular grafts and aneurysms and immunosuppression have a higher 
chance to develop chronic Q fever. In addition, our study showed that individuals 
with a specific SNP in either MyD88, NOD2 or TLR1 have a significantly higher 
chance to develop chronic Q fever (Chapter 5)[17]. Although TLR2 is an important 
receptor in the recognition of C. burnetii, polymorphisms in the TLR2 gene were 
not associated with a higher chance to develop chronic Q fever. In addition, SNPs 
in TLR2 and TLR4 were also not involved in the development of acute Q fever, 
as demonstrated by Everett et al.[18]. An explanation that the SNPs in TLR2 and 
TLR4 we and others examined did not play a role in the development of acute and 
chronic Q fever, can be that they did not interfere with the binding site of C. burnetii, 
resulting in no functional effect of the SNP on C. burnetii recognition. 
A question rising from literature and our own findings, is whether we could compare 
the immune recognition and responses between goats and human? Based on the 
induction of the pro-inflammatory cytokines, TNF-α and IFN-γ, we can hypothesize 
that PBMCs of infected goats show a similar cytokine profile to chronic Q fever 
patients, while the IL-10 mRNA expression in infected goats is not up-regulated 
as found in the chronic Q fever patients[7, 19]. These differences in IL-10 expres-
sion could be an explanation for the divergent clinical outcomes in humans and 
goats during C. burnetii infection. However, it should be taken in to account that the 
experimental set-up differed between the two hosts. The main difference was that 
in our study goats were experimentally infected with C. burnetii, while the chronic 
Q fever patients in the studies of our colleagues were infected naturally. In addi-
tion, in goats we measured mainly mRNA expression of cytokines, while human 
studies are predominantly based on protein expression. mRNA expression does 
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an adequate immune response in PBMCs and is recognized by TLR1, TLR2 and, in 
contrast to C. burnetii NM, also TLR6. We therefore conclude that the hypothesis 
that C. burnetii 3262 was able to cause disease in many individuals due to altered 
recognition by PRRs and diminished cytokine responses, is less likely.
An interesting finding is the cytokine profile of C.  burnetii isolates with a cattle 
origin, which shows the highest production of pro-inflammatory cytokine in human 
PBMCs once compared with isolates coming from either human, goats or sheep. 
It is not known what makes these cattle isolates less virulent. It can be questioned 
whether they lack several escape strategies or contain a lesser stimulatory LPS 
or other surface antigens, which enables the hosts immune system to respond 
more effectively. Structural comparison studies or in vivo studies with different 
isolates can provide more answers. The findings of this study can also be used in 
the prediction of potential Q fever outbreaks. We know from literature that cattle 
are less often the source of Q fever infection in humans, and our study relates 
to this as the human immune systems reacts with a high pro-inflammatory cyto-
kine production upon stimulation with cattle related C. burnetii isolates. During the 
Dutch Q fever outbreak, many pregnant goats were culled, as they were a poten-
tial source to infect humans with C. burnetii. In contrast, from our study we can 
assume that during a potential Q fever outbreak among cattle, there is less need 
to cull these animals as infected individuals will have a more effective immune 
response (expecting to result in no or limited clinic) against C.  burnetii isolates 
derived from cattle. From the point of infected human individuals, specific sero- 
diagnostics could be developed to identify the strains origin and relate it to its viru-
lence and chance to initiate a chronic infection. If we are able to characterize these 
host dependent virulence factors, diagnostics test could be developed to define the 
origin of the C. burnetii strains and the expected clinical cause in humans. 
One of the research questions of this thesis was to investigate the immune recogni-
tion and response in pregnant goats and why C. burnetii infection leads to abortion, 
without additional clinical symptoms. We found that goats induce a pro-inflamma-
tory cytokine response upon stimulation with C. burnetii and the mRNA of TLRs is 
also upregulated. It seems that the goat immune system is able to induce a proper 
initial recognition and immune response, both humoral and cellular[12, 13]. Our 
studies did show that in the first week of infection in pregnant goats, IFN-γ produc-
tion was reduced[13](Chapter 6). It can be hypothesized that C. burnetii suppresses 
the antigen exposure on bacteria and the interaction with the immune system 
may be altered. For example, in previous studies investigating the role of TLR2 in 
C. burnetii recognition, live C. burnetii was used to infect TLR2 specific knockout 
mice. However, the important role of TLR2 was identified both in these previous 
studies and in our study, showing the indifference of the usage of live or heat inac-
tivated C. burnetii[9, 10, 22]. In addition, both live and heat inactivated C. burnetii 
have been used in previous human cytokine studies, to which we could compare 
our findings[19, 23].  
In the studies conducted for this thesis we made use of both C. burnetii NM RSA 
493 and the Dutch outbreak strain C.  burnetii 3262. We chose these particular 
strains, because the former is the laboratory reference strain and used by other 
research groups. And the latter caused the Dutch outbreak which led to the culling 
of many goats, and acute and chronic infections in humans. As mentioned in the 
above summary, we did identify some differences between the Nine Mile and the 
Dutch outbreak isolate. One frequently asked question is what determines these 
differences and whether we can speculate about the different gene expression 
of these two strains. At the moment, the only comparison can be made based 
on MLVA genotype, which indeed differs at several loci. Additional information 
about the genetic background will come available upon the publication of the de 
novo sequence of the Dutch outbreak isolate C. burnetii 3262. Genome compari-
son between C. burnetii NM and C. burnetii 3262 could identify differences in the 
genetic parts corresponding for virulence factors like LPS or proteins. In addition, 
it could be used to compare possible changes like polymorphisms in genes coding 
for PRRs.
C. burnetii 3262 represents the CbNL01 MLVA genotype, which was the predomi-
nant genotype found during the Q fever outbreak in the Netherlands and caused the 
largest outbreak of Q fever ever reported worldwide. Besides increased exposure 
of humans to this pathogen due to intensive goat herding[24], it may be hypothe-
sized that this strain is less effectively recognized by PRRs. Inadequate recognition 
of C. burnetii 3262 can subsequently result in fewer responses such as the induc-
tion of pro-inflammatory cytokines, phagocytosis and elimination of the bacteria. 
In the end this could explain the more infectious and disease causing features of 
C. burnetii 3262. Our results however indicate that C. burnetii 3262 is able to induce 
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One of the problems is the diagnoses of C. burnetii infection in goats, as it is diffi-
cult to determine whether goats suffer from a previous or active infection. We have 
identified that goats are able to induce a pro-inflammatory cytokine response after 
encounter with C. burnetii. Diagnostics for early detection of C. burnetii infection 
in goats seems to be possible by measuring C. burnetii specific induced IFN-γ in 
whole blood, as we show that infected goats induce significant lower IFN-γ (Chap-
ter 6). However, these possibilities to measure IFN-γ and the application in these 
purposes need to be further investigated.
In this thesis we demonstrated that individuals with a specific SNP in either MyD88, 
NOD2 or TLR1 have a higher chance to develop chronic Q fever (Chapter 5). These 
findings can be implemented in the diagnosis of chronic Q fever, and making it 
possible to detect individuals with a larger preposition to develop chronic Q fever in 
an early stage. If it is known whether a patient with acute Q fever and risk factors 
to develop chronic infection carries such a mutation, prophylactic treatment may 
be considered. Another advantages of the genetic study we performed was the 
ability to obtain and use a large collection of DNA samples from chronic Q fever 
patients and matched controls. With approximately 140 samples of chronic Q fever 
patients, it is the world largest cohort and the samples are very precious for further 
studies. In the present studies, we only investigated the effect of genetic variation 
in specific recognition receptors on the development of chronic Q fever. In future 
studies it would be interesting to compare healthy C. burnetii seronegative individ-
uals with individuals with an acute Q fever infection. Even a comparison can be 
made between acute Q fever patients with and without hospitalization. It can be 
hypothesized that during Q fever infection, individuals with SNPs in genes involved 
in the initial recognition, such as cytokines and PRRs, are more often hospitalized 
than individuals without these SNPs. A previous study did not find an association 
with SNPs in TLR2 and TLR4 with disease manifestations in acute Q fever[18]. The 
role of TLR1, NOD2 and MyD88, which are linked to the development of chronic Q 
fever, are not investigated so far. The findings will provide more information about 
which receptors and pathways are involved in the initial recognition of C. burnetii. 
A final recommendation based on our research concerns the diverse clinical 
outcome in humans infected with different C. burnetii isolates. We observed higher 
pro-inflammatory cytokine response in human PBMCs stimulated with cattle 
IFN-γ responses early during infection, making it possible for the bacterium to 
be transported to the trophoblasts in the placenta without being noticed by the 
immune system. However, more research is needed to answer the question how 
the C. burnetii infection eventually leads to abortion and still birth. For example, 
to investigate the role of IFN-γ on C. burnetii replication and survival. It is known 
from literature that IFN-γ facilitates C. burnetii killing, however these experiments 
were performed in THP-1 (monocyte-like) cell-line, and not in cells more specifically 
related to the placenta[25, 26]. In addition, a successful pregnancy depends largely 
on mechanisms by which the immune system of the mother is made tolerant to 
the semi-allogeneic fetus. The effect of C.  burnetii on immunomodulators such 
as arginase and tryptophan during pregnancy have not been investigated yet and 
could provide new insights. 
In the end, the final question remains why infection with C.  burnetii results in 
chronic infection in some of the infected individuals. In my opinion, the answer can 
only partly be found in the hosts immune response to the C. burnetii isolate itself. 
It is a combination of factors, including the initial dose of C. burnetii infection, the 
virulence and origin of the C. burnetii isolate, and the immune status, presence of 
predisposing vascular factors and genetic background of the infected individual. 
There remain many possibilities to investigate in the future, in which these aspects 
should all be considered and combined.
Recommendations and future 
scientific perspectives
The results presented in this thesis contribute to answer a broad range of ques-
tions and knowledge gaps in Q fever infections. We gained more information about 
the immune response against C. burnetii in humans and goats and our findings are 
useful for other researchers in the Q fever field and future studies in both the veteri-
nary as the human field. By understanding more about the immunological response 
to C. burnetii, we eventually hope to find better diagnostic tests for humans and 
animals and treatments for patients with Q fever.
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lichamen tegen C. burnetii werden zowel de klassieke als de alternatieve weg geac-
tiveerd. De productie van IL-1β, TNF-α en IL-6 was gedeeltelijk afhankelijk van de 
activatie van het complement systeem. Dit werd gemedieerd door C5a, welke was 
gevormd na de activatie van de alternatieve weg door C. burnetii. Hoewel C. burnetii 
LPS bepaalde suikers bevat die kunnen worden herkend door MBL (D-mannose 
en N-acetyl-D-glucosamine), vonden we geen rol voor MBL in de activatie van het 
complement systeem of in de inductie van IL-1β, TNF-α en IL-6 [3, 4]. Een interes-
sant observatie was dat MBL wel de inductie van T-cellen-geproduceerde cytokinen 
verhoogde. Dit suggereert dat in geval van C. burnetii stimulatie, de interactie van 
MBL vooral plaats vindt met T-cellen om vervolgens T-cellen-geproduceerde cyto- 
kinen (IL-17, IL-22 en IFN-γ) te induceren. 
Naast het complement system, spelen de patroon herkennings receptoren (pattern 
recognition receptors (PRRs)) een zeer belangrijke rol bij het initiëren van een 
goed aangeboren immuun respons. Deze PRRs kunnen unieke componenten op 
het oppervlak van micro-organismen herkennen (pathogen-associated molecular 
patterns (PAMPs)), en vervolgens het immuun response van de gastheer active-
ren[5]. De belangrijkste PRRs in de herkenning van bacteriën zijn de Toll-like recep-
toren (TLRs; TLR1, TLR2, TLR4, en TLR6) en de nucleotide-binding oligomerization 
domain receptoren 1 (NOD1) en NOD2.
In Hoofdstuk 3 laten we zien dat zowel de C. burnetii Nine Mile (NM) stam en de 
Nederlandse uitbraak isolaat C. burnetii 3262 in staat zijn cytokines te induceren 
via TLR2. Dit betekent dat beide stammen PAMPs bezitten die TLR2 kunnen acti-
veren. Hetzelfde geldt voor NOD2, welke ook belangrijk is voor de herkenning van 
beide stammen. Naast deze overeenkomsten tussen de twee C. burnetii-stammen, 
hebben we ook enkele verschillen gevonden. Ons onderzoek, waarin gebruik wordt 
gemaakt van humane perifeer bloed mononucleaire cellen (PBMCs), suggereert 
dat C. burnetii 3262 wordt herkend door TLR6, terwijl dit niet geldt voor C. burnetii 
NM. Dit zou verklaard kunnen worden doordat TLR6 verschillende bindingsplekken 
heeft voor C. burnetii 3262 en C. burnetii NM. Onze studie laat zien dat in gezonde 
vrijwilligers, C. burnetii NM en C. burnetii 3262 worden herkend door TLR1, TLR2 
en NOD2, en dat beide stammen een robuust pro-inflammatoir cytokine response 
induceren. 
Samenvatting
Het doel van dit proefschrift was om de volgende vragen te beantwoorden: hoe 
wordt C.  burnetii herkend en hoe activeert het een immuun reactie in geiten en 
mensen? En hoe kan C. burnetii-infectie leiden tot persistentie en abortus in geiten 
en chronische infectie in mensen? Meer kennis over de immunologische reactie 
van de gastheer kan leiden tot betere diagnostiek in mens en dier, en uiteindelijk tot 
doelgerichtere behandeling van patiënten met chronische Q koorts. 
Hoofdstuk 1 geeft achtergrond informatie over Q-koorts en Coxiella burnetii. De 
zoönotische bacterie Coxiella  burnetii is de veroorzaker van Q-koorts, wat kan 
leiden tot acute en chronische infecties in mensen en abortussen in geïnfecteerde 
drachtige geiten. De Q in Q koorts staat voor ‘query’ (‘onbekend’), omdat de onder-
zoekers tijdens de ontdekking in 1935 geen idee hadden wat voor soort orga-
nisme de ziekte in mensen veroorzaakte. Tachtig jaar later is er veel meer bekend 
over C. burnetii en de ziekte die het veroorzaakt. Het onderzoek naar Q-koorts is 
exponentieel gestegen toen Nederland van 2007 tot en met 2010 te maken kreeg 
met de grootste Q-koorts uitbraak wereldwijd. De Nederlandse Q-koorts uitbraak 
leidde tot veel verschillende onderzoeken, waaronder epidemiologie, het Q-koorts 
vermoeidheid syndroom, Q-koorts in huisdieren, het optimaliseren van diagnos- 
tische testen, etc.
In Hoofdstuk 2 hebben we de rol van het complement system binnen het immuun 
response tegen C.  burnetii onderzocht. Het complement systeem is onderdeel 
van het humorale aangeboren immuun response en speelt een belangrijke rol bij 
de eliminatie van bacteriën. Het complement systeem kan geactiveerd worden 
via drie verschillende wegen; de klassieke weg, de lectine weg en de alternatieve 
weg. De klassieke weg wordt geactiveerd door antilichamen, de lectine weg door 
mannose-bindend lectine (MBL), en vele bacteriën, virussen en schimmels kunnen 
de alternatieve weg activeren. Uiteindelijk leidt de activatie van alle drie de wegen 
tot de formatie van opsonin C3b, de anaphylatoxines C3a en C5a en het termi-
nale complement complex (TCC)[1, 2]. We laten zien dat in gezonde, seronegatieve 
individuen de alternatieve weg werd geactiveerd door C. burnetii, terwijl zowel de 
klassieke als de lectine weg niet betrokken waren. In de aanwezigheid van anti- 
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Veel van het Q-koorts onderzoek is gericht op het immuun response tegen C. burnetii 
in mensen, terwijl er veel minder bekend is over het response in geiten. Het kan 
echter erg nuttig zijn om meer kennis hierover te verkrijgen, omdat geiten een van 
de belangrijkste bronnen zijn van humane Q-koorts besmettingen. Daarnaast verto-
nen geiten geen symptomen wanneer zij geïnfecteerd zijn, wat zou kunnen beteke-
nen dat hun immuun systeem anders reageert tijdens C. burnetii-infectie dan het 
humane immuun systeem. In Hoofdstuk 6 toonden we aan dat PBMCs van naïeve 
geiten een verhoogde mRNA expressie hebben van IL-1β, TNF-α, IL10 en IFN-γ na 
C. burnetii stimulatie. Daarnaast was de expressie van TLR2 ook sterk verhoogd, 
wat overeenkomt met onze bevindingen in mensen. Gedurende experimentele 
infectie van geiten met C.  burnetii vonden wij een verhoogde TNF-α en IFN-γ in 
C.  burnetii geïnfecteerde geiten in vergelijking met naïeve geiten. PBMCs van 
geiten initiëren een robuust pro-inflammatoir immuun response tegen C. burnetii 
in vitro. Maar, ondanks deze pro-inflammatoire reactie zijn geiten niet in staat om 
de C. burnetii te klaren. 
In de bovengenoemde hoofdstukken hebben we gebruik gemaakt van de Neder-
landse uitbraak isolaat C. burnetii 3262 en de referentie stam C. burnetii NM. We 
hebben enkele verschillen ontdekt tussen deze stammen, namelijk dat C. burnetii 
3262 wordt herkend door TLR6 terwijl dit niet het geval was voor C. burnetii NM. 
En het inhiberende effect van TLR10 op de cytokine productie had een groter effect 
na stimulatie met C. burnetii 3262 dan C. burnetii NM. Tijdens de Q-koorts uitbraak 
in Nederland, zijn er veel C. burnetii-isolaten afkomstig van geiten, schapen en in 
mindere mate ook van runderen, verzameld door het Centraal Veterinair Instituut 
(CVI, Wageningen University and Research Centre). Deze dierlijke isolaten, en de 
isolaten verkregen uit chronische Q-koorts patiënten uit het Radboud University 
Medical Centre en het Canisius-Wilhelmina Ziekenhuis zijn in het CVI opgewerkt. 
In Hoofdstuk 7 hebben we deze stammen gebruikt om de vraag te beantwoorden 
of isolaten met een verschillende herkomst (geit, schaap, rund, acute en chroni-
sche Q-koorts patiënten) een verschillend cytokine profiel laten zijn na stimulatie 
van humane PBMCs. We vonden dat C. burnetii-isolaten afkomstig van runderen 
significant meer pro-inflammatoire cytokines, IL-1β, TNF-α en IL-22, produceren 
dan de isolaten afkomstig van geiten, schapen of acute Q koorts patiënten. Daar-
naast laten de isolaten van acute Q-koorts patiënten een trend zien van een hogere 
cytokine inductie dan de isolaten van chronische Q-koorts patiënten. Wanneer het 
In Hoofdstuk 4 bediscussieerden we de rol van TLR10, deze receptor onderdrukt 
de cytokine productie door TLR2 liganden[6]. We laten zien dat HEK293 cellen, 
getransfecteerd met TLR2, TLR10 of TLR2/TLR10 en humane PBMCs in de aanwe-
zigheid van anti-TLR10, een verhoogd cytokine response laten zien na C. burnetii 
stimulatie in de afwezigheid van TLR10. Deze studie bevestigd zowel de functie 
van C. burnetii als een sterke TLR2 ligand, als het onderdrukkende effect van TLR10. 
De resultaten die we in de bovenstaande hoofdstukken hebben beschreven zijn 
gebaseerd op in vitro studies, zoals cellijnen, humane PBMC of knock-out muizen. 
De volgende stap was om te onderzoeken of deze bevindingen konden worden 
gekoppeld aan de ontwikkeling van een chronische Q-koorts infectie in patiënten. 
In Hoofdstuk 5 lag de aandacht op de genetische variatie binnen de TLRs, NLRs 
en adaptor moleculen en de ontwikkeling van chronische Q-koorts. In totaal zijn er 
25 single nuceotide polymorphisms (SNPs) gegenotypeerd, in TLR1, TLR2, TLR4, 
TLR6, TLR8, TIRAP, MYD88, NOD2, ITGAV, ITGB3, en ITGAM. Ons onderzoek onder 
139 chronische Q-koorts patiënten en 220 controles, toonde aan dat specifieke 
SNPs in NOD2 (1007finsC), TLR1 (R80T) en MyD88 (−938C>A) geassocieerd zijn 
met de ontwikkeling van chronische Q-koorts. Behalve dat TLR1 (R80T) significant 
minder aanwezig was in de patiënten met een bewezen chronische Q-koorts, leidt 
de aanwezigheid van deze SNP ook tot minder IL-10 productie. Dit suggereert dat 
een verminderde IL-10 productie na contact met C. burnetii mogelijk kan bescher-
men tegen de ontwikkeling van chronische Q-koorts[7]. 
Hetzelfde cohort van chronische Q-koorts patiënten hebben we gebruikt om het 
effect van de SNPs in MLB2 en TLR10 te onderzoeken. In Hoofdstuk 4 onderzoch-
ten we de verdeling van twee bekende SNPs in TLR10, maar beide zijn niet ge- 
associeerd met het ontstaan van chronische Q-koorts. In Hoofdstuk 2 laten we 
zien dat de distributie van vijf SNPs in MBL2 niet verschilt tussen chronische 
Q-koorts patiënten en de controle groep. Ook de verschillende MBL haplotypen, 
welke afhankelijk zijn van de genetische achtergrond en een direct effect op de 
MBL serum levels hebben, verschillen niet tussen beide groepen. Samenvattend 
laten de genetische studies zien dat individuen met specifieke SNPs in NOD2, TLR1 
en MyD88 een grotere kans hebben om chronische Q-koorts te ontwikkelen. In 
tegenstelling tot onze in vitro studies, die een rol voor TLR2, TLR6, TLR10 en MBL2 
in de herkenning van C. burnetii lieten zien, hebben bepaalde SNPs in deze genen 
geen invloed op de ontwikkeling van chronische Q-koorts. 
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Algemene discussie
Het doel van dit proefschrift was om een beter en vernieuwend inzicht te krijgen 
hoe C. burnetii wordt herkend door het immuun systeem en welke immuun reacties 
het initieert in gezonde individuen en drachtige geiten. De resultaten van ons funda-
mentele onderzoek hebben we gebruikt om de vraag te beantwoorden waarom 
slechts een klein gedeelte van de individuen met een initiële infectie chronische 
Q-koorts ontwikkeld, en of C. burnetii-isolaten met een diverse herkomst, zoals geit, 
schaap of rund, een verschillend immuun response genereren in humane PBMCs. 
Slechts enkele publicaties waren gericht op de herkenning van C.  burnetii door 
PRRs. Enkele studies lieten zien dat TLR2 en NOD2 een belangrijke rol spelen in 
de herkenning van C. burnetii NM en in de inductie van immuun reacties in mensen 
en muizen[9-11]. Een nadeel van deze studies, bijvoorbeeld in geval van de NOD2 
studie, was dat de resultaten alleen waren gebaseerd op muis studies. Daarnaast 
was er geen literatuur aanwezig waarin de rol van andere PRRs, zoals TLR1, TLR6 
en TLR10 zijn onderzocht. In geiten is er slechts één studie die de cytokine expres-
sie laat zien in drachtige geiten na C. burnetii infectie, maar er bestaat geen litera-
tuur over de rol van TLRs[12]. Het voordeel van ons onderzoek was dat we de verge-
lijking tussen humaan, muizen en geiten kunnen maken via in vitro experimenten, 
maar ook gebruik hebben gemaakt van de effecten van SNPs in betrokken PRRs 
in mensen. Hierdoor was het mogelijk om te bepalen of C. burnetii een algemeen 
immuun response genereert in verschillende gastheren. Daarnaast hebben we de 
huidige ‘knowledge gaps’ in de literatuur aangepakt door onderzoek te doen naar 
de rol van TLR1, TLR6 en TLR10 in mensen (Hoofdstuk 3 en 4). We onderzoch-
ten het cytokine response en de expressie van TLR1, TLR2, TLR4 en TLR6 tijdens 
C. burnetii infectie in drachtige geiten (Hoofdstuk 6). Daarnaast zijn we de eerste 
die onderzocht hebben hoe het cytokine response van humane PBMCs is wanneer 
zij worden gestimuleerd met C. burnetii-isolaten afkomstig van verschillende dieren 
(Hoofdstuk 7).
Als we onze bevindingen combineren met de bestaande literatuur, kunnen we 
concluderen dat de TLR1/TLR2 heterodimer en NOD2 een belangrijke rol spelen 
bij de initiatie van een cytokine response in gezonde personen in de herkenning 
cytokine profiel van de isolaten wordt ingedeeld op basis van hun MLVA genotype 
(in plaats van herkomst), waren er geen verschillen tussen de isolaten en de cyto-
kine inductie te zien. De huidige literatuur laat zien dat de meeste humane Q-koorts 
uitbraken werden veroorzaakt door geïnfecteerde geiten en schapen, en in mindere 
mate door geïnfecteerde runderen[8]. Gebaseerd op onze bevindingen, kunnen 
we suggereren dat de verminderde pathogene potentie van runder isolaten kan 
worden veroorzaakt door een sterker immuun reactie in de humane gastheer. 
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Schoffelen et al. zagen de zelfde bevindingen in mensen, waar de IFN-γ response 
significant hoger was in individuen met een chronische Q-koorts dan individuen 
met een doorgemaakte Q-koorts infectie[15, 16]. We weten niet hoe deze C. burnetii 
geïnduceerde IFN-γ productie relateert tot andere bacteriën of virussen in chro-
nische Q-koorts patiënten. Het is mogelijk dat de IFN-γ productie in chronische 
Q-koorts patiënten niet genoeg is om de bacterie effectief te verwijderen en daar-
naast produceren niet alle chronische Q-koorts patiënten hogere hoeveelheden 
van IFN-γ. Het behandelen van chronische Q-koorts patiënten met extra IFN-γ kan 
wellicht leiden tot regressie van de ziekte. Om deze hypothese te testen is een 
chronische Q-koorts patiënt (met een lage IFN-γ response) recentelijk behandelt 
met IFN-γ in het Radboudumc. In principe verwachten we dat IFN-γ behandeling 
van geïnfecteerde geiten ook de infecte kan helpen te overkomen. Maar, in tegen-
stelling tot bij mensen, is IFN-γ behandeling van C. burnetii geïnfecteerde geiten 
niet kosten effectief. 
In de literatuur wordt vaak gezegd dat 1-5% van de individuen met een initiële infec-
tie chronische Q-koorts ontwikkelen. Het is bekend dat personen met een aneu-
rysma, hartklepafwijking, vaatprothese of immunosuppressie een hogere kans 
hebben op het ontwikkelen van chronische Q-koorts. Daarnaast laat onze studie 
zien dat individuen met een specifieke SNP in MyD88, NOD2 of TLR1 ook een 
hogere kans hebben op chronische infectie (Hoofdstuk 5)[17]. Hoewel TLR2 een 
belangrijke receptor is in de herkenning van C. burnetii zijn polymorphismen in het 
TLR2 gen niet geassocieerd met een hogere kans op het ontwikkelen van chroni-
sche Q-koorts. Tevens is er ook geen associatie gevonden tussen polymorphismen 
in TLR2 en TLR4 en acute Q-koorts, zoals Everett et al. aantonen[18]. Een verklaring 
dat de SNPs in TLR2 en TLR4 die wij en andere hebben onderzocht geen rol spelen 
in de ontwikkeling van acute of chronische Q-koorts kan zijn dat ze niet interfereren 
met de bindingsplaats van C. burnetii, en daarom geen functioneel effect hebben.
Kijkend naar de huidige literatuur en onze eigen bevindingen is de vraag of we de 
immuun herkenning en responses kunnen vergelijken tussen mensen en geiten. 
Gebaseerd op de inductie van de pro-inflammatoire cytokines, TNF-α en IFN-γ, 
kunnen we hypothetiseren dat PBMCs van geïnfecteerde geiten een zelfde cyto-
kine profiel laten zien als chronische Q-koorts patiënten. Daarentegen is de IL-10 
mRNA expressie niet verhoogd in geïnfecteerde geiten, maar observeren we wel 
van zowel C.  burnetii NM als C.  burnetii 3262. Daarnaast is TLR6 betrokken bij 
de herkenning van de Nederlandse uitbraak stam C.  burnetii 3262 (Hoofdstuk 
3). Ondanks een goede herkenning van C. burnetii door deze TLRs, is het in staat 
geweest om een grote uitbraak te creëren onder individuen in Nederland. We 
kunnen hieruit concluderen dan een efficiënte reactie tegen C.  burnetii 3262 via 
PRRs een infectie in mensen niet weerhoudt. Een hypothese is dat de extra herken-
ning van C. burnetii 3262 door TLR6 en het geïnduceerde cytokine response kan 
leiden tot een hogere opname van de bacterie door macrofagen. Deze opname van 
C. burnetii door immuun cellen kan in het voordeel van de bacterie zijn omdat het 
repliceert in macrofagen. Deze opname door macrofagen faciliteert de replicatie 
van C. burnetii en kan zo leiden tot een meer intensieve infectie in mensen. 
De volgende vraag die we ons zelf stelden was of TRL1, TLR2 en TLR6 betrokken 
zijn bij het ontwikkelen van chronische Q-koorts. Onze bevindingen laten zien dat 
personen met een SNP in TLR1, maar niet in TLR2 of TLR6, een grotere kans hebben 
om chronische Q-koorts te ontwikkelen (Hoofdstuk 5). In gezonde geiten zagen we 
een hogere mRNA expressie van TLR1, TLR4, TLR6 en vooral TLR2 in C. burnetii 
gestimuleerde PBMCs (Hoofdstuk 6)[13]. Naast de verhoogde mRNA expressie 
van TLRs hebben we het door C. burnetii geïnduceerde cytokine response onder-
zocht in geiten en mensen. Zowel de PBMCs van mensen als geiten zijn in staat om 
een cytokine response te induceren, voornamelijk TNF-α en IFN-γ, na contact met 
C. burnetii. Ongeacht de functionele herkenning van PRRs en de initiatie van een 
immuun response, ontwikkelt een klein deel van de geïnfecteerde personen een 
chronische infectie en kan C. burnetii infectie in drachtige geiten tot abortus leiden. 
Een verklaring hiervoor kan zijn dat andere delen van het immuun systeem minder 
geactiveerd worden tijdens C. burnetii infectie, bijvoorbeeld het adaptieve immuun 
response welke onder andere T- en B cellen bevat. Daarnaast, zoals we beschrijven 
in Hoofdstuk 5, kunnen individuen polymorphismen in specifieke genen hebben 
die betrokken zijn bij de herkenning van C. burnetii, wat tot een grotere kans van 
de ontwikkeling van chronische Q-koorts leidt. Ook kan C. burnetii zelf strategieën 
bezitten die het mogelijk maken om het immuun systeem van de gastheer te 
omzeilen, zoals beschreven is bij vele andere micro-organismen[14].  
De vol bloed IFN-γ assay in geiten liet een hoger IFN-γ response zien in drachtige 
geiten experimenteel geïnfecteerd met C. burnetii dan naïeve geiten (Hoofstuk 6). 
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Omdat C. burnetii is geclassificeerd als een groep B bioterrorisme agent, moeten 
experimenten met levende bacteriën worden uitgevoerd in een level 3 laboratorium. 
Zo ver we weten, zijn er geen studies gepubliceerd die levende en hitte geïnac-
tiveerde C.  burnetii vergelijken in relatie tot het effect op cytokine response en 
herkenning door PRRs. We hebben besloten om hitte geïnactiveerde C. burnetii te 
gebruiken in onze studies vanwege twee redenen. Ten eerste onderzochten we de 
initiële herkenning van C. burnetii: zorgt stimulatie van humane en geiten PBMCs 
met C. burnetii voor een cytokine response en welke PRRs van deze PBMCs zijn 
betrokken bij de herkenning? We hebben niet gekeken naar de replicatie of bewe-
ging van C. burnetii in de immuun cellen. Daarnaast was het een praktische over-
weging, door het gebruik van hitte geïnactiveerde C. burnetii konden we gebruik 
maken van één batch voor alle experimenten in dit proefschrift. Het is mogelijk dat 
onze bevindingen niet overeenkomen met levende C. burnetii, omdat de hitte inac-
tivatie de antigenen expositie op de bacteriën kunnen veranderen en de interactie 
met het immuun system kan beïnvloeden. In andere studies is de rol van TLR2 
in C. burnetii herkenning bijvoorbeeld onderzocht door TLR2 specifieke knock out 
muizen te infecteren met levend C. burnetii. De belangrijke rol van TLR2 was zowel 
gedemonstreerd in deze studies als in onze eigen studie, wat aantoont dat er geen 
verschil was tussen het gebruik van levens of hitte geïnactiveerd C. burnetii[9, 10, 
22]. Ook werden zowel levend als hitte geïnactiveerd C. burnetii gebruikt in humane 
cytokine studies, zodat we onze huidige bevindingen kunnen vergelijken[19, 23].  
In de studies uitgevoerd voor dit proefschrift hebben we gebruik gemaakt van 
zowel C. burnetii NM RSA 493 en de Nederlandse uitbraak stam C. burnetii 3262. 
We hebben gekozen voor deze twee stammen, omdat de eerste de referentie stam 
is die ook wordt gebruikt in andere laboratoria. De tweede stam was verantwoorde-
lijk voor de Q-koorts uitbraak in Nederland, wat leidde tot het ruimen van veel geiten 
en acute en chronische Q-koorts infecties in mensen. Zoals vermeld in de boven-
staande samenvatting, hebben we enkele verschillen gevonden tussen deze twee 
stammen. Een veel gestelde vraag is wat deze verschillen veroorzaakt en of we 
kunnen speculeren over een verschillende gen expressie van deze twee stammen. 
Op dit moment is de enige vergelijking die we kunnen maken gebaseerd op het MLVA 
genotype, welke inderdaad verschilt op verschillende loci. Meer informatie over de 
genetische achtergrond zal beschikbaar komen wanneer de de novo sequence van 
de Nederlandse uitbraakstam C. burnetii 3262 wordt gepubliceerd. Genoom verge-
een verhoogd IL-10 response in chronische Q-koorts patiënten[7, 19]. Deze verschil-
len in IL-10 kunnen de diverse klinische ziektebeelden tijdens C. burnetii infectie 
in geiten en mensen verklaren. Al moet er rekening mee worden gehouden dat de 
experimentele set-up verschillend is tussen de twee groepen. Als eerste zijn de 
geiten in onze studie experimenteel geïnfecteerd met C. burnetii, terwijl de chroni-
sche Q-koorts patiënten op natuurlijke wijze zijn geïnfecteerd. Daarnaast hebben 
we in geiten vooral de mRNA expressie gemeten van cytokines, terwijl de humane 
studies met name zijn gericht op eiwit expressie. mRNA expressie komt niet altijd 
overeen met de daadwerkelijke hoeveelheid van geproduceerde eiwitten. Een ander 
verschil binnen de studies is dat de geiten drachtig waren. Dracht is een vereiste 
voor geiten om klinische Q-koorts te ontwikkelen, aangezien niet drachtige geiten 
geen symptomen van infectie laten zien. Tot recentelijk werd zwangerschap in 
mensen gezien als een risico factor voor de ontwikkeling van chronische Q-koorts. 
Maar studies tijdens de Nederlandse Q-koorts uitbraak laten geen duidelijke 
associatie zien tussen een verhoogde kans op chronische Q-koorts en zwanger-
schap[20, 21]. Gebaseerd op bovenstaande genoemde verschillen en overeenkom-
sten tussen het immuun response van geiten en mensen tegen C. burnetii is het 
moeilijk te beantwoorden of het immuun response vergelijkbaar is. Het zijn twee 
onafhankelijk modellen, welke gebruikt kunnen worden om vragen te beantwoor-
den gerelateerd aan hun eigen milieu en achtergrond situatie. Alhoewel, uit onze 
aanpak om in beide modellen het immuun response tegen C.  burnetii te onder-
zoeken, kunnen we concluderen dat C. burnetii op zichzelf in staat in een immuun 
response te initiëren en dat het wordt herkend in zowel geiten als mensen. We raden 
aan dat de toekomstige studies betreffende het C. burnetii geïnduceerd immuun 
response in mensen zich richten op in vitro studies met humane immuun cellen 
en we verwachten dat veel meer informatie uit genetische studies met Q-koorts 
patiënten kan worden gehaald. Onderzoeken die zich richten op C. burnetii infectie 
en het immuun response in geiten en andere dierlijke gastheren zijn belangrijk en 
moeten niet worden genegeerd. Vanwege de huidige intensieve veehouderij en het 
feit dat mensen en vee dichter op elkaar leven, kunnen mogelijke uitbraken worden 
verwacht wanneer de beschermende vaccinatie van geiten achterwegen wordt 
gelaten. Meer kennis over de epidemiologie, transmissie en immuun reacties in 
de dierlijke gastheren wordt gewaardeerd en is bruikbaar om nieuwe uitbraken te 
voorkomen en om de huidige diagnostiek en behandeling te verbeteren.
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teerde individuen een effectiever immuun response (waarschijnlijk resulterend in 
geen of milde kliniek) hebben tegen C. burnetii isolaten afkomstig van runderen. 
Met het oog op geïnfecteerde individuen kan er wellicht specifieke serodiagnos-
tiek worden ontwikkelt om de herkomst van het C. burnetii isolaat te bepalen en 
vervolgens te relateren aan de virulentie en de kans om een chronische infectie 
te veroorzaken. Als het namelijk mogelijk is om deze host afhankelijke virulentie 
factoren te karakteriseren, kunnen diagnostische testen worden ontwikkeld die de 
herkomst van de C. burnetii isolaten kunnen bepalen en het verwachtte klinische 
ziekte verloop in mensen vaststellen. 
Een van de onderzoeksvragen van dit proefschrift was om de immuun herken-
ning en response in drachtige geiten te onderzoeken en te beantwoorden waarom 
C. burnetii infectie kan leiden tot abortus zonder andere klinische symptomen. We 
vonden dat geiten een pro-inflammatoire cytokine response induceren na stimula-
tie met C. burnetii en dat de mRNA van TLRs ook is verhoogd. Het lijkt er op dat het 
immuun systeem van geiten in staat is goed te reageren tegen C. burnetii, zowel 
het humorale als cellulaire response[12, 13]. Onze studie toonde aan dat tijdens 
de eerste week van infectie van drachtige geiten, de IFN- γ productie was vermin-
derd[13](Hoofdstuk 6). 
Er kan gesuggereerd worden dat C. burnetii de IFN-γ responses in het begin van de 
infectie onderdrukt, wat het voor de bacterie mogelijk maakt om getransporteerd 
te worden naar de throfoblasten in de placenta zonder herkend te worden door het 
immuun systeem. Maar, er is meer onderzoek nodig om de vraag te beantwoorden 
hoe C. burnetii infectie uiteindelijk kan leiden tot abortus en doodgeborene. Bijvoor-
beeld de rol van IFN-γ op de replicatie en overleving van C. burnetii kan worden 
onderzocht. Vanuit de literatuur is het bekend dat IFN-γ de eliminatie van C. burnetii 
faciliteert, maar deze experimenten zijn uitgevoerd met THP-1 (monocyt-achtige) 
cellijnen en niet in cellen die meer specifiek gerelateerd zijn aan de placenta[25, 
26]. Daarnaast hangt een succesvolle zwangerschap grotendeels af van mechanis-
men die het immuun systeem van de moeder tolerant maken tegen de semi-allo-
geneic foetus. Het effect van C. burnetii op immunomodulatoren zoals arginase en 
thryptophan tijdens de zwangerschap zijn nog niet onderzocht en kunnen nieuwe 
inzichten geven. 
lijking tussen C. burnetii NM en C. burnetii 3262 zou verschillen kunnen aantonen 
in genetische delen die corresponderen voor virulentie factoren zoals LPS of eiwit-
ten. Daarnaast zou het gebruikt kunnen worden om mogelijke veranderingen, zoals 
polymorphisms in genen die coderen voor PRRs, te vergelijken. 
C.  burnetii 3262 representeert de CBNL01 MLVA genotype, welke domineerde 
tijdens de Q-koorts uitbraak in Nederland en verantwoordelijk was voor de grootste 
Q-koorts uitbraak wereldwijd ooit gerapporteerd. Naast dat individuen een hogere 
kans hebben om in aanraking te komen met dit pathogeen vanwege de intensieve 
veehouderij[24], kan er ook gehypothetiseerd worden dat deze stam minder goed 
herkend wordt door PRRs. Een mindere herkenning van C. burnetii 3262 kan vervol-
gens leiden tot minder reacties zoals de inductie van pro-inflammatoire cytokines, 
fagocytose en de eliminatie van bacteriën. Uiteindelijk kan dit de meer infectieuze 
en ziekte veroorzakende kenmerken van C.  burnetii 3262 verklaren. Maar onze 
resultaten laten zien dat C. burnetii 3262 in staat is een adequate immuun response 
te induceren in PBMCs en herkend wordt door TLR1, TLR2, en in tegenstelling tot 
C.  burnetii NM, ook TLR6. Daarom kunnen we concluderen dat een veranderde 
herkenning door PRRs van C. burnetii een minder aannemelijke hypothese is.
Een interessante bevinding is dat het cytokine profiel van C. burnetii isolaten afkom-
stig van runderen, welke een hoog pro-inflammatoire cytokine response produce-
ren in humane PBMCs dan isolaten afkomstig van mensen, schapen of geiten. Het 
is niet bekend wat deze runder isolaten minder virulent maakt. Wellicht bevatten 
zij minder escape strategieën of hebben zij een minder stimulerend LPS of andere 
oppervlakte antigenen, wat een beter immuun response van de gastheer moge-
lijk maakt. Structurele vergelijking van de isolaten of in vivo studies kunnen meer 
antwoorden geven. De bevinden van deze studie kunnen ook gebruikt worden om 
potentiele Q-koorts uitbraken te voorspellen. We weten uit de literatuur dat geïn-
fecteerde runderen minder vaak de oorzaak zijn van Q-koorts infecties in mensen. 
Onze studie relateert hieraan, en laat zien dat het humane immuun systeem met een 
hoge pro-inflammatoire cytokine response produceert na contact met C. burnetii 
isolaten uit runderen. Tijdens de Nederlandse Q-koorts uitbraak zijn er veel geiten 
geruimd omdat zij een potentiele bron waren voor humane infectie. Uit onze studie 
kan er echter geconcludeerd worden dat tijdens een mogelijke Q-koorts uitbraak 
onder runderen er minder reden is om deze dieren te ruimen, aangezien geïnfec-
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Aanbevelingen en toekomstperspectieven 
De resultaten die we in deze thesis beschrijven dragen bij aan het beantwoorden 
van een breed arsenaal van vragen en knowledge gaps in Q-koorts infecties. We 
hebben meer informatie verkregen over de immuun reactie tegen C. burnetii infec-
ties in mensen en geiten, en onze bevindingen zijn nuttig voor andere onderzoekers 
in het Q-koorts veld en toekomstige onderzoeken, zowel in het veterinaire als het 
humane veld. Uiteindelijk zal een beter begrip van het immunologische response 
tegen C. burnetii kunnen leiden tot betere diagnostische testen voor mensen en 
dieren, en behandelingen voor patiënten met Q-koorts. 
Een van de problemen binnen de diagnostiek van C. burnetii infectie in geiten is 
om te bepalen of een geit een actieve of een doorgemaakte infectie heeft. Onze 
studie laat zien dat geiten in staat zijn een pro-inflammatoire cytokine response 
te induceren na contact met C. burnetii. Voor vroege diagnostiek van C. burnetii in 
geiten is het wellicht mogelijk om specifiek geïnduceerd IFN-γ te meten in volbloed, 
aangezien geïnfecteerde geiten aanzienlijk minder IFN-γ induceren (Hoofdstuk 6). 
Al moeten deze eventuele mogelijkheden wel verder worden onderzocht voor dit 
doeleinde. 
In dit proefschrift tonen we aan dat individuen met een specifieke SNPs in MyD88, 
NOD2 of TLR1 een grotere kans hebben om chronische Q-koorts te ontwikkelen 
(Hoofdstuk 5). Deze bevindingen kunnen worden geïmplementeerd in de diagnose 
van chronische Q-koorts en maakt het wellicht mogelijk om individuen met een 
grotere aanleg voor de ontwikkeling van chronische Q-koorts in een vroeg stadium 
te ontdekken. Wanneer we weten dat een patiënt met acute Q-koorts en risicofacto-
ren voor het ontwikkelingen van chronische Q-koorts zulke mutaties bijdraagt, kan 
er vroegtijdig met preventieve behandeling worden gestart. Een ander voordeel van 
de genetische studie die we hebben uitgevoerd is de beschikbaarheid van een grote 
collectie DNA samples van chronische Q-koorts patienten en gematchte controles. 
De ruim 140 verzamelde samples van chronische Q-koorts patiënten is de groot-
ste in zijn soort en erg waardevol voor toekomstige studies. In de huidige studies 
hebben we alleen het effect van genetische variatie onderzocht binnen specifieke 
receptoren naar de ontwikkeling van chronische Q-koorts. Het is interessant om in 
Een van de laatste vragen die overblijft is waarom infectie met C.  burnetii in 
sommige geïnfecteerde personen tot een chronische infectie leidt. Mijn inziens 
kan het antwoord op deze vraag slechts deels gevonden worden in het immuun 
response van de gastheer. Het is een combinatie van verschillende factoren, waar-
onder de initiële dosis van C. burnetii tijdens infectie, de virulentie en de herkomst 
van het C. burnetii isolaat, en de immuun status, aanwezige of aanleg voor vascu-
laire factoren en de genetische achtergrond van de geïnfecteerde individu. Er zijn 
nog veel mogelijkheden die kunnen worden onderzocht in de toekomst, waarbij 
men rekening zal moeten houden met al deze aspecten.
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